data_6j3l_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6j3l _Structure_validation_residue.Date_analyzed 2019-08-30 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -138.43 130.12 15.73 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.747 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.44 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 9.5 Cg_endo -54.22 122.89 12.28 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.541 2.827 . . . . 0.0 112.959 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 120.42 -25.81 7.21 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.616 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.71 147.36 35.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.94 0.4 . . . . 0.0 110.613 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.6 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 48.3 mm -81.44 143.47 12.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.964 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -85.03 103.74 3.76 Favored Pre-proline 0 C--N 1.328 -0.334 0 O-C-N 123.485 0.491 . . . . 0.0 110.569 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.6 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 3.3 Cg_exo -79.91 -30.45 2.26 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.879 2.386 . . . . 0.0 113.018 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -110.65 165.93 11.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.146 0.498 . . . . 0.0 111.556 -173.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.3 m -92.72 84.76 5.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.634 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 21.1 t -82.58 134.32 27.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.523 -176.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 53.9 t -126.88 125.16 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.57 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.464 HG22 HG13 ' A' ' 154' ' ' ILE . 75.8 mt -82.36 108.16 11.01 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 19.4 Cg_exo -64.66 147.26 89.91 Favored 'Trans proline' 0 CA--C 1.511 -0.643 0 C-N-CA 122.875 2.383 . . . . 0.0 113.614 -171.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.99 81.71 1.21 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.145 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.434 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 48.1 t-80 -168.46 156.11 8.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 0.4 OUTLIER -63.31 132.09 50.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.362 0.601 . . . . 0.0 110.366 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.499 HG23 ' CZ ' ' A' ' 138' ' ' PHE . 77.6 p -83.37 -14.2 53.33 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.439 -172.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.67 -14.67 57.72 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -175.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.456 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 95.2 mt -77.31 149.07 35.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.365 -0.417 . . . . 0.0 110.539 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.67 162.33 34.25 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.617 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.36 -12.25 26.51 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 123.03 2.487 . . . . 0.0 112.689 -174.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.81 -30.36 66.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.787 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.469 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 74.3 mmtt -71.68 -6.37 40.64 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.977 0.418 . . . . 0.0 111.252 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.0 t -65.2 -21.04 66.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.553 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.2 t -65.01 -38.63 91.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.735 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -73.58 -42.48 61.54 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.424 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.56 ' CE2' HD22 ' A' ' 178' ' ' LEU . 86.1 m-85 -59.97 -48.75 80.44 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -65.79 -28.8 69.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.019 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.32 -34.36 77.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.054 0.454 . . . . 0.0 110.179 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.9 18.87 11.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.182 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t 59.81 58.29 2.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.854 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 40.8 mt -115.08 135.66 22.52 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.462 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.422 ' HB2' ' CG1' ' A' ' 155' ' ' ILE . 3.4 Cg_exo -74.59 118.01 5.17 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.037 2.492 . . . . 0.0 111.054 174.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 35.4 p -128.84 152.57 48.35 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -172.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -148.05 147.85 30.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.421 172.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 43.6 mm -84.6 128.51 38.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.89 0.376 . . . . 0.0 110.605 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 45.5 t -99.96 -83.33 0.43 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.277 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -113.36 53.34 0.77 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.955 0.407 . . . . 0.0 110.178 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 70.05 14.11 70.54 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -171.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.2 p -130.65 151.33 51.23 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.501 HD11 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -79.65 128.01 38.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.288 0.566 . . . . 0.0 110.167 -178.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.434 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 37.7 tt0 -116.86 153.93 31.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.536 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.464 HG13 HG22 ' A' ' 123' ' ' ILE . 42.5 mm -99.88 133.05 44.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.737 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 155' ' ' ILE . 16.0 pt -95.06 -34.72 5.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -176.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -122.39 132.13 54.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.057 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -54.96 115.46 2.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.434 0.635 . . . . 0.0 110.456 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 24.5 t -91.51 126.85 44.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.873 -171.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.622 ' O ' ' HE3' ' A' ' 162' ' ' LYS . 10.8 p-80 -80.24 73.87 7.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.432 0.635 . . . . 0.0 109.298 170.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.9 tp -64.94 -50.43 75.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.196 -174.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 15.7 mt -113.23 147.78 36.82 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.429 0.633 . . . . 0.0 110.664 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.622 ' HE3' ' O ' ' A' ' 159' ' ' HIS . 6.6 mptt -127.74 133.32 24.98 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.409 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.56 101.87 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.391 2.061 . . . . 0.0 111.727 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.88 -5.94 12.44 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.772 -175.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -86.32 -173.33 4.49 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -135.49 116.18 13.92 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.694 0.283 . . . . 0.0 110.304 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.7 t -61.26 121.86 10.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.289 -177.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.63 -170.91 46.69 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.969 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -76.27 -63.83 1.24 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.973 0.415 . . . . 0.0 111.669 -175.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.5 m -66.27 -23.94 66.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -70.18 -50.07 43.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.963 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.421 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -56.21 -46.69 79.37 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.289 0.566 . . . . 0.0 110.066 174.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.609 ' O ' ' HG3' ' A' ' 177' ' ' MET . 22.5 m -59.07 -42.17 89.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.585 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.525 HD12 ' CE2' ' A' ' 138' ' ' PHE . 48.9 tp -59.67 -49.11 79.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.708 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.02 -29.27 69.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.241 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -74.53 -33.22 62.71 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.141 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.609 ' HG3' ' O ' ' A' ' 173' ' ' THR . 63.9 mtm -79.33 -26.14 42.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.326 0.584 . . . . 0.0 110.089 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.56 HD22 ' CE2' ' A' ' 138' ' ' PHE . 1.4 mm? -78.28 -15.08 59.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.229 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 . . . . . 0 CA--C 1.521 -0.138 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.543 -178.56 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 120.926 0.394 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -128.97 129.78 23.43 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.567 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 167' ' ' VAL . 10.1 Cg_endo -52.72 122.51 11.08 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.262 2.642 . . . . 0.0 111.561 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 120.72 -18.37 9.23 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 119.946 -1.121 . . . . 0.0 112.017 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.53 143.51 27.68 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.95 0.405 . . . . 0.0 110.597 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.2 mm -80.84 131.73 33.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.965 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -67.37 110.81 5.82 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.203 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -77.24 -32.32 3.14 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.193 2.595 . . . . 0.0 113.433 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 90.5 mt -121.43 160.71 23.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.97 0.414 . . . . 0.0 111.609 -172.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.5 m -83.6 77.41 9.85 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.542 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 31.7 t -70.89 133.86 31.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.778 -176.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 51.1 t -123.74 129.27 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.341 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.449 HG22 HG13 ' A' ' 154' ' ' ILE . 78.7 mt -86.5 108.54 18.29 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 173.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.51 140.08 93.22 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 123.209 2.606 . . . . 0.0 114.079 -171.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.425 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -72.78 85.65 1.23 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.72 175.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.472 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 3.4 t-80 -171.85 176.14 3.69 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -174.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -62.75 137.88 58.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.042 0.448 . . . . 0.0 110.038 173.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.443 HG23 ' CZ ' ' A' ' 138' ' ' PHE . 42.9 p -92.84 -11.11 34.43 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.554 -176.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.81 15.54 80.55 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.291 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 87.7 mt -114.75 152.54 31.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.354 -0.423 . . . . 0.0 110.135 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.15 167.24 51.85 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.925 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.38 6.58 1.13 Allowed 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 123.314 2.676 . . . . 0.0 112.794 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -86.88 -35.0 19.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.697 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.481 ' HE2' ' SD ' ' A' ' 177' ' ' MET . 25.4 mmmt -74.99 -3.05 30.05 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 121.602 0.715 . . . . 0.0 110.783 -172.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.0 t -63.77 -21.8 66.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.008 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.7 p -61.09 -41.2 96.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.882 0.372 . . . . 0.0 109.997 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -70.31 -44.96 67.23 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.497 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.449 ' CE1' HD23 ' A' ' 178' ' ' LEU . 78.3 m-85 -58.69 -46.77 86.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.514 0.673 . . . . 0.0 109.861 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -69.81 -27.15 64.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.198 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.81 -31.91 73.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.996 0.427 . . . . 0.0 110.057 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.42 22.73 5.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.9 t 59.21 43.17 17.44 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.35 174.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.5 mt -102.0 134.01 20.35 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -71.79 108.72 2.49 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.721 2.281 . . . . 0.0 110.937 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.442 HG23 ' CB ' ' A' ' 138' ' ' PHE . 40.8 p -122.68 144.9 48.84 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.108 0.48 . . . . 0.0 112.053 -174.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -140.11 148.93 42.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.836 172.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 38.9 mm -88.0 131.42 35.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.836 0.35 . . . . 0.0 110.45 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.9 t -136.65 124.33 22.41 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.738 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.6 tttp 58.9 37.92 24.59 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.513 0.673 . . . . 0.0 111.022 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 71.34 13.63 73.85 Favored Glycine 0 N--CA 1.454 -0.147 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.069 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.7 p -130.06 151.96 50.04 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.541 HD11 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -77.38 123.62 34.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.303 0.573 . . . . 0.0 109.685 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.472 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 39.4 tt0 -113.42 152.38 30.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.584 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.449 HG13 HG22 ' A' ' 123' ' ' ILE . 46.3 mm -97.16 129.45 47.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.532 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 9.2 pt -92.63 -35.92 7.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.838 0.351 . . . . 0.0 111.887 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -122.53 132.09 54.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.508 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -58.12 114.48 2.4 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.69 0.757 . . . . 0.0 109.818 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.5 t -84.68 127.64 39.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.837 -170.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -82.59 72.76 9.66 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 171.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.407 HG21 HD23 ' A' ' 175' ' ' LEU . 7.2 tp -70.14 -47.14 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.475 -172.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.433 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 17.3 mt -117.01 160.0 21.63 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.286 0.565 . . . . 0.0 110.49 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -157.94 131.07 4.57 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.291 -179.17 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 89.6 Cg_exo -44.85 108.89 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.799 2.999 . . . . 0.0 113.078 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 122.36 -22.27 7.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.109 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -81.85 178.59 8.22 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -126.62 118.46 24.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.722 0.296 . . . . 0.0 110.401 -175.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 26.3 t -59.9 121.58 7.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.709 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.44 -177.2 50.55 Favored Glycine 0 C--O 1.226 -0.394 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.676 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.9 -62.65 1.47 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.897 0.379 . . . . 0.0 111.546 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.2 m -65.51 -24.93 67.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -69.09 -49.43 57.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.138 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.42 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.29 -42.27 90.91 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.18 0.514 . . . . 0.0 110.106 175.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.596 ' O ' ' HG3' ' A' ' 177' ' ' MET . 33.0 m -61.38 -39.17 89.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.738 177.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.424 ' HA ' ' HE3' ' A' ' 177' ' ' MET . 51.8 tp -61.44 -49.06 78.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.52 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.407 HD23 HG21 ' A' ' 160' ' ' ILE . 84.4 mt -71.61 -18.57 62.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -73.48 -42.27 62.08 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.596 ' HG3' ' O ' ' A' ' 173' ' ' THR . 58.2 mtm -71.67 -32.7 68.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.442 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.449 HD23 ' CE1' ' A' ' 138' ' ' PHE . 2.4 mm? -77.49 -16.37 58.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.231 -176.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 121.499 0.666 . . . . 0.0 109.592 -179.374 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.473 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -133.87 133.93 22.72 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.079 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 167' ' ' VAL . 9.3 Cg_endo -54.15 118.52 5.09 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.738 2.959 . . . . 0.0 113.101 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.91 -6.69 15.47 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.025 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.4 145.19 24.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.7 0.286 . . . . 0.0 110.372 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.3 mm -81.45 127.15 39.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.255 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.657 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -58.3 112.33 4.76 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.452 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -73.86 -49.7 0.19 Allowed 'Trans proline' 0 CA--C 1.528 0.176 0 C-N-CA 123.257 2.638 . . . . 0.0 112.88 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 75.4 mt -105.07 159.93 15.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.116 0.484 . . . . 0.0 111.697 -173.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.0 m -85.77 82.26 8.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.517 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 21.9 t -81.59 132.96 30.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.082 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 45.3 t -123.7 128.32 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.978 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.445 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . 58.1 mt -83.78 107.88 11.82 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 17.2 Cg_exo -65.84 137.89 51.04 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 C-N-CA 122.922 2.414 . . . . 0.0 113.728 -170.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -84.04 72.63 10.45 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.122 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -151.79 -56.69 0.14 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.587 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.439 HD21 ' C ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER -177.28 150.29 0.71 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.96 0.41 . . . . 0.0 110.971 175.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.475 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 81.7 p -115.06 -19.27 10.96 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.792 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 77.36 4.35 84.02 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.848 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 93.1 mt -94.82 150.65 19.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.058 0.456 . . . . 0.0 111.159 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -72.39 169.64 51.43 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.862 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.483 ' O ' HG21 ' A' ' 135' ' ' THR . 20.4 Cg_exo -64.95 -17.74 60.26 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.898 2.398 . . . . 0.0 113.167 -173.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -59.21 -36.55 75.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.416 0.627 . . . . 0.0 110.795 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.427 ' HB3' ' CE ' ' A' ' 177' ' ' MET . 70.3 mmtt -71.66 -11.47 60.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.684 -170.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.483 HG21 ' O ' ' A' ' 132' ' ' PRO . 5.1 t -65.76 -21.86 66.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.074 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 26.0 t -62.92 -39.45 94.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -75.84 -40.36 54.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.226 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.494 ' CE2' HD12 ' A' ' 174' ' ' LEU . 71.3 m-85 -59.8 -48.46 81.59 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -66.35 -29.72 69.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.111 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.27 77.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.828 0.347 . . . . 0.0 110.318 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.47 19.6 6.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.2 m 60.14 43.78 13.74 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.617 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 26.5 mt -99.66 133.56 21.72 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.61 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 3.2 Cg_exo -75.8 108.5 2.7 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.853 2.369 . . . . 0.0 110.982 175.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.494 ' CG2' HD13 ' A' ' 152' ' ' ILE . 45.9 p -122.26 164.78 17.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.226 0.536 . . . . 0.0 112.181 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.452 ' HE2' HG22 ' A' ' 155' ' ' ILE . 54.2 pttt -149.93 143.31 25.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.517 173.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 44.1 mm -87.24 110.24 20.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 27.8 p -63.97 -34.52 78.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.775 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -170.64 -67.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.486 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -130.43 4.43 5.88 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 175.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.4 p -125.04 151.67 45.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.536 HD11 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -90.16 130.95 38.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 121.242 0.544 . . . . 0.0 110.046 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.492 ' N ' HD11 ' A' ' 152' ' ' ILE . 40.0 tt0 -123.89 156.43 36.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.276 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.448 HD11 ' CE2' ' A' ' 138' ' ' PHE . 1.9 mp -101.87 137.23 30.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.389 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.512 HD13 HG23 ' A' ' 155' ' ' ILE . 7.9 pt -91.76 -37.19 8.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.877 0.37 . . . . 0.0 111.929 -177.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -121.31 123.86 43.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.01 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -52.24 122.11 8.06 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 123.737 0.648 . . . . 0.0 110.545 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 19.8 t -94.38 126.29 46.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.992 -170.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.435 ' HB3' ' HD2' ' A' ' 162' ' ' LYS . 91.7 m-70 -80.06 76.74 6.79 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 171.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.1 tp -72.72 -42.31 62.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.246 -172.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.553 ' C ' ' HD3' ' A' ' 162' ' ' LYS . 10.1 mt -121.89 142.06 50.65 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.493 0.663 . . . . 0.0 111.876 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.553 ' HD3' ' C ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER -132.62 124.6 19.04 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.705 175.066 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 89.9 Cg_exo -44.0 101.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.279 2.652 . . . . 0.0 112.837 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 130.72 -25.76 4.15 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.058 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.454 ' OD2' ' HB2' ' A' ' 162' ' ' LYS . 3.6 m-20 -76.07 158.5 31.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.853 0.359 . . . . 0.0 111.07 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -98.4 118.69 35.63 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 44.6 t -61.47 126.01 18.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.738 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.58 -178.91 52.09 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.662 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.78 -63.8 1.09 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.894 0.378 . . . . 0.0 111.582 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 36.0 t -63.94 -24.84 67.88 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -68.56 -47.18 67.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.908 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.0 -47.08 86.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.31 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 57.6 m -55.48 -46.52 76.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.422 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.494 HD12 ' CE2' ' A' ' 138' ' ' PHE . 58.3 tp -58.83 -44.48 90.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.108 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.8 mt -68.34 -29.87 68.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.44 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -73.22 -35.1 66.23 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.427 ' CE ' ' HB3' ' A' ' 134' ' ' LYS . 35.9 mtp -66.55 -34.97 79.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.781 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.475 HD22 ' CE2' ' A' ' 138' ' ' PHE . 2.1 mm? -78.3 -9.78 59.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.395 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 . . . . . 0 N--CA 1.465 0.285 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.683 -176.406 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.343 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -133.51 128.74 20.26 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.588 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.447 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 7.4 Cg_endo -51.61 124.26 14.0 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.749 2.966 . . . . 0.0 112.94 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.53 -29.48 6.63 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.648 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.26 146.48 41.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.935 0.398 . . . . 0.0 110.358 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.428 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 42.7 mm -81.7 136.95 22.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.57 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -75.2 109.71 8.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.134 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 10.1 Cg_exo -75.49 -44.66 0.29 Allowed 'Trans proline' 0 CA--C 1.527 0.164 0 C-N-CA 123.186 2.591 . . . . 0.0 113.312 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 91.3 mt -105.08 162.25 13.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.258 0.551 . . . . 0.0 111.916 -172.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.5 m -87.66 83.07 7.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.634 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.2 t -78.7 132.9 31.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.372 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 54.5 t -123.23 131.45 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.442 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.401 ' HB ' ' HB ' ' A' ' 158' ' ' VAL . 75.0 mt -91.46 107.22 20.22 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.65 146.5 95.29 Favored 'Trans proline' 0 CA--C 1.513 -0.555 0 C-N-CA 122.736 2.291 . . . . 0.0 113.085 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.34 78.26 3.1 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.491 -1.232 . . . . 0.0 110.719 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.449 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 6.9 t-80 -167.13 153.43 8.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.94 132.29 46.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.353 0.597 . . . . 0.0 111.661 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.8 p -87.92 -4.8 58.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.424 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.98 4.42 90.52 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -175.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.494 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 87.6 mt -94.64 152.3 18.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.2 -0.5 . . . . 0.0 110.559 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.41 162.68 53.26 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.823 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -57.97 -29.23 85.96 Favored 'Trans proline' 0 C--O 1.224 -0.197 0 C-N-CA 123.021 2.481 . . . . 0.0 112.451 -174.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.49 -31.43 62.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.209 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.494 ' HG3' ' HB3' ' A' ' 130' ' ' LEU . 45.3 mmtm -70.11 -10.45 58.81 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.468 0.651 . . . . 0.0 111.089 -174.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.3 t -67.82 -14.98 63.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.799 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.7 t -64.61 -42.12 95.76 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -72.64 -42.26 64.6 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.939 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.481 ' CE1' HD13 ' A' ' 154' ' ' ILE . 83.2 m-85 -59.67 -47.02 87.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.701 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -65.16 -32.75 74.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.67 -36.14 81.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.579 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.16 21.92 5.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.324 175.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.7 t 59.85 50.66 6.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.47 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 21.9 mt -105.68 133.08 20.36 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.57 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.428 ' HB2' ' CG1' ' A' ' 155' ' ' ILE . 7.5 Cg_exo -72.62 110.82 3.09 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.854 2.37 . . . . 0.0 110.693 174.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.4 p -126.62 155.94 41.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.217 -170.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -145.83 159.21 43.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.762 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 45.0 mm -100.55 102.9 14.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.2 m -80.82 -44.12 18.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.679 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -156.18 60.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.121 0.486 . . . . 0.0 111.413 -176.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 75.1 -3.69 44.39 Favored Glycine 0 C--O 1.229 -0.196 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.459 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.0 p -124.01 154.88 39.22 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.449 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -85.62 129.42 38.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.354 0.597 . . . . 0.0 110.429 -176.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.449 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 33.5 tt0 -127.46 149.18 50.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.624 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.481 HD13 ' CE1' ' A' ' 138' ' ' PHE . 3.0 mp -95.48 140.25 17.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.327 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.428 ' CG1' ' HB2' ' A' ' 144' ' ' PRO . 14.8 pt -96.22 -35.6 5.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -123.19 126.99 48.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.161 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -55.37 121.12 8.25 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.403 0.621 . . . . 0.0 110.35 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.2 t -93.89 124.25 46.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.865 -170.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -78.37 77.96 4.85 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 168.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.4 tp -68.6 -45.99 80.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.411 -172.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.4 mt -114.71 149.07 37.37 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.442 0.639 . . . . 0.0 111.211 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.55 132.13 24.26 Favored Pre-proline 0 C--N 1.315 -0.935 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.729 175.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 9.8 Cg_endo -54.02 100.82 0.07 OUTLIER 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.875 2.384 . . . . 0.0 111.839 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 123.64 -12.39 8.31 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.1 -176.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -82.75 -176.15 6.14 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -128.62 112.59 14.43 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.654 0.264 . . . . 0.0 110.346 -174.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 28.0 t -58.86 123.23 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.98 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.33 -177.42 47.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.98 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.447 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -67.66 -67.66 0.44 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.78 0.324 . . . . 0.0 111.719 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.1 p -63.7 -25.47 68.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.135 0.493 . . . . 0.0 110.187 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -68.22 -47.49 67.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.884 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.435 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -58.99 -45.09 91.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.853 174.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.606 ' O ' ' HG3' ' A' ' 177' ' ' MET . 32.3 m -56.58 -43.59 80.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.691 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 53.8 tp -60.88 -46.9 88.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.651 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.1 mt -71.22 -21.03 62.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.972 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -72.53 -43.72 63.15 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.606 ' HG3' ' O ' ' A' ' 173' ' ' THR . 44.9 mtm -69.24 -31.54 70.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.303 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -76.67 -11.54 59.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.552 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 . . . . . 0 N--CA 1.464 0.265 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.471 -178.24 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.461 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -128.58 127.33 23.58 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.929 -173.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.484 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 16.2 Cg_endo -59.48 121.42 9.85 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 123.229 2.62 . . . . 0.0 112.268 178.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 122.11 -23.02 7.41 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.36 -176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.62 143.71 36.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.861 0.362 . . . . 0.0 110.219 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.3 mm -83.1 129.79 36.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.259 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 118' ' ' PRO . . . -69.68 110.72 7.0 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.222 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 117' ' ' ALA . 6.3 Cg_exo -77.47 -38.34 0.76 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 123.199 2.6 . . . . 0.0 112.955 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 79.2 mt -112.85 160.96 17.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.567 -171.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.0 p -87.89 80.36 7.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.805 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.99 135.07 28.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.742 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 55.2 t -125.72 123.08 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.895 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.46 ' HB ' ' HB ' ' A' ' 158' ' ' VAL . 81.5 mt -81.78 108.88 12.39 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.26 145.39 77.98 Favored 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 122.952 2.435 . . . . 0.0 113.559 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.508 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -73.91 69.94 1.44 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.119 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.577 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 82.3 m-70 -154.04 -175.18 5.26 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -174.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -63.94 137.99 58.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.048 0.451 . . . . 0.0 110.34 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.444 HG23 ' CZ ' ' A' ' 138' ' ' PHE . 66.2 p -98.93 -14.9 19.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.64 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.0 6.3 87.32 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.531 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.464 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 91.2 mt -99.5 151.81 20.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.945 0.402 . . . . 0.0 111.071 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -72.32 167.91 52.87 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.513 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.62 -29.56 88.72 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.611 2.207 . . . . 0.0 112.469 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.73 -22.48 64.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.58 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 34.7 mmtp -76.75 -7.32 55.15 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.148 0.499 . . . . 0.0 110.954 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 5.8 t -67.69 -20.09 65.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.775 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.2 m -64.12 -40.13 95.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -71.7 -42.93 66.78 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.162 0.506 . . . . 0.0 110.284 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.519 ' CE1' HD12 ' A' ' 174' ' ' LEU . 70.1 m-85 -60.67 -48.42 81.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.635 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -63.11 -31.95 73.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.017 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.48 -36.35 82.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.355 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.67 27.01 3.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.569 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.4 t 55.98 52.21 10.89 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.171 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 24.2 mt -108.44 135.79 19.96 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.837 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.498 ' HB2' ' CG1' ' A' ' 155' ' ' ILE . 5.4 Cg_exo -77.73 111.71 3.17 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.059 2.506 . . . . 0.0 111.199 175.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.448 ' CG2' HD12 ' A' ' 152' ' ' ILE . 47.4 p -125.65 163.78 22.02 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.187 0.518 . . . . 0.0 112.017 -172.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -154.22 149.37 26.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.103 170.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 45.0 mm -84.17 116.68 28.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.9 t -71.83 -33.69 68.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.448 -176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -168.27 -70.88 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.015 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -131.48 9.76 5.56 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.6 p -129.57 153.92 47.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.035 -0.582 . . . . 0.0 109.558 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.474 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -89.17 128.33 41.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.242 0.544 . . . . 0.0 110.031 -178.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.577 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 32.5 tt0 -119.96 152.27 37.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.365 0.602 . . . . 0.0 110.517 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.508 ' HB ' ' HA ' ' A' ' 125' ' ' ALA . 34.5 mm -93.31 135.52 27.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.514 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.498 ' CG1' ' HB2' ' A' ' 144' ' ' PRO . 26.1 pt -94.93 -38.34 8.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -124.62 134.02 53.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.794 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -58.27 119.7 7.36 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.521 0.513 . . . . 0.0 110.302 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 18.7 t -90.25 129.91 40.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.002 -171.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.515 ' O ' ' HE3' ' A' ' 162' ' ' LYS . 71.1 m-70 -85.45 75.2 10.23 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 171.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.3 tp -71.02 -48.03 58.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.475 -171.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.5 mt -112.14 148.62 33.61 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.46 0.648 . . . . 0.0 110.806 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 6.3 mptt -128.47 131.51 23.81 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.246 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.64 105.86 0.15 Allowed 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.542 2.161 . . . . 0.0 111.719 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.01 -3.0 22.71 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.953 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -88.07 -175.57 5.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -132.07 112.07 12.03 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 24.6 t -54.13 125.42 8.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.32 -176.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.56 -176.86 48.4 Favored Glycine 0 C--O 1.226 -0.344 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.832 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -70.91 -69.5 0.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.905 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 69.8 m -68.17 -20.93 64.91 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -65.48 -48.22 73.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.523 173.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.439 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.19 -45.81 90.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.303 175.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.595 ' O ' ' HG3' ' A' ' 177' ' ' MET . 28.4 m -58.24 -40.43 81.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.028 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.519 HD12 ' CE1' ' A' ' 138' ' ' PHE . 54.7 tp -63.54 -49.96 71.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.624 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.3 mt -65.6 -23.26 66.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.723 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -74.6 -42.27 58.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.644 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.595 ' HG3' ' O ' ' A' ' 173' ' ' THR . 62.2 mtm -71.49 -31.19 66.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.409 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.84 -9.91 59.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.549 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 10.6 p30 . . . . . 0 N--CA 1.475 0.793 0 O-C-N 124.176 0.922 . . . . 0.0 110.377 -170.572 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.484 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -129.68 128.08 22.98 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.511 -175.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.524 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 10.9 Cg_endo -56.61 118.23 5.04 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.549 2.833 . . . . 0.0 112.935 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.02 -21.04 6.61 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.13 153.5 26.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.862 0.363 . . . . 0.0 110.327 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.408 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 46.5 mm -86.63 135.01 26.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.73 -177.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -75.82 109.62 8.58 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.614 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 6.8 Cg_exo -76.33 -38.12 1.18 Allowed 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 123.125 2.55 . . . . 0.0 113.308 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.5 mt -116.93 167.54 11.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.193 0.52 . . . . 0.0 111.683 -171.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.0 m -87.94 79.17 8.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.823 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.4 t -69.1 134.28 30.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.564 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 43.2 t -123.83 131.52 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.332 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.473 HG23 HG13 ' A' ' 154' ' ' ILE . 88.0 mt -90.36 101.86 4.21 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 122' ' ' VAL . 29.8 Cg_exo -61.81 141.93 91.88 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.506 2.804 . . . . 0.0 114.172 -170.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.446 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -71.78 84.67 0.92 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.903 -1.499 . . . . 0.0 112.53 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.531 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 7.6 p80 -175.52 179.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -57.13 135.89 56.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.0 0.429 . . . . 0.0 110.654 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.6 p -94.57 -4.84 47.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.215 0.531 . . . . 0.0 110.717 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.49 2.49 89.61 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.434 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.2 mt -93.82 150.76 20.1 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.469 -0.365 . . . . 0.0 110.315 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.41 162.61 54.25 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.465 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 150' ' ' GLY . 52.1 Cg_exo -53.54 -28.43 45.38 Favored 'Trans proline' 0 C--O 1.225 -0.173 0 C-N-CA 123.074 2.516 . . . . 0.0 112.909 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -55.31 -33.01 62.91 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.521 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 68.4 mmtt -71.57 -7.85 50.29 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.225 0.536 . . . . 0.0 110.976 -174.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 4.4 t -65.95 -21.91 66.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.993 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.7 t -63.67 -39.12 93.54 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -73.09 -42.82 62.59 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.359 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.526 ' CE2' HD12 ' A' ' 154' ' ' ILE . 71.9 m-85 -59.41 -49.37 78.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.43 0.633 . . . . 0.0 109.406 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -66.5 -28.94 68.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.304 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.05 -39.78 93.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.974 0.416 . . . . 0.0 110.125 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.78 23.55 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.149 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 40.0 m 58.65 50.4 9.0 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.996 174.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 35.5 mt -105.72 133.32 20.25 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.629 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.434 ' HB2' ' CG1' ' A' ' 155' ' ' ILE . 6.7 Cg_exo -71.96 119.18 6.02 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.997 2.465 . . . . 0.0 110.845 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 38.2 p -127.46 148.96 50.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -169.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.515 ' HD3' HG23 ' A' ' 155' ' ' ILE . 11.5 mtpp -149.64 139.89 22.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.76 174.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 50.4 mm -81.48 121.73 35.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.067 0.461 . . . . 0.0 110.747 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 14.2 t -76.85 -66.17 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.232 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -158.51 81.76 0.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.462 0.648 . . . . 0.0 110.229 174.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.48 ' O ' ' HD3' ' A' ' 132' ' ' PRO . . . 69.26 17.22 71.99 Favored Glycine 0 CA--C 1.511 -0.185 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -173.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.6 p -139.18 149.91 44.97 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.486 HD11 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -90.75 125.7 43.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.339 0.59 . . . . 0.0 109.624 179.12 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.531 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 26.0 tt0 -116.03 148.83 39.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.687 0.756 . . . . 0.0 111.065 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.526 HD12 ' CE2' ' A' ' 138' ' ' PHE . 38.6 mm -92.37 132.28 37.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.155 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.515 HG23 ' HD3' ' A' ' 146' ' ' LYS . 32.4 pt -97.51 -37.38 6.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.874 0.368 . . . . 0.0 111.772 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -119.78 127.83 53.16 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -53.76 116.68 2.64 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.345 0.403 . . . . 0.0 110.116 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.7 t -88.43 129.69 39.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -172.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -83.44 72.94 10.22 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.422 HG23 HD21 ' A' ' 175' ' ' LEU . 6.6 tp -66.55 -54.67 23.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.596 -171.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 16.1 mt -108.26 151.76 25.53 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.335 0.588 . . . . 0.0 111.081 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 9.5 mptt -130.37 133.24 24.66 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.034 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 76.6 Cg_exo -51.32 103.81 0.08 OUTLIER 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.01 2.473 . . . . 0.0 112.38 176.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.99 -13.11 10.59 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.14 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -81.73 -179.86 7.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -128.11 117.04 20.9 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 21.5 t -52.51 122.44 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.248 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -82.6 -179.41 52.74 Favored Glycine 0 C--O 1.228 -0.257 0 CA-C-N 116.027 -0.533 . . . . 0.0 113.107 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -70.11 -70.33 0.3 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.759 0.314 . . . . 0.0 111.37 -177.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 41.0 m -67.72 -21.25 65.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.054 0.454 . . . . 0.0 110.132 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -66.56 -46.26 76.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.661 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.461 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -63.08 -44.65 95.16 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.192 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.571 ' O ' ' HG3' ' A' ' 177' ' ' MET . 14.9 m -54.93 -47.14 74.81 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.087 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.672 ' O ' HD23 ' A' ' 178' ' ' LEU . 37.3 tp -54.98 -60.96 2.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.626 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.512 ' HA ' ' CD2' ' A' ' 178' ' ' LEU . 73.1 mt -59.26 -26.74 65.18 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.553 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -70.04 -42.47 72.87 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.571 ' HG3' ' O ' ' A' ' 173' ' ' THR . 55.5 mtm -68.14 -32.17 72.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.11 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 174' ' ' LEU . 0.1 OUTLIER -68.9 -21.27 64.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.885 176.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 4.6 t30 . . . . . 0 C--O 1.231 0.116 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.534 -176.466 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.423 0 CA-C-O 120.863 0.363 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.403 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 5.9 tmm_? -129.76 127.2 22.84 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.303 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.473 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 9.9 Cg_endo -53.85 116.27 2.9 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.525 2.817 . . . . 0.0 112.597 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.2 -26.28 4.2 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.44 152.34 34.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.845 0.355 . . . . 0.0 110.646 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.402 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 51.2 mm -87.09 130.8 36.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.391 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -69.64 110.2 6.02 Favored Pre-proline 0 C--N 1.328 -0.345 0 O-C-N 123.589 0.556 . . . . 0.0 110.899 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.464 ' HB2' HD21 ' A' ' 119' ' ' LEU . 4.2 Cg_exo -79.83 -28.82 3.08 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 123.27 2.647 . . . . 0.0 113.62 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.464 HD21 ' HB2' ' A' ' 118' ' ' PRO . 2.4 mm? -116.43 160.25 20.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.153 0.501 . . . . 0.0 111.727 -174.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.2 m -84.57 71.24 10.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.599 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 21.9 t -64.73 136.49 26.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.022 -175.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 45.1 t -124.27 130.88 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.837 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 75.2 mt -88.48 107.01 14.38 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.485 ' HB2' ' CD2' ' A' ' 126' ' ' HIS . 24.3 Cg_exo -63.15 140.25 76.99 Favored 'Trans proline' 0 CA--C 1.518 -0.313 0 C-N-CA 122.935 2.424 . . . . 0.0 112.95 -174.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.78 83.15 2.74 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.168 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.529 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 32.1 p80 -166.88 169.92 12.72 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -55.85 135.54 51.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.139 0.495 . . . . 0.0 110.746 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.0 p -95.68 -2.6 47.7 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.286 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 73.5 6.44 70.75 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.715 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.487 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 96.3 mt -92.34 156.04 17.51 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.617 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.63 151.97 45.95 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.17 -27.63 66.65 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.846 -174.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.64 -25.14 66.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.214 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.543 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 74.3 mmtt -67.01 -9.81 42.95 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.063 0.459 . . . . 0.0 111.095 -177.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.453 ' HB ' HG13 ' A' ' 152' ' ' ILE . 12.9 t -65.56 -20.91 66.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.905 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.1 t -65.09 -36.22 83.62 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -75.0 -44.34 48.69 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.327 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.619 ' CE1' HD13 ' A' ' 154' ' ' ILE . 85.0 m-85 -59.58 -49.44 77.76 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -64.48 -30.9 71.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.837 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.93 82.7 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.955 0.407 . . . . 0.0 110.195 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -93.13 26.15 2.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.381 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.2 m 58.59 41.08 22.86 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.066 174.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 27.8 mt -97.3 133.35 23.99 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.796 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.448 ' O ' HG12 ' A' ' 155' ' ' ILE . 4.7 Cg_exo -73.06 107.15 2.3 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.977 2.451 . . . . 0.0 111.106 174.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.442 HG23 ' CB ' ' A' ' 138' ' ' PHE . 43.1 p -124.78 171.51 10.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.249 0.547 . . . . 0.0 112.445 -173.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.422 ' HE3' HG22 ' A' ' 155' ' ' ILE . 21.4 pttp -165.36 163.8 19.81 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.747 173.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 41.0 mm -101.56 125.69 55.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.7 m -73.46 -44.69 57.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.565 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 149' ' ' LYS . 0.1 OUTLIER -163.3 -58.73 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.686 178.082 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -136.43 4.86 3.77 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.018 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.1 p -129.74 149.93 51.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.514 HD12 ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -85.25 130.36 36.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.268 0.556 . . . . 0.0 110.041 -178.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.529 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 30.0 tt0 -120.19 149.82 41.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.157 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.619 HD13 ' CE1' ' A' ' 138' ' ' PHE . 2.9 mp -97.64 136.98 26.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.898 176.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 144' ' ' PRO . 13.4 pt -95.62 -35.27 5.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.003 0.43 . . . . 0.0 111.893 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -122.46 125.23 45.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.108 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -51.8 123.14 9.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.313 0.578 . . . . 0.0 110.523 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 12.0 t -95.94 130.04 45.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.401 -168.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.458 ' O ' ' HE3' ' A' ' 162' ' ' LYS . 37.7 m80 -79.15 71.33 5.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 168.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.0 tp -63.25 -49.42 83.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.223 -173.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 13.8 mt -112.3 156.19 22.83 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.303 0.573 . . . . 0.0 111.176 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.46 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 7.7 mptt -132.46 132.22 22.68 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.631 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 10.7 Cg_endo -55.86 96.01 0.05 OUTLIER 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.766 2.311 . . . . 0.0 112.024 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 129.71 -13.41 5.85 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.95 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -84.46 153.93 23.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -97.5 107.59 20.13 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 54.8 t -46.72 124.5 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 O-C-N 123.861 0.725 . . . . 0.0 111.945 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.75 -179.29 50.21 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.207 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.473 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -70.84 -68.33 0.44 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.773 0.32 . . . . 0.0 111.598 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.8 m -61.82 -25.05 67.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.355 0.598 . . . . 0.0 109.679 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -69.73 -48.75 58.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.354 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.449 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -60.47 -44.19 96.16 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.246 176.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.655 ' O ' ' HG3' ' A' ' 177' ' ' MET . 27.0 m -59.76 -40.93 89.82 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.544 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.502 HD11 ' CE1' ' A' ' 138' ' ' PHE . 36.5 tp -60.32 -49.08 79.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.823 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 83.3 mt -64.63 -30.22 71.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.906 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -70.05 -42.73 72.49 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.329 0.585 . . . . 0.0 109.616 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.655 ' HG3' ' O ' ' A' ' 173' ' ' THR . 60.3 mtm -71.11 -28.56 64.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.425 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.476 HD22 ' CZ ' ' A' ' 138' ' ' PHE . 0.9 OUTLIER -78.97 -15.3 58.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.654 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 . . . . . 0 N--CA 1.461 0.12 0 O-C-N 123.958 0.786 . . . . 0.0 109.74 -177.782 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.451 0 CA-C-O 121.087 0.47 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -130.38 127.66 22.5 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.614 -174.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.447 ' HD3' ' CB ' ' A' ' 172' ' ' ALA . 26.0 Cg_endo -62.92 143.01 90.53 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.323 2.682 . . . . 0.0 112.552 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.98 -12.86 26.84 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.061 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.0 153.08 17.96 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.711 0.291 . . . . 0.0 110.571 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.7 mm -85.58 126.94 40.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.097 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -60.6 110.27 2.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 123.845 0.716 . . . . 0.0 111.387 -177.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -74.38 -46.69 0.27 Allowed 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 123.146 2.564 . . . . 0.0 112.578 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 91.0 mt -106.88 159.96 15.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.217 -173.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.8 t -85.02 75.72 10.35 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 25.9 t -63.88 134.98 28.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.359 -1.291 . . . . 0.0 110.671 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 46.5 t -125.1 129.04 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.519 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.461 HG22 HG13 ' A' ' 154' ' ' ILE . 75.8 mt -86.51 101.31 1.92 Allowed Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -71.18 137.18 30.86 Favored 'Trans proline' 0 CA--C 1.514 -0.484 0 C-N-CA 123.118 2.546 . . . . 0.0 114.318 -168.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.33 92.79 3.37 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.841 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -158.78 -50.53 0.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.238 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 173.57 150.19 0.07 Allowed 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.411 HG23 ' CZ ' ' A' ' 138' ' ' PHE . 71.0 p -110.54 -30.22 7.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.085 0.469 . . . . 0.0 110.639 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.81 2.85 88.43 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.464 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 94.4 mt -96.49 155.22 16.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.047 0.451 . . . . 0.0 110.789 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.89 174.3 54.88 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.567 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.442 ' O ' HG22 ' A' ' 135' ' ' THR . 20.6 Cg_exo -65.34 -19.14 61.77 Favored 'Trans proline' 0 N--CA 1.466 -0.144 0 C-N-CA 122.877 2.385 . . . . 0.0 112.966 -173.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.65 -27.87 66.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.957 0.408 . . . . 0.0 111.071 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.523 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 34.4 mmtp -73.32 -6.82 48.54 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.057 0.456 . . . . 0.0 111.44 -175.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 132' ' ' PRO . 6.1 t -66.47 -20.49 66.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.865 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.1 t -62.32 -42.2 99.18 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -70.52 -46.4 63.71 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.308 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.573 ' CE2' HD21 ' A' ' 178' ' ' LEU . 74.4 m-85 -58.63 -47.33 84.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.301 0.572 . . . . 0.0 109.547 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -68.75 -25.64 64.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.436 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.31 -33.18 75.16 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.162 0.506 . . . . 0.0 109.945 176.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -98.78 26.35 5.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.073 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.9 t 55.69 55.16 7.43 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.687 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 39.8 mt -112.6 135.54 21.52 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.037 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 2.8 Cg_exo -74.38 117.42 4.97 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.008 2.472 . . . . 0.0 111.079 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.485 ' CG2' HD12 ' A' ' 152' ' ' ILE . 40.7 p -131.43 148.62 52.67 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.802 -172.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -138.74 137.67 36.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.087 174.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 48.1 mm -83.63 109.18 16.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.1 p -74.86 -72.34 0.3 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.025 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -145.19 80.16 1.6 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.949 0.404 . . . . 0.0 110.153 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.57 -0.09 56.93 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.35 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.7 p -128.22 150.24 50.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.491 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -90.51 124.35 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.208 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.463 ' N ' HD13 ' A' ' 152' ' ' ILE . 33.8 tt0 -116.97 154.56 30.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.365 0.603 . . . . 0.0 110.508 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.503 HD12 ' CE2' ' A' ' 138' ' ' PHE . 48.2 mm -96.14 131.07 43.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.424 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.423 HD13 HG22 ' A' ' 155' ' ' ILE . 13.5 pt -94.49 -37.81 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.008 0.432 . . . . 0.0 111.714 -175.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -121.13 128.55 52.65 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -60.16 126.2 26.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.312 0.577 . . . . 0.0 109.475 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 20.8 t -99.92 128.62 51.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.402 -169.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -75.48 73.44 2.52 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 167.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.8 tp -64.93 -42.58 95.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.826 -175.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.4 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 15.6 mt -118.46 155.15 31.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.191 0.52 . . . . 0.0 110.176 175.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.494 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -149.4 130.87 7.36 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.409 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 81.2 Cg_exo -44.87 106.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.566 2.844 . . . . 0.0 112.835 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 127.96 -22.59 5.4 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.237 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -85.66 153.7 22.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.653 0.264 . . . . 0.0 110.374 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -102.09 111.86 24.29 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 56.4 t -49.14 123.41 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.5 0 O-C-N 123.955 0.784 . . . . 0.0 111.858 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.32 177.42 51.7 Favored Glycine 0 CA--C 1.519 0.291 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.094 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.94 -65.88 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.915 0.388 . . . . 0.0 111.774 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 49.8 m -65.55 -24.15 67.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.201 0.524 . . . . 0.0 109.829 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.1 -50.2 62.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.016 177.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.447 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -60.94 -39.67 90.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.309 175.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.546 ' O ' ' HG3' ' A' ' 177' ' ' MET . 49.9 m -60.23 -44.08 95.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.549 177.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.499 HD12 ' CE2' ' A' ' 138' ' ' PHE . 48.2 tp -60.34 -49.88 75.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.386 177.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 87.4 mt -61.82 -30.24 70.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.368 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -72.11 -42.81 65.66 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.546 ' HG3' ' O ' ' A' ' 173' ' ' THR . 63.2 mtm -67.07 -32.91 74.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.703 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.573 HD21 ' CE2' ' A' ' 138' ' ' PHE . 2.7 mm? -72.96 -11.93 60.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.732 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 CA--C 1.532 0.255 0 CA-C-O 121.528 0.68 . . . . 0.0 109.8 -178.584 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -129.2 128.86 23.3 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.004 -173.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.548 ' HA ' ' O ' ' A' ' 167' ' ' VAL . 10.1 Cg_endo -54.59 126.19 21.53 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.496 2.797 . . . . 0.0 112.653 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 116.5 -23.6 10.25 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.695 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.8 140.25 38.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.81 131.5 34.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.675 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -65.09 110.27 4.01 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.814 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.93 -37.79 3.38 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.942 2.428 . . . . 0.0 112.637 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.9 mt -119.46 160.02 23.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.331 -173.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.3 t -86.32 77.03 9.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.801 0.81 . . . . 0.0 108.949 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.81 134.75 29.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.759 -176.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 59.3 t -125.71 121.66 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.38 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 158' ' ' VAL . 47.8 mt -79.23 106.38 4.45 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.424 ' HB2' ' CE1' ' A' ' 126' ' ' HIS . 16.2 Cg_exo -66.3 145.48 78.02 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.995 2.463 . . . . 0.0 113.461 -170.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.416 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -73.01 82.39 1.23 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.335 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.484 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 1.6 p-80 -174.72 179.32 1.71 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.415 175.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -55.61 135.75 50.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.988 0.423 . . . . 0.0 110.595 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.7 p -96.38 -2.41 45.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.008 0.432 . . . . 0.0 111.425 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 76.69 19.98 77.09 Favored Glycine 0 N--CA 1.453 -0.208 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.6 mt -116.08 147.97 40.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.315 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.55 168.27 54.58 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.897 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.05 14.53 0.27 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 123.349 2.7 . . . . 0.0 113.637 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -90.41 -31.64 16.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.437 0.637 . . . . 0.0 109.769 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.476 ' HB3' ' SD ' ' A' ' 177' ' ' MET . 47.3 mmtm -72.88 -11.04 60.44 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.823 -175.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 15.3 t -64.8 -22.5 67.0 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.634 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.0 p -63.43 -37.26 86.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.001 0.429 . . . . 0.0 109.937 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.543 ' CD1' ' HE2' ' A' ' 177' ' ' MET . 94.8 m-85 -76.02 -42.43 47.99 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.22 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.579 ' CE2' HD11 ' A' ' 174' ' ' LEU . 76.2 m-85 -59.12 -51.03 71.78 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 121.448 0.642 . . . . 0.0 109.391 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -65.91 -30.38 70.96 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.244 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.18 98.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.477 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -86.33 23.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.948 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.3 m 56.24 50.16 13.93 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.533 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 23.4 mt -104.25 131.23 22.11 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.688 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 2.7 Cg_exo -73.93 112.18 3.48 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.883 2.389 . . . . 0.0 111.059 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 55.8 p -127.59 162.41 26.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.122 0.487 . . . . 0.0 111.974 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.445 ' HE2' HG23 ' A' ' 155' ' ' ILE . 60.9 pttt -150.85 148.69 28.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.124 172.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 45.0 mm -88.81 115.14 28.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.014 0.435 . . . . 0.0 109.997 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 35.2 t -80.13 -80.78 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.026 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -127.23 65.49 1.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.882 0.372 . . . . 0.0 110.07 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 70.43 15.82 73.14 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -174.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.8 p -136.19 150.77 49.16 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.491 HD11 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -84.88 128.46 38.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.197 0.522 . . . . 0.0 110.457 -178.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.484 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 20.0 tt0 -118.3 148.04 42.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.589 0.709 . . . . 0.0 110.963 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.451 HD12 ' CE2' ' A' ' 138' ' ' PHE . 41.7 mm -93.13 138.02 21.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.297 177.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.445 HG23 ' HE2' ' A' ' 146' ' ' LYS . 16.5 pt -100.93 -37.72 5.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.599 -0.44 . . . . 0.0 112.161 -176.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -121.04 139.61 53.06 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -56.41 111.13 0.9 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.377 0.608 . . . . 0.0 110.665 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.468 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 16.6 t -85.72 128.55 39.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.079 -175.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -91.72 72.39 5.81 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.1 tp -66.83 -42.74 89.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.755 -170.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 13.3 mt -119.04 140.79 49.45 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.63 0.728 . . . . 0.0 111.803 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.97 127.02 27.01 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.302 174.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 9.4 Cg_endo -54.33 100.2 0.06 OUTLIER 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.501 2.134 . . . . 0.0 111.622 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 127.22 -16.13 6.38 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.289 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -78.4 175.61 10.13 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.51 ' HZ3' ' HB2' ' A' ' 166' ' ' LYS . 4.1 ttmp? -119.69 109.82 16.09 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 42.1 t -51.4 125.64 5.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 123.881 0.738 . . . . 0.0 111.367 -176.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.28 -177.6 51.9 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.996 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.08 -65.2 0.87 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.81 0.338 . . . . 0.0 111.9 -175.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 51.0 m -65.1 -24.51 67.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -67.35 -48.67 66.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.094 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.428 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -58.58 -46.37 87.07 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.277 0.56 . . . . 0.0 110.193 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 21.3 m -58.11 -38.99 77.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.699 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.579 HD11 ' CE2' ' A' ' 138' ' ' PHE . 25.8 tp -68.24 -42.42 79.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.209 0.528 . . . . 0.0 110.937 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.6 mt -70.19 -17.48 63.16 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.95 0.405 . . . . 0.0 110.605 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -81.08 -47.84 12.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.184 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.543 ' HE2' ' CD1' ' A' ' 137' ' ' PHE . 20.6 ptp -64.99 -33.42 75.99 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.229 0.538 . . . . 0.0 110.67 177.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 174' ' ' LEU . 0.3 OUTLIER -65.78 -32.21 73.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.946 178.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.896 0.855 . . . . 0.0 108.797 -173.585 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.562 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -121.29 125.55 26.87 Favored Pre-proline 0 C--N 1.314 -0.942 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.785 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.433 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 9.5 Cg_endo -53.87 118.54 5.06 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.574 2.849 . . . . 0.0 112.481 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.45 -17.67 11.22 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.645 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.27 150.48 28.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.911 0.386 . . . . 0.0 110.28 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.3 mm -86.11 135.61 24.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.394 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -73.71 109.34 6.44 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.738 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -78.88 -36.62 0.73 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.255 2.636 . . . . 0.0 113.421 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.5 mt -114.66 159.74 20.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.18 0.514 . . . . 0.0 111.654 -172.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.5 m -81.78 71.57 8.8 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.284 173.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 19.7 t -66.67 129.59 31.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.362 -177.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 47.8 t -123.21 122.54 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.441 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.4 HG21 HG13 ' A' ' 154' ' ' ILE . 56.9 mt -80.6 106.21 4.96 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.91 142.15 80.75 Favored 'Trans proline' 0 CA--C 1.511 -0.67 0 C-N-CA 123.209 2.606 . . . . 0.0 113.952 -170.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.423 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -68.56 83.52 0.27 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.301 175.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -172.94 157.55 3.6 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -170.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.15 130.58 43.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.057 0.456 . . . . 0.0 110.969 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 37.2 p -84.89 -9.49 58.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.063 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.46 -0.61 87.64 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.571 -177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 90.3 mt -86.3 154.19 21.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.773 0.321 . . . . 0.0 110.471 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.9 168.67 54.07 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.987 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.462 ' O ' HG21 ' A' ' 135' ' ' THR . 17.0 Cg_exo -67.46 -3.1 9.47 Favored 'Trans proline' 0 CA--C 1.527 0.138 0 C-N-CA 123.198 2.599 . . . . 0.0 113.119 -174.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -78.8 -32.32 46.32 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.17 0.51 . . . . 0.0 110.548 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -69.79 -11.38 60.81 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.472 -174.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 132' ' ' PRO . 6.8 t -66.38 -17.97 65.08 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.029 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.0 t -62.16 -42.25 99.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.458 ' CD1' ' HE2' ' A' ' 177' ' ' MET . 92.2 m-85 -75.0 -40.86 60.42 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.233 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.559 ' CE1' HD12 ' A' ' 174' ' ' LEU . 71.3 m-85 -59.81 -50.66 72.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.225 0.536 . . . . 0.0 109.688 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -65.05 -30.62 71.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.221 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.29 93.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.876 0.369 . . . . 0.0 110.578 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.38 31.41 1.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.709 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.0 p 52.2 49.62 20.19 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.88 0.872 . . . . 0.0 112.574 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 24.9 mt -108.55 131.16 21.95 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 3.5 Cg_exo -76.6 114.63 3.9 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.072 2.515 . . . . 0.0 111.339 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 82.3 p -129.25 162.65 27.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.978 0.418 . . . . 0.0 111.427 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -151.89 142.99 23.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.641 171.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 44.5 mm -81.28 119.44 30.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.891 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.2 t -68.12 -36.09 79.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.135 -178.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -173.96 -66.31 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.438 ' O ' ' HD3' ' A' ' 132' ' ' PRO . . . -128.91 6.62 6.47 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 173.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 22.7 p -128.42 152.12 48.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.87 0.367 . . . . 0.0 110.296 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.477 HD11 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -86.64 130.79 36.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.222 179.653 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -117.79 153.23 33.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.307 0.575 . . . . 0.0 110.716 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.475 HD13 ' CE1' ' A' ' 138' ' ' PHE . 29.1 mm -98.04 130.81 46.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.259 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.438 HG13 HD21 ' A' ' 156' ' ' ASN . 25.3 pt -93.14 -35.8 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.918 0.39 . . . . 0.0 111.885 -176.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.438 HD21 HG13 ' A' ' 155' ' ' ILE . 43.4 m-80 -123.83 136.88 54.66 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.343 177.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -61.09 118.59 6.98 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.461 0.475 . . . . 0.0 109.774 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.3 t -92.91 128.77 44.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.09 -172.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -78.45 67.98 4.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 170.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.1 tp -61.19 -51.46 72.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.875 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 14.8 mt -114.77 159.87 20.09 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.287 0.565 . . . . 0.0 110.059 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.556 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -153.49 132.36 6.85 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.94 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 4.2 Cg_endo -48.26 110.59 0.34 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.596 2.864 . . . . 0.0 112.706 -176.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.09 -19.09 8.84 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.304 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -79.84 174.9 11.12 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -125.85 107.2 10.27 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 34.3 t -51.89 122.66 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 O-C-N 123.857 0.723 . . . . 0.0 111.44 -176.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.83 -175.63 46.87 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.794 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.433 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -71.39 -65.02 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 111.886 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.8 m -62.07 -29.31 70.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.476 0.655 . . . . 0.0 109.615 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -67.51 -48.31 67.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.083 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.426 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.54 -39.14 83.02 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.241 0.543 . . . . 0.0 110.451 175.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 26.5 m -61.26 -41.29 96.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.528 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.559 HD12 ' CE1' ' A' ' 138' ' ' PHE . 28.6 tp -67.88 -42.16 81.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.896 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.2 mt -69.02 -20.95 64.15 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.845 0.355 . . . . 0.0 110.648 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -78.51 -46.97 18.31 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.141 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.489 ' HG2' ' HA ' ' A' ' 174' ' ' LEU . 22.1 ptp -66.19 -24.18 66.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.51 0.671 . . . . 0.0 110.342 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.11 -29.56 48.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.289 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 122.026 0.917 . . . . 0.0 108.727 -174.341 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -138.95 -58.94 0.6 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.831 0.348 . . . . 0.0 110.31 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.14 54.79 0.65 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.399 0.618 . . . . 0.0 109.826 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.33 -37.01 78.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.231 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.519 ' NE2' ' HA ' ' A' ' 176' ' ' ASN . 47.6 tt0 -86.54 109.93 19.45 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.466 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.504 ' HB1' ' O ' ' A' ' 184' ' ' SER . . . -66.8 147.64 98.99 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.79 86.36 0.14 Allowed 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.185 2.59 . . . . 0.0 112.637 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.86 116.76 12.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.931 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -138.43 130.12 15.73 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.747 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.44 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 9.5 Cg_endo -54.22 122.89 12.28 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.541 2.827 . . . . 0.0 112.959 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 120.42 -25.81 7.21 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.616 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.71 147.36 35.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.94 0.4 . . . . 0.0 110.613 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.6 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 48.3 mm -81.44 143.47 12.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.964 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -85.03 103.74 3.76 Favored Pre-proline 0 C--N 1.328 -0.334 0 O-C-N 123.485 0.491 . . . . 0.0 110.569 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.6 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 3.3 Cg_exo -79.91 -30.45 2.26 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.879 2.386 . . . . 0.0 113.018 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -110.65 165.93 11.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.146 0.498 . . . . 0.0 111.556 -173.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.3 m -92.72 84.76 5.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.634 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 21.1 t -82.58 134.32 27.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.523 -176.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 53.9 t -126.88 125.16 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.57 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.464 HG22 HG13 ' A' ' 154' ' ' ILE . 75.8 mt -82.36 108.16 11.01 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 19.4 Cg_exo -64.66 147.26 89.91 Favored 'Trans proline' 0 CA--C 1.511 -0.643 0 C-N-CA 122.875 2.383 . . . . 0.0 113.614 -171.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.99 81.71 1.21 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.145 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.434 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 48.1 t-80 -168.46 156.11 8.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 0.4 OUTLIER -63.31 132.09 50.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.362 0.601 . . . . 0.0 110.366 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.499 HG23 ' CZ ' ' A' ' 138' ' ' PHE . 77.6 p -83.37 -14.2 53.33 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.439 -172.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.67 -14.67 57.72 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -175.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.456 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 95.2 mt -77.31 149.07 35.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.365 -0.417 . . . . 0.0 110.539 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.67 162.33 34.25 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.617 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.36 -12.25 26.51 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 123.03 2.487 . . . . 0.0 112.689 -174.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.81 -30.36 66.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.787 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.469 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 74.3 mmtt -71.68 -6.37 40.64 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.977 0.418 . . . . 0.0 111.252 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.0 t -65.2 -21.04 66.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.553 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.2 t -65.01 -38.63 91.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.735 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -73.58 -42.48 61.54 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.424 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.56 ' CE2' HD22 ' A' ' 178' ' ' LEU . 86.1 m-85 -59.97 -48.75 80.44 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -65.79 -28.8 69.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.019 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.32 -34.36 77.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.054 0.454 . . . . 0.0 110.179 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.9 18.87 11.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.182 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t 59.81 58.29 2.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.854 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 40.8 mt -115.08 135.66 22.52 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.462 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.422 ' HB2' ' CG1' ' A' ' 155' ' ' ILE . 3.4 Cg_exo -74.59 118.01 5.17 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.037 2.492 . . . . 0.0 111.054 174.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 35.4 p -128.84 152.57 48.35 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -172.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -148.05 147.85 30.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.421 172.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 43.6 mm -84.6 128.51 38.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.89 0.376 . . . . 0.0 110.605 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 45.5 t -99.96 -83.33 0.43 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.277 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -113.36 53.34 0.77 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.955 0.407 . . . . 0.0 110.178 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 70.05 14.11 70.54 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -171.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.2 p -130.65 151.33 51.23 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.501 HD11 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -79.65 128.01 38.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.288 0.566 . . . . 0.0 110.167 -178.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.434 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 37.7 tt0 -116.86 153.93 31.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.536 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.464 HG13 HG22 ' A' ' 123' ' ' ILE . 42.5 mm -99.88 133.05 44.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.737 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 155' ' ' ILE . 16.0 pt -95.06 -34.72 5.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -176.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -122.39 132.13 54.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.057 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -54.96 115.46 2.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.434 0.635 . . . . 0.0 110.456 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 24.5 t -91.51 126.85 44.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.873 -171.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.622 ' O ' ' HE3' ' A' ' 162' ' ' LYS . 10.8 p-80 -80.24 73.87 7.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.432 0.635 . . . . 0.0 109.298 170.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.9 tp -64.94 -50.43 75.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.196 -174.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 15.7 mt -113.23 147.78 36.82 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.429 0.633 . . . . 0.0 110.664 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.622 ' HE3' ' O ' ' A' ' 159' ' ' HIS . 6.6 mptt -127.74 133.32 24.98 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.409 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.56 101.87 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.391 2.061 . . . . 0.0 111.727 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.88 -5.94 12.44 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.772 -175.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -86.32 -173.33 4.49 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -135.49 116.18 13.92 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.694 0.283 . . . . 0.0 110.304 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.7 t -61.26 121.86 10.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.289 -177.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.63 -170.91 46.69 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.969 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -76.27 -63.83 1.24 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.973 0.415 . . . . 0.0 111.669 -175.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.5 m -66.27 -23.94 66.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -70.18 -50.07 43.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.963 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.421 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -56.21 -46.69 79.37 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.289 0.566 . . . . 0.0 110.066 174.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.609 ' O ' ' HG3' ' A' ' 177' ' ' MET . 22.5 m -59.07 -42.17 89.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.585 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.525 HD12 ' CE2' ' A' ' 138' ' ' PHE . 48.9 tp -59.67 -49.11 79.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.708 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.02 -29.27 69.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.241 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.519 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 79.8 m-20 -74.53 -33.22 62.71 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.141 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.609 ' HG3' ' O ' ' A' ' 173' ' ' THR . 63.9 mtm -79.33 -26.14 42.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.326 0.584 . . . . 0.0 110.089 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.56 HD22 ' CE2' ' A' ' 138' ' ' PHE . 1.4 mm? -78.28 -15.08 59.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.229 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 61.25 34.47 18.66 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.543 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.502 ' O ' ' HD3' ' A' ' 182' ' ' PRO . 73.2 mt -105.43 143.89 15.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.43 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 14.1 t -96.69 104.69 19.08 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 120.881 0.372 . . . . 0.0 110.922 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 180' ' ' ILE . 95.1 Cg_endo -85.12 6.48 5.67 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.558 2.172 . . . . 0.0 113.191 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.426 ' HB2' ' HB2' ' A' ' 109' ' ' ALA . 98.0 m-85 -135.5 -79.21 0.43 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.062 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.504 ' O ' ' HB1' ' A' ' 109' ' ' ALA . 13.1 p -153.57 159.4 42.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.764 0.316 . . . . 0.0 111.258 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -120.9 12.97 11.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.954 0.407 . . . . 0.0 111.285 -176.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.914 0 CA-C-O 118.59 -1.117 . . . . 0.0 111.935 178.763 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.618 0.247 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -149.06 -38.18 0.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 0.0 110.946 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -142.45 60.11 1.45 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.682 0.753 . . . . 0.0 109.59 172.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.14 -9.43 12.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.394 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.443 ' HB2' ' HA ' ' A' ' 179' ' ' ASN . 47.6 tt0 -50.07 141.31 11.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.325 0.583 . . . . 0.0 112.084 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 184' ' ' SER . . . -105.36 157.24 34.86 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.257 175.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.29 84.18 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.859 2.373 . . . . 0.0 112.599 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -83.01 113.41 20.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.429 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -128.97 129.78 23.43 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.567 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 167' ' ' VAL . 10.1 Cg_endo -52.72 122.51 11.08 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.262 2.642 . . . . 0.0 111.561 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 120.72 -18.37 9.23 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 119.946 -1.121 . . . . 0.0 112.017 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.53 143.51 27.68 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.95 0.405 . . . . 0.0 110.597 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.2 mm -80.84 131.73 33.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.965 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -67.37 110.81 5.82 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.203 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -77.24 -32.32 3.14 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.193 2.595 . . . . 0.0 113.433 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 90.5 mt -121.43 160.71 23.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.97 0.414 . . . . 0.0 111.609 -172.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.5 m -83.6 77.41 9.85 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.542 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.441 ' CG2' ' HA ' ' A' ' 182' ' ' PRO . 31.7 t -70.89 133.86 31.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.778 -176.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 51.1 t -123.74 129.27 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.341 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.449 HG22 HG13 ' A' ' 154' ' ' ILE . 78.7 mt -86.5 108.54 18.29 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 173.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.51 140.08 93.22 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 123.209 2.606 . . . . 0.0 114.079 -171.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.425 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -72.78 85.65 1.23 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.72 175.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.472 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 3.4 t-80 -171.85 176.14 3.69 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -174.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -62.75 137.88 58.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.042 0.448 . . . . 0.0 110.038 173.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.443 HG23 ' CZ ' ' A' ' 138' ' ' PHE . 42.9 p -92.84 -11.11 34.43 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.554 -176.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.81 15.54 80.55 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.291 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 87.7 mt -114.75 152.54 31.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.354 -0.423 . . . . 0.0 110.135 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.15 167.24 51.85 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.925 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.38 6.58 1.13 Allowed 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 123.314 2.676 . . . . 0.0 112.794 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -86.88 -35.0 19.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.697 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.481 ' HE2' ' SD ' ' A' ' 177' ' ' MET . 25.4 mmmt -74.99 -3.05 30.05 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 121.602 0.715 . . . . 0.0 110.783 -172.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.0 t -63.77 -21.8 66.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.008 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.7 p -61.09 -41.2 96.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.882 0.372 . . . . 0.0 109.997 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -70.31 -44.96 67.23 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.497 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.449 ' CE1' HD23 ' A' ' 178' ' ' LEU . 78.3 m-85 -58.69 -46.77 86.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.514 0.673 . . . . 0.0 109.861 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -69.81 -27.15 64.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.198 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.81 -31.91 73.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.996 0.427 . . . . 0.0 110.057 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.42 22.73 5.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.9 t 59.21 43.17 17.44 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.35 174.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.5 mt -102.0 134.01 20.35 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -71.79 108.72 2.49 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.721 2.281 . . . . 0.0 110.937 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.442 HG23 ' CB ' ' A' ' 138' ' ' PHE . 40.8 p -122.68 144.9 48.84 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.108 0.48 . . . . 0.0 112.053 -174.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -140.11 148.93 42.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.836 172.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 38.9 mm -88.0 131.42 35.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.836 0.35 . . . . 0.0 110.45 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.9 t -136.65 124.33 22.41 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.738 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.6 tttp 58.9 37.92 24.59 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.513 0.673 . . . . 0.0 111.022 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 71.34 13.63 73.85 Favored Glycine 0 N--CA 1.454 -0.147 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.069 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.7 p -130.06 151.96 50.04 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.541 HD11 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -77.38 123.62 34.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.303 0.573 . . . . 0.0 109.685 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.472 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 39.4 tt0 -113.42 152.38 30.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.584 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.449 HG13 HG22 ' A' ' 123' ' ' ILE . 46.3 mm -97.16 129.45 47.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.532 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 9.2 pt -92.63 -35.92 7.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.838 0.351 . . . . 0.0 111.887 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -122.53 132.09 54.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.508 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -58.12 114.48 2.4 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.69 0.757 . . . . 0.0 109.818 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.5 t -84.68 127.64 39.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.837 -170.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -82.59 72.76 9.66 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 171.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.407 HG21 HD23 ' A' ' 175' ' ' LEU . 7.2 tp -70.14 -47.14 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.475 -172.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.433 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 17.3 mt -117.01 160.0 21.63 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.286 0.565 . . . . 0.0 110.49 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -157.94 131.07 4.57 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.291 -179.17 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 89.6 Cg_exo -44.85 108.89 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.799 2.999 . . . . 0.0 113.078 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 122.36 -22.27 7.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.109 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -81.85 178.59 8.22 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -126.62 118.46 24.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.722 0.296 . . . . 0.0 110.401 -175.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 26.3 t -59.9 121.58 7.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.709 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.44 -177.2 50.55 Favored Glycine 0 C--O 1.226 -0.394 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.676 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.9 -62.65 1.47 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.897 0.379 . . . . 0.0 111.546 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.2 m -65.51 -24.93 67.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -69.09 -49.43 57.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.138 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.42 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.29 -42.27 90.91 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.18 0.514 . . . . 0.0 110.106 175.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.596 ' O ' ' HG3' ' A' ' 177' ' ' MET . 33.0 m -61.38 -39.17 89.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.738 177.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.424 ' HA ' ' HE3' ' A' ' 177' ' ' MET . 51.8 tp -61.44 -49.06 78.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.52 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.407 HD23 HG21 ' A' ' 160' ' ' ILE . 84.4 mt -71.61 -18.57 62.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -73.48 -42.27 62.08 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.596 ' HG3' ' O ' ' A' ' 173' ' ' THR . 58.2 mtm -71.67 -32.7 68.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.442 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.518 ' HB3' HG13 ' A' ' 180' ' ' ILE . 2.4 mm? -77.49 -16.37 58.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.231 -176.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . 0.443 ' HA ' ' HB2' ' A' ' 108' ' ' GLN . 40.1 t-20 60.42 47.98 8.24 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.499 0.666 . . . . 0.0 109.592 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.634 ' O ' ' HD3' ' A' ' 182' ' ' PRO . 86.3 mt -110.52 159.08 10.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.027 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.2 m -103.98 90.33 2.92 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.634 ' HD3' ' O ' ' A' ' 180' ' ' ILE . 27.9 Cg_exo -68.0 -16.39 45.06 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 121.786 1.657 . . . . 0.0 112.222 172.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.401 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 82.6 m-85 -120.23 -70.32 0.79 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.436 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 69.0 p -159.18 159.74 34.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.862 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -99.78 158.21 15.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.486 -1.175 . . . . 0.0 111.668 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 95.7 mmm . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 111.286 0.106 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -160.56 -72.89 0.07 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.758 0.313 . . . . 0.0 110.361 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -66.37 -35.16 79.64 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 173.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.8 p -104.15 70.95 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 122.355 1.074 . . . . 0.0 109.414 169.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.467 ' NE2' ' HA ' ' A' ' 176' ' ' ASN . 58.9 tp60 -162.39 95.18 0.92 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.278 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 184' ' ' SER . . . -53.51 146.41 24.48 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.429 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.5 74.68 0.2 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.473 2.782 . . . . 0.0 112.475 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.27 104.5 4.32 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.672 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -133.87 133.93 22.72 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.079 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 167' ' ' VAL . 9.3 Cg_endo -54.15 118.52 5.09 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.738 2.959 . . . . 0.0 113.101 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.91 -6.69 15.47 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.025 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.4 145.19 24.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.7 0.286 . . . . 0.0 110.372 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.3 mm -81.45 127.15 39.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.255 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.657 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -58.3 112.33 4.76 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.452 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -73.86 -49.7 0.19 Allowed 'Trans proline' 0 CA--C 1.528 0.176 0 C-N-CA 123.257 2.638 . . . . 0.0 112.88 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 75.4 mt -105.07 159.93 15.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.116 0.484 . . . . 0.0 111.697 -173.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.0 m -85.77 82.26 8.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.517 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.42 ' CG1' HG21 ' A' ' 180' ' ' ILE . 21.9 t -81.59 132.96 30.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.082 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 45.3 t -123.7 128.32 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.978 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.445 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . 58.1 mt -83.78 107.88 11.82 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 17.2 Cg_exo -65.84 137.89 51.04 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 C-N-CA 122.922 2.414 . . . . 0.0 113.728 -170.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -84.04 72.63 10.45 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.122 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -151.79 -56.69 0.14 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.587 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.439 HD21 ' C ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER -177.28 150.29 0.71 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.96 0.41 . . . . 0.0 110.971 175.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.475 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 81.7 p -115.06 -19.27 10.96 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.792 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 77.36 4.35 84.02 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.848 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 93.1 mt -94.82 150.65 19.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.058 0.456 . . . . 0.0 111.159 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -72.39 169.64 51.43 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.862 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.483 ' O ' HG21 ' A' ' 135' ' ' THR . 20.4 Cg_exo -64.95 -17.74 60.26 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.898 2.398 . . . . 0.0 113.167 -173.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -59.21 -36.55 75.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.416 0.627 . . . . 0.0 110.795 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.427 ' HB3' ' CE ' ' A' ' 177' ' ' MET . 70.3 mmtt -71.66 -11.47 60.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.684 -170.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.483 HG21 ' O ' ' A' ' 132' ' ' PRO . 5.1 t -65.76 -21.86 66.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.074 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 26.0 t -62.92 -39.45 94.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -75.84 -40.36 54.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.226 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.494 ' CE2' HD12 ' A' ' 174' ' ' LEU . 71.3 m-85 -59.8 -48.46 81.59 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -66.35 -29.72 69.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.111 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.27 77.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.828 0.347 . . . . 0.0 110.318 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.47 19.6 6.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.2 m 60.14 43.78 13.74 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.617 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 26.5 mt -99.66 133.56 21.72 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.61 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 3.2 Cg_exo -75.8 108.5 2.7 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.853 2.369 . . . . 0.0 110.982 175.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.494 ' CG2' HD13 ' A' ' 152' ' ' ILE . 45.9 p -122.26 164.78 17.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.226 0.536 . . . . 0.0 112.181 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.452 ' HE2' HG22 ' A' ' 155' ' ' ILE . 54.2 pttt -149.93 143.31 25.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.517 173.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 44.1 mm -87.24 110.24 20.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 27.8 p -63.97 -34.52 78.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.775 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -170.64 -67.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.486 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -130.43 4.43 5.88 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 175.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.4 p -125.04 151.67 45.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.536 HD11 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -90.16 130.95 38.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 121.242 0.544 . . . . 0.0 110.046 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.492 ' N ' HD11 ' A' ' 152' ' ' ILE . 40.0 tt0 -123.89 156.43 36.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.276 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.448 HD11 ' CE2' ' A' ' 138' ' ' PHE . 1.9 mp -101.87 137.23 30.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.389 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.512 HD13 HG23 ' A' ' 155' ' ' ILE . 7.9 pt -91.76 -37.19 8.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.877 0.37 . . . . 0.0 111.929 -177.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -121.31 123.86 43.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.01 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -52.24 122.11 8.06 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 123.737 0.648 . . . . 0.0 110.545 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 19.8 t -94.38 126.29 46.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.992 -170.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.435 ' HB3' ' HD2' ' A' ' 162' ' ' LYS . 91.7 m-70 -80.06 76.74 6.79 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 171.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.1 tp -72.72 -42.31 62.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.246 -172.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.553 ' C ' ' HD3' ' A' ' 162' ' ' LYS . 10.1 mt -121.89 142.06 50.65 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.493 0.663 . . . . 0.0 111.876 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.553 ' HD3' ' C ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER -132.62 124.6 19.04 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.705 175.066 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 89.9 Cg_exo -44.0 101.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.279 2.652 . . . . 0.0 112.837 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 130.72 -25.76 4.15 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.058 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.454 ' OD2' ' HB2' ' A' ' 162' ' ' LYS . 3.6 m-20 -76.07 158.5 31.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.853 0.359 . . . . 0.0 111.07 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -98.4 118.69 35.63 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 44.6 t -61.47 126.01 18.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.738 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.58 -178.91 52.09 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.662 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.78 -63.8 1.09 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.894 0.378 . . . . 0.0 111.582 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 36.0 t -63.94 -24.84 67.88 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -68.56 -47.18 67.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.908 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.0 -47.08 86.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.31 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 57.6 m -55.48 -46.52 76.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.422 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.494 HD12 ' CE2' ' A' ' 138' ' ' PHE . 58.3 tp -58.83 -44.48 90.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.108 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.8 mt -68.34 -29.87 68.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.44 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.467 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 33.5 m-80 -73.22 -35.1 66.23 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.427 ' CE ' ' HB3' ' A' ' 134' ' ' LYS . 35.9 mtp -66.55 -34.97 79.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.781 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.475 HD22 ' CE2' ' A' ' 138' ' ' PHE . 2.1 mm? -78.3 -9.78 59.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.395 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 64.79 28.38 12.9 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.683 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.456 ' O ' ' HD3' ' A' ' 182' ' ' PRO . 81.2 mt -102.65 128.05 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.434 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.7 m -94.26 105.12 16.0 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.725 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.461 ' HB3' HD11 ' A' ' 161' ' ' LEU . 5.3 Cg_exo -75.53 -13.65 20.26 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.86 2.373 . . . . 0.0 113.357 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.457 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 26.7 m-85 -113.85 -76.36 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.152 0.501 . . . . 0.0 110.908 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 46.9 t -136.84 156.75 48.09 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.339 -176.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -93.83 5.13 52.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.145 0.498 . . . . 0.0 110.179 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.141 0 CA-C-O 118.163 -1.354 . . . . 0.0 111.173 178.931 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 121.264 0.554 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -158.45 138.85 12.55 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.6 mttm 52.72 47.9 23.68 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.68 0.612 . . . . 0.0 109.89 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.9 t -72.48 -73.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.041 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.405 ' OE1' ' HA ' ' A' ' 108' ' ' GLN . 6.3 tp60 -70.28 109.31 4.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.23 0.538 . . . . 0.0 111.35 -174.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.566 ' HB2' ' O ' ' A' ' 184' ' ' SER . . . -63.63 150.41 90.54 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.87 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.06 78.69 0.3 Allowed 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 123.355 2.703 . . . . 0.0 113.311 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.37 103.65 3.51 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 174.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -133.51 128.74 20.26 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.588 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.447 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 7.4 Cg_endo -51.61 124.26 14.0 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.749 2.966 . . . . 0.0 112.94 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.53 -29.48 6.63 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.648 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.26 146.48 41.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.935 0.398 . . . . 0.0 110.358 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.428 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 42.7 mm -81.7 136.95 22.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.57 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -75.2 109.71 8.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.134 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 10.1 Cg_exo -75.49 -44.66 0.29 Allowed 'Trans proline' 0 CA--C 1.527 0.164 0 C-N-CA 123.186 2.591 . . . . 0.0 113.312 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 91.3 mt -105.08 162.25 13.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.258 0.551 . . . . 0.0 111.916 -172.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.5 m -87.66 83.07 7.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.634 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.2 t -78.7 132.9 31.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.372 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 54.5 t -123.23 131.45 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.442 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.401 ' HB ' ' HB ' ' A' ' 158' ' ' VAL . 75.0 mt -91.46 107.22 20.22 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.65 146.5 95.29 Favored 'Trans proline' 0 CA--C 1.513 -0.555 0 C-N-CA 122.736 2.291 . . . . 0.0 113.085 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.34 78.26 3.1 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.491 -1.232 . . . . 0.0 110.719 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.449 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 6.9 t-80 -167.13 153.43 8.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.94 132.29 46.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.353 0.597 . . . . 0.0 111.661 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.8 p -87.92 -4.8 58.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.424 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.98 4.42 90.52 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -175.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.494 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 87.6 mt -94.64 152.3 18.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.2 -0.5 . . . . 0.0 110.559 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.41 162.68 53.26 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.823 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -57.97 -29.23 85.96 Favored 'Trans proline' 0 C--O 1.224 -0.197 0 C-N-CA 123.021 2.481 . . . . 0.0 112.451 -174.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.49 -31.43 62.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.209 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.494 ' HG3' ' HB3' ' A' ' 130' ' ' LEU . 45.3 mmtm -70.11 -10.45 58.81 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.468 0.651 . . . . 0.0 111.089 -174.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.3 t -67.82 -14.98 63.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.799 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.7 t -64.61 -42.12 95.76 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -72.64 -42.26 64.6 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.939 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.481 ' CE1' HD13 ' A' ' 154' ' ' ILE . 83.2 m-85 -59.67 -47.02 87.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.701 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -65.16 -32.75 74.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.67 -36.14 81.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.579 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.16 21.92 5.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.324 175.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.7 t 59.85 50.66 6.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.47 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 21.9 mt -105.68 133.08 20.36 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.57 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.428 ' HB2' ' CG1' ' A' ' 155' ' ' ILE . 7.5 Cg_exo -72.62 110.82 3.09 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.854 2.37 . . . . 0.0 110.693 174.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.4 p -126.62 155.94 41.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.217 -170.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -145.83 159.21 43.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.762 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 45.0 mm -100.55 102.9 14.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.2 m -80.82 -44.12 18.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.679 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -156.18 60.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.121 0.486 . . . . 0.0 111.413 -176.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 75.1 -3.69 44.39 Favored Glycine 0 C--O 1.229 -0.196 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.459 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.0 p -124.01 154.88 39.22 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.449 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -85.62 129.42 38.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.354 0.597 . . . . 0.0 110.429 -176.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.449 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 33.5 tt0 -127.46 149.18 50.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.624 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.481 HD13 ' CE1' ' A' ' 138' ' ' PHE . 3.0 mp -95.48 140.25 17.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.327 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.428 ' CG1' ' HB2' ' A' ' 144' ' ' PRO . 14.8 pt -96.22 -35.6 5.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -123.19 126.99 48.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.161 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -55.37 121.12 8.25 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.403 0.621 . . . . 0.0 110.35 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.2 t -93.89 124.25 46.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.865 -170.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -78.37 77.96 4.85 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 168.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.4 tp -68.6 -45.99 80.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.411 -172.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.4 mt -114.71 149.07 37.37 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.442 0.639 . . . . 0.0 111.211 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.55 132.13 24.26 Favored Pre-proline 0 C--N 1.315 -0.935 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.729 175.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 9.8 Cg_endo -54.02 100.82 0.07 OUTLIER 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.875 2.384 . . . . 0.0 111.839 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 123.64 -12.39 8.31 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.1 -176.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -82.75 -176.15 6.14 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -128.62 112.59 14.43 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.654 0.264 . . . . 0.0 110.346 -174.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 28.0 t -58.86 123.23 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.98 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.33 -177.42 47.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.98 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.447 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -67.66 -67.66 0.44 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.78 0.324 . . . . 0.0 111.719 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.1 p -63.7 -25.47 68.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.135 0.493 . . . . 0.0 110.187 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -68.22 -47.49 67.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.884 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.435 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -58.99 -45.09 91.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.853 174.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.606 ' O ' ' HG3' ' A' ' 177' ' ' MET . 32.3 m -56.58 -43.59 80.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.691 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 53.8 tp -60.88 -46.9 88.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.651 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.1 mt -71.22 -21.03 62.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.972 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -72.53 -43.72 63.15 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.606 ' HG3' ' O ' ' A' ' 173' ' ' THR . 44.9 mtm -69.24 -31.54 70.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.303 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -76.67 -11.54 59.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.552 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 61.08 25.63 15.63 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.471 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 83.0 mt -101.64 125.12 55.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.23 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.7 m -88.28 113.32 54.68 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.137 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.474 ' HG2' ' CD2' ' A' ' 183' ' ' PHE . 72.7 Cg_endo -79.67 -11.48 14.08 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.703 2.269 . . . . 0.0 113.162 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.474 ' CD2' ' HG2' ' A' ' 182' ' ' PRO . 92.1 m-85 -109.16 -73.85 0.67 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.814 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.566 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 30.1 t -158.01 150.23 22.14 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.805 0.336 . . . . 0.0 110.808 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -129.18 125.01 36.07 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 CA-C-O 118.531 -1.15 . . . . 0.0 111.698 -176.749 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.407 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 121.465 0.65 . . . . 0.0 110.945 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -145.32 -56.49 0.32 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.521 ' HE2' ' HA ' ' A' ' 106' ' ' LYS . 8.9 mmpt? -100.7 -33.01 10.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.793 173.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.2 p -156.68 154.67 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.13 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 67.19 92.67 0.08 Allowed 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 172.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.72 155.37 77.0 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.648 168.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 104' ' ' MET . 26.1 Cg_endo -61.99 102.92 0.27 Allowed 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.448 2.099 . . . . 0.0 112.56 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.33 104.75 9.13 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.59 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -128.58 127.33 23.58 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.929 -173.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.484 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 16.2 Cg_endo -59.48 121.42 9.85 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 123.229 2.62 . . . . 0.0 112.268 178.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 122.11 -23.02 7.41 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.36 -176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.62 143.71 36.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.861 0.362 . . . . 0.0 110.219 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.3 mm -83.1 129.79 36.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.259 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 118' ' ' PRO . . . -69.68 110.72 7.0 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.222 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 117' ' ' ALA . 6.3 Cg_exo -77.47 -38.34 0.76 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 123.199 2.6 . . . . 0.0 112.955 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 79.2 mt -112.85 160.96 17.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.567 -171.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.0 p -87.89 80.36 7.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.805 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.99 135.07 28.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.742 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 55.2 t -125.72 123.08 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.895 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.46 ' HB ' ' HB ' ' A' ' 158' ' ' VAL . 81.5 mt -81.78 108.88 12.39 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.26 145.39 77.98 Favored 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 122.952 2.435 . . . . 0.0 113.559 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.508 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -73.91 69.94 1.44 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.119 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.577 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 82.3 m-70 -154.04 -175.18 5.26 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -174.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -63.94 137.99 58.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.048 0.451 . . . . 0.0 110.34 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.444 HG23 ' CZ ' ' A' ' 138' ' ' PHE . 66.2 p -98.93 -14.9 19.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.64 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.0 6.3 87.32 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.531 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.464 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 91.2 mt -99.5 151.81 20.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.945 0.402 . . . . 0.0 111.071 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -72.32 167.91 52.87 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.513 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.62 -29.56 88.72 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.611 2.207 . . . . 0.0 112.469 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.73 -22.48 64.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.58 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 34.7 mmtp -76.75 -7.32 55.15 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.148 0.499 . . . . 0.0 110.954 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 5.8 t -67.69 -20.09 65.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.775 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.2 m -64.12 -40.13 95.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -71.7 -42.93 66.78 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.162 0.506 . . . . 0.0 110.284 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.519 ' CE1' HD12 ' A' ' 174' ' ' LEU . 70.1 m-85 -60.67 -48.42 81.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.635 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -63.11 -31.95 73.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.017 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.48 -36.35 82.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.355 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.67 27.01 3.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.569 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.4 t 55.98 52.21 10.89 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.171 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 24.2 mt -108.44 135.79 19.96 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.837 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.498 ' HB2' ' CG1' ' A' ' 155' ' ' ILE . 5.4 Cg_exo -77.73 111.71 3.17 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.059 2.506 . . . . 0.0 111.199 175.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.448 ' CG2' HD12 ' A' ' 152' ' ' ILE . 47.4 p -125.65 163.78 22.02 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.187 0.518 . . . . 0.0 112.017 -172.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -154.22 149.37 26.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.103 170.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 45.0 mm -84.17 116.68 28.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.9 t -71.83 -33.69 68.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.448 -176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -168.27 -70.88 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.015 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -131.48 9.76 5.56 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.6 p -129.57 153.92 47.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.035 -0.582 . . . . 0.0 109.558 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.474 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -89.17 128.33 41.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.242 0.544 . . . . 0.0 110.031 -178.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.577 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 32.5 tt0 -119.96 152.27 37.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.365 0.602 . . . . 0.0 110.517 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.508 ' HB ' ' HA ' ' A' ' 125' ' ' ALA . 34.5 mm -93.31 135.52 27.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.514 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.498 ' CG1' ' HB2' ' A' ' 144' ' ' PRO . 26.1 pt -94.93 -38.34 8.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -124.62 134.02 53.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.794 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -58.27 119.7 7.36 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.521 0.513 . . . . 0.0 110.302 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 18.7 t -90.25 129.91 40.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.002 -171.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.515 ' O ' ' HE3' ' A' ' 162' ' ' LYS . 71.1 m-70 -85.45 75.2 10.23 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 171.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.3 tp -71.02 -48.03 58.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.475 -171.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.5 mt -112.14 148.62 33.61 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.46 0.648 . . . . 0.0 110.806 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 6.3 mptt -128.47 131.51 23.81 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.246 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.64 105.86 0.15 Allowed 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.542 2.161 . . . . 0.0 111.719 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.01 -3.0 22.71 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.953 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -88.07 -175.57 5.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -132.07 112.07 12.03 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 24.6 t -54.13 125.42 8.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.32 -176.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.56 -176.86 48.4 Favored Glycine 0 C--O 1.226 -0.344 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.832 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -70.91 -69.5 0.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.905 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 69.8 m -68.17 -20.93 64.91 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -65.48 -48.22 73.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.523 173.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.439 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.19 -45.81 90.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.303 175.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.595 ' O ' ' HG3' ' A' ' 177' ' ' MET . 28.4 m -58.24 -40.43 81.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.028 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.519 HD12 ' CE1' ' A' ' 138' ' ' PHE . 54.7 tp -63.54 -49.96 71.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.624 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.406 HD22 HG23 ' A' ' 180' ' ' ILE . 52.3 mt -65.6 -23.26 66.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.723 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -74.6 -42.27 58.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.644 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.595 ' HG3' ' O ' ' A' ' 173' ' ' THR . 62.2 mtm -71.49 -31.19 66.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.409 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.446 ' HB3' ' HB ' ' A' ' 180' ' ' ILE . 2.7 mm? -77.84 -9.91 59.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.549 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 10.6 p30 42.69 36.66 0.86 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 124.176 0.922 . . . . 0.0 110.377 -170.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 178' ' ' LEU . 11.5 tt -76.18 -13.2 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.893 -1.048 . . . . 0.0 112.059 -165.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 184' ' ' SER . 14.8 m 60.76 71.87 0.78 Allowed Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.072 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.423 ' HG2' ' CD1' ' A' ' 183' ' ' PHE . 65.0 Cg_endo -74.46 -4.83 16.03 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.702 2.268 . . . . 0.0 113.659 -175.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.423 ' CD1' ' HG2' ' A' ' 182' ' ' PRO . 89.6 m-85 -125.62 -61.37 1.26 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.396 0.617 . . . . 0.0 109.963 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 181' ' ' SER . 25.3 p -155.35 -171.71 3.9 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.237 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -97.98 -35.7 10.37 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.166 0.508 . . . . 0.0 109.871 176.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.383 -1.232 . . . . 0.0 111.468 176.487 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.822 0.344 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -158.1 105.59 1.95 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.396 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 93.7 mttt 55.87 54.32 8.25 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.467 0.479 . . . . 0.0 110.65 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.3 m -72.33 -14.97 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -171.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -73.53 99.85 3.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.268 0.556 . . . . 0.0 110.335 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.624 ' CB ' ' HB2' ' A' ' 183' ' ' PHE . . . -66.04 148.48 98.35 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.67 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.4 96.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.225 2.616 . . . . 0.0 112.918 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.76 105.73 9.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.969 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -129.68 128.08 22.98 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.511 -175.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.524 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 10.9 Cg_endo -56.61 118.23 5.04 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.549 2.833 . . . . 0.0 112.935 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.02 -21.04 6.61 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.13 153.5 26.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.862 0.363 . . . . 0.0 110.327 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.408 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 46.5 mm -86.63 135.01 26.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.73 -177.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -75.82 109.62 8.58 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.614 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 6.8 Cg_exo -76.33 -38.12 1.18 Allowed 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 123.125 2.55 . . . . 0.0 113.308 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.5 mt -116.93 167.54 11.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.193 0.52 . . . . 0.0 111.683 -171.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.0 m -87.94 79.17 8.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.823 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.4 t -69.1 134.28 30.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.564 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 43.2 t -123.83 131.52 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.332 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.473 HG23 HG13 ' A' ' 154' ' ' ILE . 88.0 mt -90.36 101.86 4.21 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 122' ' ' VAL . 29.8 Cg_exo -61.81 141.93 91.88 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.506 2.804 . . . . 0.0 114.172 -170.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.446 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -71.78 84.67 0.92 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.903 -1.499 . . . . 0.0 112.53 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.531 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 7.6 p80 -175.52 179.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -57.13 135.89 56.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.0 0.429 . . . . 0.0 110.654 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.6 p -94.57 -4.84 47.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.215 0.531 . . . . 0.0 110.717 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.49 2.49 89.61 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.434 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.2 mt -93.82 150.76 20.1 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.469 -0.365 . . . . 0.0 110.315 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.41 162.61 54.25 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.465 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 150' ' ' GLY . 52.1 Cg_exo -53.54 -28.43 45.38 Favored 'Trans proline' 0 C--O 1.225 -0.173 0 C-N-CA 123.074 2.516 . . . . 0.0 112.909 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -55.31 -33.01 62.91 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.521 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 68.4 mmtt -71.57 -7.85 50.29 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.225 0.536 . . . . 0.0 110.976 -174.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 4.4 t -65.95 -21.91 66.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.993 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.7 t -63.67 -39.12 93.54 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -73.09 -42.82 62.59 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.359 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.526 ' CE2' HD12 ' A' ' 154' ' ' ILE . 71.9 m-85 -59.41 -49.37 78.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.43 0.633 . . . . 0.0 109.406 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -66.5 -28.94 68.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.304 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.05 -39.78 93.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.974 0.416 . . . . 0.0 110.125 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.78 23.55 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.149 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 40.0 m 58.65 50.4 9.0 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.996 174.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 35.5 mt -105.72 133.32 20.25 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.629 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.434 ' HB2' ' CG1' ' A' ' 155' ' ' ILE . 6.7 Cg_exo -71.96 119.18 6.02 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.997 2.465 . . . . 0.0 110.845 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 38.2 p -127.46 148.96 50.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -169.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.515 ' HD3' HG23 ' A' ' 155' ' ' ILE . 11.5 mtpp -149.64 139.89 22.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.76 174.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 50.4 mm -81.48 121.73 35.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.067 0.461 . . . . 0.0 110.747 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 14.2 t -76.85 -66.17 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.232 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -158.51 81.76 0.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.462 0.648 . . . . 0.0 110.229 174.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.48 ' O ' ' HD3' ' A' ' 132' ' ' PRO . . . 69.26 17.22 71.99 Favored Glycine 0 CA--C 1.511 -0.185 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -173.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.6 p -139.18 149.91 44.97 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.486 HD11 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -90.75 125.7 43.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.339 0.59 . . . . 0.0 109.624 179.12 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.531 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 26.0 tt0 -116.03 148.83 39.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.687 0.756 . . . . 0.0 111.065 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.526 HD12 ' CE2' ' A' ' 138' ' ' PHE . 38.6 mm -92.37 132.28 37.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.155 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.515 HG23 ' HD3' ' A' ' 146' ' ' LYS . 32.4 pt -97.51 -37.38 6.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.874 0.368 . . . . 0.0 111.772 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -119.78 127.83 53.16 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -53.76 116.68 2.64 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.345 0.403 . . . . 0.0 110.116 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.7 t -88.43 129.69 39.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -172.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -83.44 72.94 10.22 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.422 HG23 HD21 ' A' ' 175' ' ' LEU . 6.6 tp -66.55 -54.67 23.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.596 -171.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 16.1 mt -108.26 151.76 25.53 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.335 0.588 . . . . 0.0 111.081 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 9.5 mptt -130.37 133.24 24.66 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.034 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 76.6 Cg_exo -51.32 103.81 0.08 OUTLIER 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.01 2.473 . . . . 0.0 112.38 176.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.99 -13.11 10.59 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.14 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -81.73 -179.86 7.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -128.11 117.04 20.9 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 21.5 t -52.51 122.44 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.248 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -82.6 -179.41 52.74 Favored Glycine 0 C--O 1.228 -0.257 0 CA-C-N 116.027 -0.533 . . . . 0.0 113.107 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -70.11 -70.33 0.3 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.759 0.314 . . . . 0.0 111.37 -177.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 41.0 m -67.72 -21.25 65.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.054 0.454 . . . . 0.0 110.132 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -66.56 -46.26 76.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.661 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.461 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -63.08 -44.65 95.16 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.192 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.571 ' O ' ' HG3' ' A' ' 177' ' ' MET . 14.9 m -54.93 -47.14 74.81 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.087 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.672 ' O ' HD23 ' A' ' 178' ' ' LEU . 37.3 tp -54.98 -60.96 2.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.626 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.512 ' HA ' ' CD2' ' A' ' 178' ' ' LEU . 73.1 mt -59.26 -26.74 65.18 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.553 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -70.04 -42.47 72.87 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.571 ' HG3' ' O ' ' A' ' 173' ' ' THR . 55.5 mtm -68.14 -32.17 72.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.11 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 174' ' ' LEU . 0.1 OUTLIER -68.9 -21.27 64.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.885 176.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 4.6 t30 65.59 26.17 11.62 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.534 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.427 HG13 ' HB3' ' A' ' 178' ' ' LEU . 84.6 mt -96.27 139.38 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.246 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 10.9 t -88.73 114.79 61.35 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.272 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.495 ' HG2' ' CD2' ' A' ' 183' ' ' PHE . 64.6 Cg_endo -83.88 -10.73 9.25 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.338 2.025 . . . . 0.0 112.545 175.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.624 ' HB2' ' CB ' ' A' ' 109' ' ' ALA . 71.7 m-85 -120.9 -125.15 0.27 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 31.4 m -108.12 -73.39 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.488 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -148.4 168.62 22.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.512 0.196 . . . . 0.0 110.527 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.707 -1.052 . . . . 0.0 112.226 -177.824 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.71 ' SD ' ' HD3' ' A' ' 110' ' ' PRO . 3.3 mpp? . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.504 0.192 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -163.33 -60.6 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.592 ' HG3' ' H ' ' A' ' 107' ' ' VAL . 14.5 ptpt -111.29 -72.25 0.73 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.372 175.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.592 ' H ' ' HG3' ' A' ' 106' ' ' LYS . 1.1 m -160.87 46.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 O-C-N 123.309 0.381 . . . . 0.0 111.002 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 181' ' ' SER . 51.0 tt0 -141.33 119.83 12.38 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.929 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.502 ' CB ' ' HB2' ' A' ' 183' ' ' PHE . . . -88.75 160.79 43.4 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.505 174.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.71 ' HD3' ' SD ' ' A' ' 104' ' ' MET . 45.1 Cg_endo -68.43 93.84 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.378 2.052 . . . . 0.0 112.799 -175.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.64 108.27 10.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.269 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.403 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 5.9 tmm_? -129.76 127.2 22.84 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.303 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.473 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 9.9 Cg_endo -53.85 116.27 2.9 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.525 2.817 . . . . 0.0 112.597 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.2 -26.28 4.2 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.44 152.34 34.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.845 0.355 . . . . 0.0 110.646 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.402 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 51.2 mm -87.09 130.8 36.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.391 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -69.64 110.2 6.02 Favored Pre-proline 0 C--N 1.328 -0.345 0 O-C-N 123.589 0.556 . . . . 0.0 110.899 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 182' ' ' PRO . 4.2 Cg_exo -79.83 -28.82 3.08 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 123.27 2.647 . . . . 0.0 113.62 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.464 HD21 ' HB2' ' A' ' 118' ' ' PRO . 2.4 mm? -116.43 160.25 20.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.153 0.501 . . . . 0.0 111.727 -174.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.2 m -84.57 71.24 10.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.599 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 21.9 t -64.73 136.49 26.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.022 -175.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 45.1 t -124.27 130.88 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.837 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 75.2 mt -88.48 107.01 14.38 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.485 ' HB2' ' CD2' ' A' ' 126' ' ' HIS . 24.3 Cg_exo -63.15 140.25 76.99 Favored 'Trans proline' 0 CA--C 1.518 -0.313 0 C-N-CA 122.935 2.424 . . . . 0.0 112.95 -174.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.78 83.15 2.74 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.168 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.529 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 32.1 p80 -166.88 169.92 12.72 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -55.85 135.54 51.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.139 0.495 . . . . 0.0 110.746 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.0 p -95.68 -2.6 47.7 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.286 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 73.5 6.44 70.75 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.715 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.487 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 96.3 mt -92.34 156.04 17.51 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.617 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.63 151.97 45.95 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.17 -27.63 66.65 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.846 -174.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.64 -25.14 66.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.214 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.543 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 74.3 mmtt -67.01 -9.81 42.95 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.063 0.459 . . . . 0.0 111.095 -177.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.453 ' HB ' HG13 ' A' ' 152' ' ' ILE . 12.9 t -65.56 -20.91 66.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.905 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.1 t -65.09 -36.22 83.62 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -75.0 -44.34 48.69 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.327 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.619 ' CE1' HD13 ' A' ' 154' ' ' ILE . 85.0 m-85 -59.58 -49.44 77.76 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -64.48 -30.9 71.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.837 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.93 82.7 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.955 0.407 . . . . 0.0 110.195 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -93.13 26.15 2.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.381 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.2 m 58.59 41.08 22.86 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.066 174.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 27.8 mt -97.3 133.35 23.99 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.796 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.448 ' O ' HG12 ' A' ' 155' ' ' ILE . 4.7 Cg_exo -73.06 107.15 2.3 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.977 2.451 . . . . 0.0 111.106 174.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.442 HG23 ' CB ' ' A' ' 138' ' ' PHE . 43.1 p -124.78 171.51 10.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.249 0.547 . . . . 0.0 112.445 -173.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.422 ' HE3' HG22 ' A' ' 155' ' ' ILE . 21.4 pttp -165.36 163.8 19.81 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.747 173.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 41.0 mm -101.56 125.69 55.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.7 m -73.46 -44.69 57.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.565 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 149' ' ' LYS . 0.1 OUTLIER -163.3 -58.73 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.686 178.082 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -136.43 4.86 3.77 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.018 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.1 p -129.74 149.93 51.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.514 HD12 ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -85.25 130.36 36.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.268 0.556 . . . . 0.0 110.041 -178.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.529 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 30.0 tt0 -120.19 149.82 41.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.157 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.619 HD13 ' CE1' ' A' ' 138' ' ' PHE . 2.9 mp -97.64 136.98 26.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.898 176.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 144' ' ' PRO . 13.4 pt -95.62 -35.27 5.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.003 0.43 . . . . 0.0 111.893 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -122.46 125.23 45.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.108 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -51.8 123.14 9.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.313 0.578 . . . . 0.0 110.523 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 12.0 t -95.94 130.04 45.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.401 -168.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.458 ' O ' ' HE3' ' A' ' 162' ' ' LYS . 37.7 m80 -79.15 71.33 5.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 168.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.0 tp -63.25 -49.42 83.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.223 -173.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 13.8 mt -112.3 156.19 22.83 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.303 0.573 . . . . 0.0 111.176 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.46 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 7.7 mptt -132.46 132.22 22.68 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.631 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 10.7 Cg_endo -55.86 96.01 0.05 OUTLIER 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.766 2.311 . . . . 0.0 112.024 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 129.71 -13.41 5.85 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.95 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -84.46 153.93 23.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -97.5 107.59 20.13 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 54.8 t -46.72 124.5 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 O-C-N 123.861 0.725 . . . . 0.0 111.945 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.75 -179.29 50.21 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.207 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.473 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -70.84 -68.33 0.44 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.773 0.32 . . . . 0.0 111.598 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.8 m -61.82 -25.05 67.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.355 0.598 . . . . 0.0 109.679 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -69.73 -48.75 58.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.354 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.449 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -60.47 -44.19 96.16 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.246 176.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.655 ' O ' ' HG3' ' A' ' 177' ' ' MET . 27.0 m -59.76 -40.93 89.82 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.544 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.502 HD11 ' CE1' ' A' ' 138' ' ' PHE . 36.5 tp -60.32 -49.08 79.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.823 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 83.3 mt -64.63 -30.22 71.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.906 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -70.05 -42.73 72.49 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.329 0.585 . . . . 0.0 109.616 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.655 ' HG3' ' O ' ' A' ' 173' ' ' THR . 60.3 mtm -71.11 -28.56 64.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.425 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.476 HD22 ' CZ ' ' A' ' 138' ' ' PHE . 0.9 OUTLIER -78.97 -15.3 58.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.654 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 64.3 32.94 11.89 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 123.958 0.786 . . . . 0.0 109.74 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 81.4 mt -107.21 131.43 57.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.019 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.403 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 22.8 t -86.02 120.73 72.77 Favored Pre-proline 0 N--CA 1.447 -0.589 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.236 -177.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.471 ' O ' ' HD2' ' A' ' 118' ' ' PRO . 72.2 Cg_endo -87.77 -0.83 7.3 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.594 2.196 . . . . 0.0 112.666 174.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.502 ' HB2' ' CB ' ' A' ' 109' ' ' ALA . 92.4 m-85 -130.3 -89.39 0.48 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.651 0.262 . . . . 0.0 111.008 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 17.3 m -112.66 126.27 55.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.0 0.428 . . . . 0.0 111.145 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -83.14 102.88 12.14 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.319 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.335 0 CA-C-O 118.917 -0.935 . . . . 0.0 111.718 179.616 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -131.05 82.07 2.03 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 55.03 76.52 0.25 Allowed 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.737 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 185' ' ' TYR . 27.1 m -76.33 -10.99 13.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.482 -173.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.501 ' NE2' ' HA ' ' A' ' 176' ' ' ASN . 60.3 tt0 -80.47 106.67 12.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.035 0.445 . . . . 0.0 110.964 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.78 147.14 98.61 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.56 171.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.65 106.51 0.2 Allowed 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 123.039 2.493 . . . . 0.0 112.569 -177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -74.46 105.56 5.66 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.944 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -130.38 127.66 22.5 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.614 -174.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.447 ' HD3' ' CB ' ' A' ' 172' ' ' ALA . 26.0 Cg_endo -62.92 143.01 90.53 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.323 2.682 . . . . 0.0 112.552 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.98 -12.86 26.84 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.061 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.0 153.08 17.96 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.711 0.291 . . . . 0.0 110.571 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.7 mm -85.58 126.94 40.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.097 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -60.6 110.27 2.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 123.845 0.716 . . . . 0.0 111.387 -177.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -74.38 -46.69 0.27 Allowed 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 123.146 2.564 . . . . 0.0 112.578 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 91.0 mt -106.88 159.96 15.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.217 -173.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.8 t -85.02 75.72 10.35 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.44 ' CG2' ' HA ' ' A' ' 182' ' ' PRO . 25.9 t -63.88 134.98 28.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.359 -1.291 . . . . 0.0 110.671 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 46.5 t -125.1 129.04 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.519 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.461 HG22 HG13 ' A' ' 154' ' ' ILE . 75.8 mt -86.51 101.31 1.92 Allowed Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -71.18 137.18 30.86 Favored 'Trans proline' 0 CA--C 1.514 -0.484 0 C-N-CA 123.118 2.546 . . . . 0.0 114.318 -168.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.33 92.79 3.37 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.841 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -158.78 -50.53 0.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.238 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 173.57 150.19 0.07 Allowed 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.411 HG23 ' CZ ' ' A' ' 138' ' ' PHE . 71.0 p -110.54 -30.22 7.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.085 0.469 . . . . 0.0 110.639 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.81 2.85 88.43 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.464 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 94.4 mt -96.49 155.22 16.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.047 0.451 . . . . 0.0 110.789 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.89 174.3 54.88 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.567 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.442 ' O ' HG22 ' A' ' 135' ' ' THR . 20.6 Cg_exo -65.34 -19.14 61.77 Favored 'Trans proline' 0 N--CA 1.466 -0.144 0 C-N-CA 122.877 2.385 . . . . 0.0 112.966 -173.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.65 -27.87 66.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.957 0.408 . . . . 0.0 111.071 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.523 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 34.4 mmtp -73.32 -6.82 48.54 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.057 0.456 . . . . 0.0 111.44 -175.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 132' ' ' PRO . 6.1 t -66.47 -20.49 66.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.865 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.1 t -62.32 -42.2 99.18 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -70.52 -46.4 63.71 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.308 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.573 ' CE2' HD21 ' A' ' 178' ' ' LEU . 74.4 m-85 -58.63 -47.33 84.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.301 0.572 . . . . 0.0 109.547 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -68.75 -25.64 64.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.436 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.31 -33.18 75.16 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.162 0.506 . . . . 0.0 109.945 176.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -98.78 26.35 5.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.073 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.9 t 55.69 55.16 7.43 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.687 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 39.8 mt -112.6 135.54 21.52 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.037 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 2.8 Cg_exo -74.38 117.42 4.97 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.008 2.472 . . . . 0.0 111.079 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.485 ' CG2' HD12 ' A' ' 152' ' ' ILE . 40.7 p -131.43 148.62 52.67 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.802 -172.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -138.74 137.67 36.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.087 174.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 48.1 mm -83.63 109.18 16.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.1 p -74.86 -72.34 0.3 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.025 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -145.19 80.16 1.6 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.949 0.404 . . . . 0.0 110.153 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.57 -0.09 56.93 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.35 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.7 p -128.22 150.24 50.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.491 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -90.51 124.35 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.208 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.463 ' N ' HD13 ' A' ' 152' ' ' ILE . 33.8 tt0 -116.97 154.56 30.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.365 0.603 . . . . 0.0 110.508 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.503 HD12 ' CE2' ' A' ' 138' ' ' PHE . 48.2 mm -96.14 131.07 43.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.424 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.423 HD13 HG22 ' A' ' 155' ' ' ILE . 13.5 pt -94.49 -37.81 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.008 0.432 . . . . 0.0 111.714 -175.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -121.13 128.55 52.65 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -60.16 126.2 26.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.312 0.577 . . . . 0.0 109.475 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 20.8 t -99.92 128.62 51.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.402 -169.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -75.48 73.44 2.52 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 167.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.8 tp -64.93 -42.58 95.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.826 -175.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.4 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 15.6 mt -118.46 155.15 31.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.191 0.52 . . . . 0.0 110.176 175.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.494 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -149.4 130.87 7.36 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.409 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 81.2 Cg_exo -44.87 106.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.566 2.844 . . . . 0.0 112.835 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 127.96 -22.59 5.4 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.237 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -85.66 153.7 22.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.653 0.264 . . . . 0.0 110.374 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -102.09 111.86 24.29 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 56.4 t -49.14 123.41 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.5 0 O-C-N 123.955 0.784 . . . . 0.0 111.858 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.32 177.42 51.7 Favored Glycine 0 CA--C 1.519 0.291 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.094 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.94 -65.88 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.915 0.388 . . . . 0.0 111.774 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 49.8 m -65.55 -24.15 67.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.201 0.524 . . . . 0.0 109.829 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.1 -50.2 62.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.016 177.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.447 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -60.94 -39.67 90.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.309 175.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.546 ' O ' ' HG3' ' A' ' 177' ' ' MET . 49.9 m -60.23 -44.08 95.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.549 177.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.499 HD12 ' CE2' ' A' ' 138' ' ' PHE . 48.2 tp -60.34 -49.88 75.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.386 177.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 87.4 mt -61.82 -30.24 70.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.368 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.501 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 62.1 t30 -72.11 -42.81 65.66 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.546 ' HG3' ' O ' ' A' ' 173' ' ' THR . 63.2 mtm -67.07 -32.91 74.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.703 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.573 HD21 ' CE2' ' A' ' 138' ' ' PHE . 2.7 mm? -72.96 -11.93 60.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.732 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 61.28 31.84 19.35 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.528 0.68 . . . . 0.0 109.8 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.538 ' O ' ' HD3' ' A' ' 182' ' ' PRO . 78.2 mt -104.4 141.45 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.506 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.2 m -84.19 107.4 10.67 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.842 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 180' ' ' ILE . 95.7 Cg_endo -92.0 -3.74 3.97 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.196 1.93 . . . . 0.0 113.286 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.422 ' CD1' ' HG2' ' A' ' 182' ' ' PRO . 94.2 m-85 -132.2 -73.39 0.52 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.916 0.389 . . . . 0.0 111.405 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 26.6 t -129.21 174.66 9.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.045 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.599 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 90.1 m-85 -110.27 -171.15 1.78 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.498 ' N ' ' HA ' ' A' ' 107' ' ' VAL . . . . . . . . 0 C--O 1.248 1.012 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.595 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 5.0 mpp? . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.389 0.138 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -179.39 161.9 1.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -176.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.485 ' HE3' ' OXT' ' A' ' 186' ' ' GLY . 56.2 pttt 38.48 59.28 1.52 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.868 0.867 . . . . 0.0 111.982 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.543 HG21 HD22 ' A' ' 179' ' ' ASN . 15.9 m -65.82 -28.37 43.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.148 -175.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.627 ' OE1' ' HA ' ' A' ' 179' ' ' ASN . 52.3 tp60 -90.69 92.95 9.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.164 0.507 . . . . 0.0 111.226 -176.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.81 144.14 81.54 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.017 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.36 92.57 0.07 OUTLIER 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.113 2.542 . . . . 0.0 112.894 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.08 107.07 10.38 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -129.2 128.86 23.3 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.004 -173.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.548 ' HA ' ' O ' ' A' ' 167' ' ' VAL . 10.1 Cg_endo -54.59 126.19 21.53 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.496 2.797 . . . . 0.0 112.653 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 116.5 -23.6 10.25 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.695 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.8 140.25 38.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.81 131.5 34.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.675 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -65.09 110.27 4.01 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.814 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.93 -37.79 3.38 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.942 2.428 . . . . 0.0 112.637 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.9 mt -119.46 160.02 23.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.331 -173.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.3 t -86.32 77.03 9.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.801 0.81 . . . . 0.0 108.949 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.81 134.75 29.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.759 -176.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 59.3 t -125.71 121.66 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.38 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 158' ' ' VAL . 47.8 mt -79.23 106.38 4.45 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.424 ' HB2' ' CE1' ' A' ' 126' ' ' HIS . 16.2 Cg_exo -66.3 145.48 78.02 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.995 2.463 . . . . 0.0 113.461 -170.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.416 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -73.01 82.39 1.23 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.335 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.484 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 1.6 p-80 -174.72 179.32 1.71 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.415 175.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -55.61 135.75 50.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.988 0.423 . . . . 0.0 110.595 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.7 p -96.38 -2.41 45.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.008 0.432 . . . . 0.0 111.425 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 76.69 19.98 77.09 Favored Glycine 0 N--CA 1.453 -0.208 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.6 mt -116.08 147.97 40.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.315 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.55 168.27 54.58 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.897 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.05 14.53 0.27 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 123.349 2.7 . . . . 0.0 113.637 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -90.41 -31.64 16.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.437 0.637 . . . . 0.0 109.769 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.476 ' HB3' ' SD ' ' A' ' 177' ' ' MET . 47.3 mmtm -72.88 -11.04 60.44 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.823 -175.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 15.3 t -64.8 -22.5 67.0 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.634 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.0 p -63.43 -37.26 86.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.001 0.429 . . . . 0.0 109.937 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.543 ' CD1' ' HE2' ' A' ' 177' ' ' MET . 94.8 m-85 -76.02 -42.43 47.99 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.22 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.579 ' CE2' HD11 ' A' ' 174' ' ' LEU . 76.2 m-85 -59.12 -51.03 71.78 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 121.448 0.642 . . . . 0.0 109.391 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -65.91 -30.38 70.96 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.244 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.18 98.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.477 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -86.33 23.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.948 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.3 m 56.24 50.16 13.93 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.533 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 23.4 mt -104.25 131.23 22.11 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.688 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 2.7 Cg_exo -73.93 112.18 3.48 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.883 2.389 . . . . 0.0 111.059 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 55.8 p -127.59 162.41 26.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.122 0.487 . . . . 0.0 111.974 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.445 ' HE2' HG23 ' A' ' 155' ' ' ILE . 60.9 pttt -150.85 148.69 28.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.124 172.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 45.0 mm -88.81 115.14 28.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.014 0.435 . . . . 0.0 109.997 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 35.2 t -80.13 -80.78 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.026 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -127.23 65.49 1.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.882 0.372 . . . . 0.0 110.07 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 70.43 15.82 73.14 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -174.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.8 p -136.19 150.77 49.16 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.491 HD11 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -84.88 128.46 38.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.197 0.522 . . . . 0.0 110.457 -178.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.484 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 20.0 tt0 -118.3 148.04 42.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.589 0.709 . . . . 0.0 110.963 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.451 HD12 ' CE2' ' A' ' 138' ' ' PHE . 41.7 mm -93.13 138.02 21.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.297 177.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.445 HG23 ' HE2' ' A' ' 146' ' ' LYS . 16.5 pt -100.93 -37.72 5.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.599 -0.44 . . . . 0.0 112.161 -176.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -121.04 139.61 53.06 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -56.41 111.13 0.9 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.377 0.608 . . . . 0.0 110.665 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.468 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 16.6 t -85.72 128.55 39.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.079 -175.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -91.72 72.39 5.81 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.1 tp -66.83 -42.74 89.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.755 -170.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 13.3 mt -119.04 140.79 49.45 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.63 0.728 . . . . 0.0 111.803 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.97 127.02 27.01 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.302 174.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 9.4 Cg_endo -54.33 100.2 0.06 OUTLIER 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.501 2.134 . . . . 0.0 111.622 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 127.22 -16.13 6.38 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.289 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -78.4 175.61 10.13 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.51 ' HB2' ' HZ3' ' A' ' 166' ' ' LYS . 4.1 ttmp? -119.69 109.82 16.09 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 42.1 t -51.4 125.64 5.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 123.881 0.738 . . . . 0.0 111.367 -176.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.28 -177.6 51.9 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.996 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.08 -65.2 0.87 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.81 0.338 . . . . 0.0 111.9 -175.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 51.0 m -65.1 -24.51 67.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -67.35 -48.67 66.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.094 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.428 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -58.58 -46.37 87.07 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.277 0.56 . . . . 0.0 110.193 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 21.3 m -58.11 -38.99 77.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.699 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.579 HD11 ' CE2' ' A' ' 138' ' ' PHE . 25.8 tp -68.24 -42.42 79.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.209 0.528 . . . . 0.0 110.937 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.6 mt -70.19 -17.48 63.16 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.95 0.405 . . . . 0.0 110.605 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.431 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 8.5 t30 -81.08 -47.84 12.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.184 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.543 ' HE2' ' CD1' ' A' ' 137' ' ' PHE . 20.6 ptp -64.99 -33.42 75.99 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.229 0.538 . . . . 0.0 110.67 177.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.444 ' HB3' ' HB ' ' A' ' 180' ' ' ILE . 0.3 OUTLIER -65.78 -32.21 73.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.946 178.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . 0.627 ' HA ' ' OE1' ' A' ' 108' ' ' GLN . 2.5 t-20 56.88 42.5 26.33 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.896 0.855 . . . . 0.0 108.797 -173.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 178' ' ' LEU . 16.2 tt -94.76 -7.53 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.254 -171.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.0 m 60.21 72.47 0.74 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.565 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.93 -7.07 18.06 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.25 1.967 . . . . 0.0 113.282 -176.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -123.14 -63.15 1.28 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.107 0.48 . . . . 0.0 110.053 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 25.6 t -138.97 153.61 48.2 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.331 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -110.0 14.7 22.93 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.142 0.496 . . . . 0.0 110.219 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.485 ' OXT' ' HE3' ' A' ' 106' ' ' LYS . . . . . . . . 0 C--O 1.25 1.136 0 CA-C-O 118.181 -1.344 . . . . 0.0 111.114 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 74.4 mtm . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -127.96 106.94 9.43 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.481 -171.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 54.51 34.37 20.95 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 123.559 0.537 . . . . 0.0 110.675 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.408 ' HA ' ' HB2' ' A' ' 185' ' ' TYR . 59.1 t -71.99 -27.55 27.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.114 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -59.29 111.16 1.26 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.718 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' A' ' 183' ' ' PHE . . . -76.51 149.21 81.06 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.65 173.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.88 96.4 0.09 OUTLIER 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.782 2.321 . . . . 0.0 112.615 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -74.3 102.54 4.39 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -121.29 125.55 26.87 Favored Pre-proline 0 C--N 1.314 -0.942 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.785 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.433 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 9.5 Cg_endo -53.87 118.54 5.06 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.574 2.849 . . . . 0.0 112.481 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.45 -17.67 11.22 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.645 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.27 150.48 28.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.911 0.386 . . . . 0.0 110.28 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.3 mm -86.11 135.61 24.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.394 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -73.71 109.34 6.44 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.738 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -78.88 -36.62 0.73 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.255 2.636 . . . . 0.0 113.421 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.5 mt -114.66 159.74 20.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.18 0.514 . . . . 0.0 111.654 -172.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.5 m -81.78 71.57 8.8 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.284 173.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 19.7 t -66.67 129.59 31.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.362 -177.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 47.8 t -123.21 122.54 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.441 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.4 HG21 HG13 ' A' ' 154' ' ' ILE . 56.9 mt -80.6 106.21 4.96 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.91 142.15 80.75 Favored 'Trans proline' 0 CA--C 1.511 -0.67 0 C-N-CA 123.209 2.606 . . . . 0.0 113.952 -170.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.423 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -68.56 83.52 0.27 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.301 175.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -172.94 157.55 3.6 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -170.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.15 130.58 43.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.057 0.456 . . . . 0.0 110.969 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 37.2 p -84.89 -9.49 58.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.063 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.46 -0.61 87.64 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.571 -177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 90.3 mt -86.3 154.19 21.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.773 0.321 . . . . 0.0 110.471 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.9 168.67 54.07 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.987 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.462 ' O ' HG21 ' A' ' 135' ' ' THR . 17.0 Cg_exo -67.46 -3.1 9.47 Favored 'Trans proline' 0 CA--C 1.527 0.138 0 C-N-CA 123.198 2.599 . . . . 0.0 113.119 -174.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -78.8 -32.32 46.32 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.17 0.51 . . . . 0.0 110.548 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -69.79 -11.38 60.81 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.472 -174.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 132' ' ' PRO . 6.8 t -66.38 -17.97 65.08 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.029 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.0 t -62.16 -42.25 99.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.458 ' CD1' ' HE2' ' A' ' 177' ' ' MET . 92.2 m-85 -75.0 -40.86 60.42 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.233 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.559 ' CE1' HD12 ' A' ' 174' ' ' LEU . 71.3 m-85 -59.81 -50.66 72.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.225 0.536 . . . . 0.0 109.688 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -65.05 -30.62 71.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.221 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.29 93.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.876 0.369 . . . . 0.0 110.578 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.38 31.41 1.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.709 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.0 p 52.2 49.62 20.19 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.88 0.872 . . . . 0.0 112.574 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 24.9 mt -108.55 131.16 21.95 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 3.5 Cg_exo -76.6 114.63 3.9 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.072 2.515 . . . . 0.0 111.339 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 82.3 p -129.25 162.65 27.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.978 0.418 . . . . 0.0 111.427 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -151.89 142.99 23.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.641 171.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 44.5 mm -81.28 119.44 30.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.891 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.2 t -68.12 -36.09 79.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.135 -178.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -173.96 -66.31 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.438 ' O ' ' HD3' ' A' ' 132' ' ' PRO . . . -128.91 6.62 6.47 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 173.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 22.7 p -128.42 152.12 48.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.87 0.367 . . . . 0.0 110.296 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.477 HD11 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -86.64 130.79 36.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.222 179.653 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -117.79 153.23 33.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.307 0.575 . . . . 0.0 110.716 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.475 HD13 ' CE1' ' A' ' 138' ' ' PHE . 29.1 mm -98.04 130.81 46.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.259 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.438 HG13 HD21 ' A' ' 156' ' ' ASN . 25.3 pt -93.14 -35.8 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.918 0.39 . . . . 0.0 111.885 -176.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.438 HD21 HG13 ' A' ' 155' ' ' ILE . 43.4 m-80 -123.83 136.88 54.66 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.343 177.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -61.09 118.59 6.98 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.461 0.475 . . . . 0.0 109.774 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.3 t -92.91 128.77 44.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.09 -172.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -78.45 67.98 4.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 170.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.1 tp -61.19 -51.46 72.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.875 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 14.8 mt -114.77 159.87 20.09 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.287 0.565 . . . . 0.0 110.059 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.556 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -153.49 132.36 6.85 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.94 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 4.2 Cg_endo -48.26 110.59 0.34 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.596 2.864 . . . . 0.0 112.706 -176.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.09 -19.09 8.84 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.304 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -79.84 174.9 11.12 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -125.85 107.2 10.27 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 34.3 t -51.89 122.66 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 O-C-N 123.857 0.723 . . . . 0.0 111.44 -176.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.83 -175.63 46.87 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.794 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.433 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -71.39 -65.02 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 111.886 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.8 m -62.07 -29.31 70.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.476 0.655 . . . . 0.0 109.615 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -67.51 -48.31 67.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.083 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.426 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.54 -39.14 83.02 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.241 0.543 . . . . 0.0 110.451 175.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 26.5 m -61.26 -41.29 96.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.528 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.559 HD12 ' CE1' ' A' ' 138' ' ' PHE . 28.6 tp -67.88 -42.16 81.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.896 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.2 mt -69.02 -20.95 64.15 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.845 0.355 . . . . 0.0 110.648 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -78.51 -46.97 18.31 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.141 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.489 ' HG2' ' HA ' ' A' ' 174' ' ' LEU . 22.1 ptp -66.19 -24.18 66.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.51 0.671 . . . . 0.0 110.342 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 180' ' ' ILE . 0.3 OUTLIER -78.11 -29.56 48.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.289 179.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 57.91 34.3 24.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 122.026 0.917 . . . . 0.0 108.727 -174.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 178' ' ' LEU . 17.7 tt -86.48 -12.47 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.646 -169.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 18.8 t 59.37 82.34 0.23 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.207 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.42 -7.08 19.85 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.405 2.07 . . . . 0.0 113.162 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.523 ' HB2' ' CB ' ' A' ' 109' ' ' ALA . 82.5 m-85 -119.95 -96.93 0.47 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.607 0.241 . . . . 0.0 110.756 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 27.2 t -162.02 149.3 14.12 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.766 0.317 . . . . 0.0 110.688 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.408 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 42.5 t80 -72.12 -51.48 21.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.625 0.726 . . . . 0.0 109.124 171.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.12 0 CA-C-O 118.371 -1.239 . . . . 0.0 110.95 178.54 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' A' ' 113' ' ' PRO . 6.7 tmm_? -138.43 130.12 15.73 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.747 -175.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 9.5 Cg_endo -54.22 122.89 12.28 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.541 2.827 . . . . 0.0 112.959 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 120.42 -25.81 7.21 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.616 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.71 147.36 35.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.94 0.4 . . . . 0.0 110.613 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.58 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 48.3 mm -81.44 143.47 12.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.964 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 118' ' ' PRO . . . -85.03 103.74 3.76 Favored Pre-proline 0 C--N 1.328 -0.334 0 O-C-N 123.485 0.491 . . . . 0.0 110.569 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.58 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 3.3 Cg_exo -79.91 -30.45 2.26 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.879 2.386 . . . . 0.0 113.018 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.435 HD22 ' HB2' ' A' ' 118' ' ' PRO . 2.0 mm? -110.65 165.93 11.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.146 0.498 . . . . 0.0 111.556 -173.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.3 m -92.72 84.76 5.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.634 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 21.1 t -82.58 134.32 27.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.523 -176.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 53.9 t -126.88 125.16 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.57 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.503 HG22 HG13 ' A' ' 154' ' ' ILE . 75.8 mt -82.36 108.16 11.01 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 19.4 Cg_exo -64.66 147.26 89.91 Favored 'Trans proline' 0 CA--C 1.511 -0.643 0 C-N-CA 122.875 2.383 . . . . 0.0 113.614 -171.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.411 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -72.99 81.71 1.21 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.145 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.444 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 48.1 t-80 -168.46 156.11 8.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 0.4 OUTLIER -63.31 132.09 50.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.362 0.601 . . . . 0.0 110.366 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.511 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 77.6 p -83.37 -14.2 53.33 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.439 -172.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.67 -14.67 57.72 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -175.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.485 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 95.2 mt -77.31 149.07 35.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.365 -0.417 . . . . 0.0 110.539 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.67 162.33 34.25 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.617 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.36 -12.25 26.51 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 123.03 2.487 . . . . 0.0 112.689 -174.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.81 -30.36 66.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.787 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.485 ' HG3' ' HB3' ' A' ' 130' ' ' LEU . 74.3 mmtt -71.68 -6.37 40.64 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.977 0.418 . . . . 0.0 111.252 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.0 t -65.2 -21.04 66.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.553 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.2 t -65.01 -38.63 91.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.735 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -73.58 -42.48 61.54 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.424 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.574 ' CZ ' HD21 ' A' ' 178' ' ' LEU . 86.1 m-85 -59.97 -48.75 80.44 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -65.79 -28.8 69.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.019 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.32 -34.36 77.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.054 0.454 . . . . 0.0 110.179 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 141' ' ' LEU . 3.9 mm? -94.9 18.87 11.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.182 174.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t 59.81 58.29 2.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.854 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 40.8 mt -115.08 135.66 22.52 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.462 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.43 ' HB2' ' CG1' ' A' ' 155' ' ' ILE . 3.4 Cg_exo -74.59 118.01 5.17 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.037 2.492 . . . . 0.0 111.054 174.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.411 ' CG2' HD11 ' A' ' 152' ' ' ILE . 35.4 p -128.84 152.57 48.35 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -172.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -148.05 147.85 30.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.421 172.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 43.6 mm -84.6 128.51 38.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.89 0.376 . . . . 0.0 110.605 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 45.5 t -99.96 -83.33 0.43 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.277 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -113.36 53.34 0.77 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.955 0.407 . . . . 0.0 110.178 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 70.05 14.11 70.54 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -171.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.2 p -130.65 151.33 51.23 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.491 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -79.65 128.01 38.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.288 0.566 . . . . 0.0 110.167 -178.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.444 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 37.7 tt0 -116.86 153.93 31.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.536 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.503 HG13 HG22 ' A' ' 123' ' ' ILE . 42.5 mm -99.88 133.05 44.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.737 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.43 ' CG1' ' HB2' ' A' ' 144' ' ' PRO . 16.0 pt -95.06 -34.72 5.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -176.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -122.39 132.13 54.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.057 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -54.96 115.46 2.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.434 0.635 . . . . 0.0 110.456 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 24.5 t -91.51 126.85 44.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.873 -171.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.621 ' O ' ' HE3' ' A' ' 162' ' ' LYS . 10.8 p-80 -80.24 73.87 7.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.432 0.635 . . . . 0.0 109.298 170.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.42 HD11 ' HG3' ' A' ' 171' ' ' GLU . 6.9 tp -64.94 -50.43 75.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.196 -174.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 15.7 mt -113.23 147.78 36.82 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.429 0.633 . . . . 0.0 110.664 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.621 ' HE3' ' O ' ' A' ' 159' ' ' HIS . 6.6 mptt -127.74 133.32 24.98 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.409 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 11.5 Cg_endo -56.56 101.87 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.391 2.061 . . . . 0.0 111.727 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.88 -5.94 12.44 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.772 -175.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -86.32 -173.33 4.49 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -135.49 116.18 13.92 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.694 0.283 . . . . 0.0 110.304 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.7 t -61.26 121.86 10.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.289 -177.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.63 -170.91 46.69 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.969 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -76.27 -63.83 1.24 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.973 0.415 . . . . 0.0 111.669 -175.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.5 m -66.27 -23.94 66.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.42 ' HG3' HD11 ' A' ' 160' ' ' ILE . 22.2 tt0 -70.18 -50.07 43.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.963 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.426 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -56.21 -46.69 79.37 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.289 0.566 . . . . 0.0 110.066 174.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.609 ' O ' ' HG3' ' A' ' 177' ' ' MET . 22.5 m -59.07 -42.17 89.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.585 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.528 HD11 ' CE2' ' A' ' 138' ' ' PHE . 48.9 tp -59.67 -49.11 79.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.708 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.02 -29.27 69.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.241 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -74.53 -33.22 62.71 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.141 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.609 ' HG3' ' O ' ' A' ' 173' ' ' THR . 63.9 mtm -79.33 -26.14 42.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.326 0.584 . . . . 0.0 110.089 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.574 HD21 ' CZ ' ' A' ' 138' ' ' PHE . 1.4 mm? -78.28 -15.08 59.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.229 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 . . . . . 0 CA--C 1.521 -0.138 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.543 -178.56 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 120.926 0.394 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.464 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 4.2 tmt_? -128.97 129.78 23.43 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.567 -177.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 167' ' ' VAL . 10.1 Cg_endo -52.72 122.51 11.08 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.262 2.642 . . . . 0.0 111.561 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 120.72 -18.37 9.23 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 119.946 -1.121 . . . . 0.0 112.017 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.53 143.51 27.68 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.95 0.405 . . . . 0.0 110.597 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.2 mm -80.84 131.73 33.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.965 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -67.37 110.81 5.82 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.203 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -77.24 -32.32 3.14 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.193 2.595 . . . . 0.0 113.433 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 90.5 mt -121.43 160.71 23.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.97 0.414 . . . . 0.0 111.609 -172.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.5 m -83.6 77.41 9.85 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.542 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 31.7 t -70.89 133.86 31.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.778 -176.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 51.1 t -123.74 129.27 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.341 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.49 HG22 HG13 ' A' ' 154' ' ' ILE . 78.7 mt -86.5 108.54 18.29 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 173.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.51 140.08 93.22 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 123.209 2.606 . . . . 0.0 114.079 -171.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.442 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -72.78 85.65 1.23 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.72 175.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.484 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 3.4 t-80 -171.85 176.14 3.69 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -174.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -62.75 137.88 58.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.042 0.448 . . . . 0.0 110.038 173.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.453 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 42.9 p -92.84 -11.11 34.43 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.554 -176.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.81 15.54 80.55 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.291 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 87.7 mt -114.75 152.54 31.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.354 -0.423 . . . . 0.0 110.135 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.15 167.24 51.85 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.925 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.38 6.58 1.13 Allowed 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 123.314 2.676 . . . . 0.0 112.794 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -86.88 -35.0 19.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.697 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.504 ' HE2' ' SD ' ' A' ' 177' ' ' MET . 25.4 mmmt -74.99 -3.05 30.05 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 121.602 0.715 . . . . 0.0 110.783 -172.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.0 t -63.77 -21.8 66.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.008 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.7 p -61.09 -41.2 96.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.882 0.372 . . . . 0.0 109.997 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -70.31 -44.96 67.23 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.497 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.492 ' CZ ' HD21 ' A' ' 178' ' ' LEU . 78.3 m-85 -58.69 -46.77 86.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.514 0.673 . . . . 0.0 109.861 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -69.81 -27.15 64.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.198 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.81 -31.91 73.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.996 0.427 . . . . 0.0 110.057 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 141' ' ' LEU . 4.0 mm? -94.42 22.73 5.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 173.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.9 t 59.21 43.17 17.44 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.35 174.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 29.5 mt -102.0 134.01 20.35 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 4.6 Cg_exo -71.79 108.72 2.49 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.721 2.281 . . . . 0.0 110.937 175.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.466 HG21 ' CB ' ' A' ' 138' ' ' PHE . 40.8 p -122.68 144.9 48.84 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.108 0.48 . . . . 0.0 112.053 -174.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -140.11 148.93 42.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.836 172.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 38.9 mm -88.0 131.42 35.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.836 0.35 . . . . 0.0 110.45 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.9 t -136.65 124.33 22.41 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.738 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.6 tttp 58.9 37.92 24.59 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.513 0.673 . . . . 0.0 111.022 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 71.34 13.63 73.85 Favored Glycine 0 N--CA 1.454 -0.147 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.069 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.7 p -130.06 151.96 50.04 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.51 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -77.38 123.62 34.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.303 0.573 . . . . 0.0 109.685 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.484 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 39.4 tt0 -113.42 152.38 30.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.584 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.49 HG13 HG22 ' A' ' 123' ' ' ILE . 46.3 mm -97.16 129.45 47.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.532 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 9.2 pt -92.63 -35.92 7.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.838 0.351 . . . . 0.0 111.887 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -122.53 132.09 54.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.508 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -58.12 114.48 2.4 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.69 0.757 . . . . 0.0 109.818 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.5 t -84.68 127.64 39.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.837 -170.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -82.59 72.76 9.66 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 171.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.495 HG21 HD21 ' A' ' 175' ' ' LEU . 7.2 tp -70.14 -47.14 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.475 -172.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 17.3 mt -117.01 160.0 21.63 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.286 0.565 . . . . 0.0 110.49 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -157.94 131.07 4.57 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.291 -179.17 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 89.6 Cg_exo -44.85 108.89 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.799 2.999 . . . . 0.0 113.078 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 122.36 -22.27 7.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.109 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -81.85 178.59 8.22 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -126.62 118.46 24.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.722 0.296 . . . . 0.0 110.401 -175.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 26.3 t -59.9 121.58 7.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.709 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.44 -177.2 50.55 Favored Glycine 0 C--O 1.226 -0.394 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.676 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.9 -62.65 1.47 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.897 0.379 . . . . 0.0 111.546 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.2 m -65.51 -24.93 67.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -69.09 -49.43 57.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.138 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.421 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.29 -42.27 90.91 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.18 0.514 . . . . 0.0 110.106 175.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.606 ' O ' ' HG3' ' A' ' 177' ' ' MET . 33.0 m -61.38 -39.17 89.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.738 177.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 51.8 tp -61.44 -49.06 78.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.52 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.495 HD21 HG21 ' A' ' 160' ' ' ILE . 84.4 mt -71.61 -18.57 62.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -73.48 -42.27 62.08 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.606 ' HG3' ' O ' ' A' ' 173' ' ' THR . 58.2 mtm -71.67 -32.7 68.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.442 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.492 HD21 ' CZ ' ' A' ' 138' ' ' PHE . 2.4 mm? -77.49 -16.37 58.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.231 -176.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 121.499 0.666 . . . . 0.0 109.592 -179.374 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.407 ' HB3' ' ND2' ' A' ' 176' ' ' ASN . . . . . . . . 0 CA--C 1.513 -0.473 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -133.87 133.93 22.72 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.079 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 167' ' ' VAL . 9.3 Cg_endo -54.15 118.52 5.09 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.738 2.959 . . . . 0.0 113.101 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.91 -6.69 15.47 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.025 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.4 145.19 24.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.7 0.286 . . . . 0.0 110.372 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.3 mm -81.45 127.15 39.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.255 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.684 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -58.3 112.33 4.76 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.452 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 117' ' ' ALA . 12.8 Cg_exo -73.86 -49.7 0.19 Allowed 'Trans proline' 0 CA--C 1.528 0.176 0 C-N-CA 123.257 2.638 . . . . 0.0 112.88 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 75.4 mt -105.07 159.93 15.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.116 0.484 . . . . 0.0 111.697 -173.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.0 m -85.77 82.26 8.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.517 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 21.9 t -81.59 132.96 30.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.082 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 45.3 t -123.7 128.32 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.978 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . 58.1 mt -83.78 107.88 11.82 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 17.2 Cg_exo -65.84 137.89 51.04 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 C-N-CA 122.922 2.414 . . . . 0.0 113.728 -170.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -84.04 72.63 10.45 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.122 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -151.79 -56.69 0.14 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.587 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.448 HD22 ' C ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER -177.28 150.29 0.71 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.96 0.41 . . . . 0.0 110.971 175.519 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.485 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 81.7 p -115.06 -19.27 10.96 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.792 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 77.36 4.35 84.02 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.848 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.412 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 93.1 mt -94.82 150.65 19.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.058 0.456 . . . . 0.0 111.159 -175.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -72.39 169.64 51.43 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.862 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.497 ' O ' HG22 ' A' ' 135' ' ' THR . 20.4 Cg_exo -64.95 -17.74 60.26 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.898 2.398 . . . . 0.0 113.167 -173.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -59.21 -36.55 75.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.416 0.627 . . . . 0.0 110.795 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.426 ' HB3' ' CE ' ' A' ' 177' ' ' MET . 70.3 mmtt -71.66 -11.47 60.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.684 -170.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 132' ' ' PRO . 5.1 t -65.76 -21.86 66.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.074 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 26.0 t -62.92 -39.45 94.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -75.84 -40.36 54.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.226 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.506 ' CE2' HD11 ' A' ' 154' ' ' ILE . 71.3 m-85 -59.8 -48.46 81.59 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -66.35 -29.72 69.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.111 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.27 77.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.828 0.347 . . . . 0.0 110.318 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.46 HD13 ' HA ' ' A' ' 141' ' ' LEU . 4.0 mm? -91.47 19.6 6.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 174.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.2 m 60.14 43.78 13.74 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.617 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.479 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 26.5 mt -99.66 133.56 21.72 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.61 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 3.2 Cg_exo -75.8 108.5 2.7 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.853 2.369 . . . . 0.0 110.982 175.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.51 ' CG2' HD11 ' A' ' 152' ' ' ILE . 45.9 p -122.26 164.78 17.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.226 0.536 . . . . 0.0 112.181 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.588 ' HE2' HG22 ' A' ' 155' ' ' ILE . 54.2 pttt -149.93 143.31 25.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.517 173.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 44.1 mm -87.24 110.24 20.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 27.8 p -63.97 -34.52 78.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.775 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -170.64 -67.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.486 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -130.43 4.43 5.88 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 175.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.4 p -125.04 151.67 45.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.517 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -90.16 130.95 38.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 121.242 0.544 . . . . 0.0 110.046 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.501 ' N ' HD13 ' A' ' 152' ' ' ILE . 40.0 tt0 -123.89 156.43 36.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.276 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.506 HD11 ' CE2' ' A' ' 138' ' ' PHE . 1.9 mp -101.87 137.23 30.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.389 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.588 HG22 ' HE2' ' A' ' 146' ' ' LYS . 7.9 pt -91.76 -37.19 8.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.877 0.37 . . . . 0.0 111.929 -177.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -121.31 123.86 43.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.01 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -52.24 122.11 8.06 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 123.737 0.648 . . . . 0.0 110.545 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 19.8 t -94.38 126.29 46.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.992 -170.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.466 ' HB3' ' HD2' ' A' ' 162' ' ' LYS . 91.7 m-70 -80.06 76.74 6.79 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 171.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.1 tp -72.72 -42.31 62.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.246 -172.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.558 ' C ' ' HD3' ' A' ' 162' ' ' LYS . 10.1 mt -121.89 142.06 50.65 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.493 0.663 . . . . 0.0 111.876 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.558 ' HD3' ' C ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER -132.62 124.6 19.04 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.705 175.066 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 89.9 Cg_exo -44.0 101.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.279 2.652 . . . . 0.0 112.837 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 130.72 -25.76 4.15 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.058 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 162' ' ' LYS . 3.6 m-20 -76.07 158.5 31.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.853 0.359 . . . . 0.0 111.07 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -98.4 118.69 35.63 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 44.6 t -61.47 126.01 18.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.738 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.58 -178.91 52.09 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.662 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.78 -63.8 1.09 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.894 0.378 . . . . 0.0 111.582 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 36.0 t -63.94 -24.84 67.88 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -68.56 -47.18 67.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.908 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.404 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.0 -47.08 86.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.31 174.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.404 HG22 ' SD ' ' A' ' 177' ' ' MET . 57.6 m -55.48 -46.52 76.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.422 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.499 HD11 ' CE2' ' A' ' 138' ' ' PHE . 58.3 tp -58.83 -44.48 90.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.108 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.8 mt -68.34 -29.87 68.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.44 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.407 ' ND2' ' HB3' ' A' ' 111' ' ' ALA . 33.5 m-80 -73.22 -35.1 66.23 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.426 ' CE ' ' HB3' ' A' ' 134' ' ' LYS . 35.9 mtp -66.55 -34.97 79.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.781 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.488 HD21 ' CE2' ' A' ' 138' ' ' PHE . 2.1 mm? -78.3 -9.78 59.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.395 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 . . . . . 0 N--CA 1.465 0.285 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.683 -176.406 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.343 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.452 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 7.8 tmm_? -133.51 128.74 20.26 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.588 -174.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.465 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 7.4 Cg_endo -51.61 124.26 14.0 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.749 2.966 . . . . 0.0 112.94 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.53 -29.48 6.63 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.648 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.26 146.48 41.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.935 0.398 . . . . 0.0 110.358 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.404 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 42.7 mm -81.7 136.95 22.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.57 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -75.2 109.71 8.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.134 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 10.1 Cg_exo -75.49 -44.66 0.29 Allowed 'Trans proline' 0 CA--C 1.527 0.164 0 C-N-CA 123.186 2.591 . . . . 0.0 113.312 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 91.3 mt -105.08 162.25 13.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.258 0.551 . . . . 0.0 111.916 -172.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.5 m -87.66 83.07 7.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.634 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.2 t -78.7 132.9 31.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.372 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 54.5 t -123.23 131.45 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.442 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 158' ' ' VAL . 75.0 mt -91.46 107.22 20.22 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.65 146.5 95.29 Favored 'Trans proline' 0 CA--C 1.513 -0.555 0 C-N-CA 122.736 2.291 . . . . 0.0 113.085 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.34 78.26 3.1 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.491 -1.232 . . . . 0.0 110.719 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.454 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 6.9 t-80 -167.13 153.43 8.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.94 132.29 46.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.353 0.597 . . . . 0.0 111.661 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.8 p -87.92 -4.8 58.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.424 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.98 4.42 90.52 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -175.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.529 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 87.6 mt -94.64 152.3 18.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.2 -0.5 . . . . 0.0 110.559 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.41 162.68 53.26 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.823 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -57.97 -29.23 85.96 Favored 'Trans proline' 0 C--O 1.224 -0.197 0 C-N-CA 123.021 2.481 . . . . 0.0 112.451 -174.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.49 -31.43 62.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.209 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.529 ' HG3' ' HB3' ' A' ' 130' ' ' LEU . 45.3 mmtm -70.11 -10.45 58.81 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.468 0.651 . . . . 0.0 111.089 -174.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.3 t -67.82 -14.98 63.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.799 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.7 t -64.61 -42.12 95.76 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -72.64 -42.26 64.6 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.939 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.49 ' CE1' HD11 ' A' ' 154' ' ' ILE . 83.2 m-85 -59.67 -47.02 87.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.701 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -65.16 -32.75 74.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.67 -36.14 81.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.579 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 141' ' ' LEU . 3.9 mm? -93.16 21.92 5.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.324 175.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.7 t 59.85 50.66 6.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.47 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.498 HG23 HG21 ' A' ' 158' ' ' VAL . 21.9 mt -105.68 133.08 20.36 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.57 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 7.5 Cg_exo -72.62 110.82 3.09 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.854 2.37 . . . . 0.0 110.693 174.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.428 HG21 ' CB ' ' A' ' 138' ' ' PHE . 17.4 p -126.62 155.94 41.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.217 -170.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -145.83 159.21 43.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.762 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 45.0 mm -100.55 102.9 14.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.2 m -80.82 -44.12 18.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.679 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -156.18 60.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.121 0.486 . . . . 0.0 111.413 -176.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 75.1 -3.69 44.39 Favored Glycine 0 C--O 1.229 -0.196 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.459 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.0 p -124.01 154.88 39.22 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.454 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -85.62 129.42 38.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.354 0.597 . . . . 0.0 110.429 -176.659 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.454 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 33.5 tt0 -127.46 149.18 50.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.624 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.49 HD11 ' CE1' ' A' ' 138' ' ' PHE . 3.0 mp -95.48 140.25 17.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.327 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.441 ' CG1' ' HB2' ' A' ' 144' ' ' PRO . 14.8 pt -96.22 -35.6 5.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -123.19 126.99 48.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.161 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -55.37 121.12 8.25 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.403 0.621 . . . . 0.0 110.35 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.2 t -93.89 124.25 46.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.865 -170.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -78.37 77.96 4.85 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 168.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.424 HG21 HD21 ' A' ' 175' ' ' LEU . 6.4 tp -68.6 -45.99 80.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.411 -172.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.4 mt -114.71 149.07 37.37 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.442 0.639 . . . . 0.0 111.211 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.55 132.13 24.26 Favored Pre-proline 0 C--N 1.315 -0.935 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.729 175.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 9.8 Cg_endo -54.02 100.82 0.07 OUTLIER 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.875 2.384 . . . . 0.0 111.839 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 123.64 -12.39 8.31 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.1 -176.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -82.75 -176.15 6.14 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -128.62 112.59 14.43 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.654 0.264 . . . . 0.0 110.346 -174.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 28.0 t -58.86 123.23 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.98 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.33 -177.42 47.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.98 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -67.66 -67.66 0.44 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.78 0.324 . . . . 0.0 111.719 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.1 p -63.7 -25.47 68.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.135 0.493 . . . . 0.0 110.187 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -68.22 -47.49 67.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.884 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.438 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -58.99 -45.09 91.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.853 174.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.615 ' O ' ' HG3' ' A' ' 177' ' ' MET . 32.3 m -56.58 -43.59 80.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.691 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 53.8 tp -60.88 -46.9 88.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.651 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.424 HD21 HG21 ' A' ' 160' ' ' ILE . 85.1 mt -71.22 -21.03 62.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.972 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -72.53 -43.72 63.15 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.615 ' HG3' ' O ' ' A' ' 173' ' ' THR . 44.9 mtm -69.24 -31.54 70.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.303 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -76.67 -11.54 59.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.552 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 . . . . . 0 N--CA 1.464 0.265 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.471 -178.24 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.461 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -128.58 127.33 23.58 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.929 -173.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.504 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 16.2 Cg_endo -59.48 121.42 9.85 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 123.229 2.62 . . . . 0.0 112.268 178.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA2' ' HE2' ' A' ' 166' ' ' LYS . . . 122.11 -23.02 7.41 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.36 -176.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.62 143.71 36.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.861 0.362 . . . . 0.0 110.219 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.3 mm -83.1 129.79 36.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.259 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 118' ' ' PRO . . . -69.68 110.72 7.0 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.222 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 117' ' ' ALA . 6.3 Cg_exo -77.47 -38.34 0.76 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 123.199 2.6 . . . . 0.0 112.955 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 79.2 mt -112.85 160.96 17.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.567 -171.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.0 p -87.89 80.36 7.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.805 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 22.1 t -73.99 135.07 28.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.742 -175.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 55.2 t -125.72 123.08 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.895 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 158' ' ' VAL . 81.5 mt -81.78 108.88 12.39 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 14.9 Cg_exo -66.26 145.39 77.98 Favored 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 122.952 2.435 . . . . 0.0 113.559 -171.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.549 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -73.91 69.94 1.44 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.119 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.584 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 82.3 m-70 -154.04 -175.18 5.26 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -174.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -63.94 137.99 58.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.048 0.451 . . . . 0.0 110.34 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.465 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 66.2 p -98.93 -14.9 19.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.64 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.0 6.3 87.32 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.531 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.491 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 91.2 mt -99.5 151.81 20.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.945 0.402 . . . . 0.0 111.071 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -72.32 167.91 52.87 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.513 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.62 -29.56 88.72 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.611 2.207 . . . . 0.0 112.469 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.73 -22.48 64.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.578 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 34.7 mmtp -76.75 -7.32 55.15 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.148 0.499 . . . . 0.0 110.954 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 5.8 t -67.69 -20.09 65.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.775 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.2 m -64.12 -40.13 95.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -71.7 -42.93 66.78 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.162 0.506 . . . . 0.0 110.284 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.524 ' CE1' HD11 ' A' ' 174' ' ' LEU . 70.1 m-85 -60.67 -48.42 81.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.635 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -63.11 -31.95 73.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.017 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.48 -36.35 82.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.355 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 141' ' ' LEU . 3.9 mm? -95.67 27.01 3.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.569 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.4 t 55.98 52.21 10.89 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.171 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.509 HG23 HG21 ' A' ' 158' ' ' VAL . 24.2 mt -108.44 135.79 19.96 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.837 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.509 ' HB2' ' CG1' ' A' ' 155' ' ' ILE . 5.4 Cg_exo -77.73 111.71 3.17 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.059 2.506 . . . . 0.0 111.199 175.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.457 ' CG2' HD11 ' A' ' 152' ' ' ILE . 47.4 p -125.65 163.78 22.02 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.187 0.518 . . . . 0.0 112.017 -172.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -154.22 149.37 26.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.103 170.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 45.0 mm -84.17 116.68 28.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.9 t -71.83 -33.69 68.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.448 -176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -168.27 -70.88 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.015 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -131.48 9.76 5.56 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.6 p -129.57 153.92 47.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.035 -0.582 . . . . 0.0 109.558 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.487 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -89.17 128.33 41.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.242 0.544 . . . . 0.0 110.031 -178.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.584 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 32.5 tt0 -119.96 152.27 37.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.365 0.602 . . . . 0.0 110.517 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 125' ' ' ALA . 34.5 mm -93.31 135.52 27.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.514 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.509 ' CG1' ' HB2' ' A' ' 144' ' ' PRO . 26.1 pt -94.93 -38.34 8.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -124.62 134.02 53.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.794 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -58.27 119.7 7.36 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.521 0.513 . . . . 0.0 110.302 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 18.7 t -90.25 129.91 40.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.002 -171.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.522 ' O ' ' HE3' ' A' ' 162' ' ' LYS . 71.1 m-70 -85.45 75.2 10.23 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 171.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.3 tp -71.02 -48.03 58.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.475 -171.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 14.5 mt -112.14 148.62 33.61 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.46 0.648 . . . . 0.0 110.806 176.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.527 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 6.3 mptt -128.47 131.51 23.81 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.246 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.64 105.86 0.15 Allowed 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.542 2.161 . . . . 0.0 111.719 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.01 -3.0 22.71 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.953 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -88.07 -175.57 5.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.413 ' HE2' ' HA2' ' A' ' 114' ' ' GLY . 87.0 tttt -132.07 112.07 12.03 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -177.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 24.6 t -54.13 125.42 8.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.32 -176.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.56 -176.86 48.4 Favored Glycine 0 C--O 1.226 -0.344 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.832 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.504 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -70.91 -69.5 0.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.905 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 69.8 m -68.17 -20.93 64.91 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -65.48 -48.22 73.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.523 173.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.437 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.19 -45.81 90.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.303 175.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.608 ' O ' ' HG3' ' A' ' 177' ' ' MET . 28.4 m -58.24 -40.43 81.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.028 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.524 HD11 ' CE1' ' A' ' 138' ' ' PHE . 54.7 tp -63.54 -49.96 71.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.624 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.3 mt -65.6 -23.26 66.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.723 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -74.6 -42.27 58.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.644 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.608 ' HG3' ' O ' ' A' ' 173' ' ' THR . 62.2 mtm -71.49 -31.19 66.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.409 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.84 -9.91 59.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.549 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 10.6 p30 . . . . . 0 N--CA 1.475 0.793 0 O-C-N 124.176 0.922 . . . . 0.0 110.377 -170.572 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.484 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.439 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 6.2 tmm_? -129.68 128.08 22.98 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.511 -175.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.556 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 10.9 Cg_endo -56.61 118.23 5.04 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.549 2.833 . . . . 0.0 112.935 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.02 -21.04 6.61 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.13 153.5 26.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.862 0.363 . . . . 0.0 110.327 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.5 mm -86.63 135.01 26.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.73 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -75.82 109.62 8.58 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.614 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -76.33 -38.12 1.18 Allowed 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 123.125 2.55 . . . . 0.0 113.308 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.5 mt -116.93 167.54 11.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.193 0.52 . . . . 0.0 111.683 -171.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.0 m -87.94 79.17 8.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.823 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 30.4 t -69.1 134.28 30.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.564 -177.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 43.2 t -123.83 131.52 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.332 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.485 HG22 HG13 ' A' ' 154' ' ' ILE . 88.0 mt -90.36 101.86 4.21 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 122' ' ' VAL . 29.8 Cg_exo -61.81 141.93 91.88 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.506 2.804 . . . . 0.0 114.172 -170.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.5 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -71.78 84.67 0.92 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.903 -1.499 . . . . 0.0 112.53 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.528 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 40.9 p-80 -175.52 179.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -57.13 135.89 56.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.0 0.429 . . . . 0.0 110.654 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.6 p -94.57 -4.84 47.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.215 0.531 . . . . 0.0 110.717 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.49 2.49 89.61 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.434 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.2 mt -93.82 150.76 20.1 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.469 -0.365 . . . . 0.0 110.315 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.41 162.61 54.25 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.465 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 150' ' ' GLY . 52.1 Cg_exo -53.54 -28.43 45.38 Favored 'Trans proline' 0 C--O 1.225 -0.173 0 C-N-CA 123.074 2.516 . . . . 0.0 112.909 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -55.31 -33.01 62.91 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.511 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 68.4 mmtt -71.57 -7.85 50.29 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.225 0.536 . . . . 0.0 110.976 -174.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 4.4 t -65.95 -21.91 66.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.993 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.7 t -63.67 -39.12 93.54 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -73.09 -42.82 62.59 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.359 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.548 ' CE2' HD11 ' A' ' 178' ' ' LEU . 71.9 m-85 -59.41 -49.37 78.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.43 0.633 . . . . 0.0 109.406 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -66.5 -28.94 68.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.304 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.05 -39.78 93.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.974 0.416 . . . . 0.0 110.125 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.78 23.55 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.149 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 40.0 m 58.65 50.4 9.0 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.996 174.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.479 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 35.5 mt -105.72 133.32 20.25 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.629 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 6.7 Cg_exo -71.96 119.18 6.02 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.997 2.465 . . . . 0.0 110.845 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.407 HG22 HD11 ' A' ' 152' ' ' ILE . 38.2 p -127.46 148.96 50.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -169.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.566 ' HD3' HG21 ' A' ' 155' ' ' ILE . 11.5 mtpp -149.64 139.89 22.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.76 174.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 50.4 mm -81.48 121.73 35.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.067 0.461 . . . . 0.0 110.747 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 14.2 t -76.85 -66.17 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.232 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -158.51 81.76 0.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.462 0.648 . . . . 0.0 110.229 174.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' A' ' 132' ' ' PRO . . . 69.26 17.22 71.99 Favored Glycine 0 CA--C 1.511 -0.185 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -173.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.6 p -139.18 149.91 44.97 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.471 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -90.75 125.7 43.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.339 0.59 . . . . 0.0 109.624 179.12 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.528 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 26.0 tt0 -116.03 148.83 39.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.687 0.756 . . . . 0.0 111.065 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.536 HD11 ' CE2' ' A' ' 138' ' ' PHE . 38.6 mm -92.37 132.28 37.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.155 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.566 HG21 ' HD3' ' A' ' 146' ' ' LYS . 32.4 pt -97.51 -37.38 6.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.874 0.368 . . . . 0.0 111.772 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -119.78 127.83 53.16 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -53.76 116.68 2.64 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.345 0.403 . . . . 0.0 110.116 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.7 t -88.43 129.69 39.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -172.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -83.44 72.94 10.22 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.558 HG21 HD21 ' A' ' 175' ' ' LEU . 6.6 tp -66.55 -54.67 23.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.596 -171.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.403 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 16.1 mt -108.26 151.76 25.53 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.335 0.588 . . . . 0.0 111.081 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 9.5 mptt -130.37 133.24 24.66 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.034 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 76.6 Cg_exo -51.32 103.81 0.08 OUTLIER 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.01 2.473 . . . . 0.0 112.38 176.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.99 -13.11 10.59 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.14 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -81.73 -179.86 7.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -128.11 117.04 20.9 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 21.5 t -52.51 122.44 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.248 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -82.6 -179.41 52.74 Favored Glycine 0 C--O 1.228 -0.257 0 CA-C-N 116.027 -0.533 . . . . 0.0 113.107 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.556 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -70.11 -70.33 0.3 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.759 0.314 . . . . 0.0 111.37 -177.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 41.0 m -67.72 -21.25 65.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.054 0.454 . . . . 0.0 110.132 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -66.56 -46.26 76.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.661 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.461 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -63.08 -44.65 95.16 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.192 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.582 ' O ' ' HG3' ' A' ' 177' ' ' MET . 14.9 m -54.93 -47.14 74.81 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.087 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.686 ' O ' HD22 ' A' ' 178' ' ' LEU . 37.3 tp -54.98 -60.96 2.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.626 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.558 HD21 HG21 ' A' ' 160' ' ' ILE . 73.1 mt -59.26 -26.74 65.18 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.553 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -70.04 -42.47 72.87 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.582 ' HG3' ' O ' ' A' ' 173' ' ' THR . 55.5 mtm -68.14 -32.17 72.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.11 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.686 HD22 ' O ' ' A' ' 174' ' ' LEU . 0.1 OUTLIER -68.9 -21.27 64.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.885 176.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 4.6 t30 . . . . . 0 C--O 1.231 0.116 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.534 -176.466 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.423 0 CA-C-O 120.863 0.363 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.451 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 5.9 tmm_? -129.76 127.2 22.84 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.303 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.501 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 9.9 Cg_endo -53.85 116.27 2.9 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.525 2.817 . . . . 0.0 112.597 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.2 -26.28 4.2 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.44 152.34 34.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.845 0.355 . . . . 0.0 110.646 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.2 mm -87.09 130.8 36.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.391 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -69.64 110.2 6.02 Favored Pre-proline 0 C--N 1.328 -0.345 0 O-C-N 123.589 0.556 . . . . 0.0 110.899 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.571 ' HB2' HD22 ' A' ' 119' ' ' LEU . 4.2 Cg_exo -79.83 -28.82 3.08 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 123.27 2.647 . . . . 0.0 113.62 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.571 HD22 ' HB2' ' A' ' 118' ' ' PRO . 2.4 mm? -116.43 160.25 20.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.153 0.501 . . . . 0.0 111.727 -174.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.2 m -84.57 71.24 10.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.599 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 21.9 t -64.73 136.49 26.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.022 -175.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 45.1 t -124.27 130.88 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.837 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' A' ' 158' ' ' VAL . 75.2 mt -88.48 107.01 14.38 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.504 ' HB2' ' CD2' ' A' ' 126' ' ' HIS . 24.3 Cg_exo -63.15 140.25 76.99 Favored 'Trans proline' 0 CA--C 1.518 -0.313 0 C-N-CA 122.935 2.424 . . . . 0.0 112.95 -174.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.78 83.15 2.74 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.168 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.53 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 32.1 p80 -166.88 169.92 12.72 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -55.85 135.54 51.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.139 0.495 . . . . 0.0 110.746 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.0 p -95.68 -2.6 47.7 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.286 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 73.5 6.44 70.75 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.715 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.525 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 96.3 mt -92.34 156.04 17.51 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.617 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.63 151.97 45.95 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.17 -27.63 66.65 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.846 -174.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.64 -25.14 66.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.214 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.538 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 74.3 mmtt -67.01 -9.81 42.95 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.063 0.459 . . . . 0.0 111.095 -177.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.483 ' HB ' HG13 ' A' ' 152' ' ' ILE . 12.9 t -65.56 -20.91 66.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.905 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.1 t -65.09 -36.22 83.62 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.412 ' O ' ' HB3' ' A' ' 140' ' ' ALA . 54.2 m-85 -75.0 -44.34 48.69 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.327 177.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.629 ' CE1' HD11 ' A' ' 154' ' ' ILE . 85.0 m-85 -59.58 -49.44 77.76 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -64.48 -30.9 71.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.837 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 137' ' ' PHE . . . -58.84 -39.93 82.7 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.955 0.407 . . . . 0.0 110.195 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 141' ' ' LEU . 4.0 mm? -93.13 26.15 2.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.381 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.2 m 58.59 41.08 22.86 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.066 174.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.455 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 27.8 mt -97.3 133.35 23.99 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.796 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 4.7 Cg_exo -73.06 107.15 2.3 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.977 2.451 . . . . 0.0 111.106 174.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.473 HG21 ' CB ' ' A' ' 138' ' ' PHE . 43.1 p -124.78 171.51 10.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.249 0.547 . . . . 0.0 112.445 -173.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.489 ' HE3' HG22 ' A' ' 155' ' ' ILE . 21.4 pttp -165.36 163.8 19.81 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.747 173.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 41.0 mm -101.56 125.69 55.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.7 m -73.46 -44.69 57.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.565 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.543 ' HA ' ' HE3' ' A' ' 149' ' ' LYS . 0.1 OUTLIER -163.3 -58.73 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.686 178.082 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -136.43 4.86 3.77 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.018 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.1 p -129.74 149.93 51.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -85.25 130.36 36.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.268 0.556 . . . . 0.0 110.041 -178.423 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.552 ' N ' HD13 ' A' ' 152' ' ' ILE . 30.0 tt0 -120.19 149.82 41.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.157 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.629 HD11 ' CE1' ' A' ' 138' ' ' PHE . 2.9 mp -97.64 136.98 26.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.898 176.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.489 HG22 ' HE3' ' A' ' 146' ' ' LYS . 13.4 pt -95.62 -35.27 5.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.003 0.43 . . . . 0.0 111.893 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -122.46 125.23 45.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.108 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -51.8 123.14 9.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.313 0.578 . . . . 0.0 110.523 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 12.0 t -95.94 130.04 45.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.401 -168.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.457 ' O ' ' HE3' ' A' ' 162' ' ' LYS . 37.7 m80 -79.15 71.33 5.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 168.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.0 tp -63.25 -49.42 83.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.223 -173.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.431 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 13.8 mt -112.3 156.19 22.83 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.303 0.573 . . . . 0.0 111.176 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 7.7 mptt -132.46 132.22 22.68 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.631 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 10.7 Cg_endo -55.86 96.01 0.05 OUTLIER 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.766 2.311 . . . . 0.0 112.024 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 129.71 -13.41 5.85 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.95 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -84.46 153.93 23.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -97.5 107.59 20.13 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 54.8 t -46.72 124.5 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 O-C-N 123.861 0.725 . . . . 0.0 111.945 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.75 -179.29 50.21 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.207 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.501 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -70.84 -68.33 0.44 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.773 0.32 . . . . 0.0 111.598 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.8 m -61.82 -25.05 67.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.355 0.598 . . . . 0.0 109.679 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -69.73 -48.75 58.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.354 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.446 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -60.47 -44.19 96.16 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.246 176.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.654 ' O ' ' HG3' ' A' ' 177' ' ' MET . 27.0 m -59.76 -40.93 89.82 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.544 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.506 HD11 ' CE1' ' A' ' 138' ' ' PHE . 36.5 tp -60.32 -49.08 79.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.823 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 83.3 mt -64.63 -30.22 71.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.906 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -70.05 -42.73 72.49 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.329 0.585 . . . . 0.0 109.616 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.654 ' HG3' ' O ' ' A' ' 173' ' ' THR . 60.3 mtm -71.11 -28.56 64.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.425 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.508 HD21 ' CZ ' ' A' ' 138' ' ' PHE . 0.9 OUTLIER -78.97 -15.3 58.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.654 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 62.2 t30 . . . . . 0 N--CA 1.461 0.12 0 O-C-N 123.958 0.786 . . . . 0.0 109.74 -177.782 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.451 0 CA-C-O 121.087 0.47 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -130.38 127.66 22.5 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.614 -174.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.44 ' HD3' ' CB ' ' A' ' 172' ' ' ALA . 26.0 Cg_endo -62.92 143.01 90.53 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.323 2.682 . . . . 0.0 112.552 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.419 ' HA2' ' HE2' ' A' ' 166' ' ' LYS . . . 111.98 -12.86 26.84 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.061 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.0 153.08 17.96 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.711 0.291 . . . . 0.0 110.571 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.7 mm -85.58 126.94 40.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.097 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.581 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -60.6 110.27 2.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 123.845 0.716 . . . . 0.0 111.387 -177.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -74.38 -46.69 0.27 Allowed 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 123.146 2.564 . . . . 0.0 112.578 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 91.0 mt -106.88 159.96 15.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.217 -173.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.8 t -85.02 75.72 10.35 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 25.9 t -63.88 134.98 28.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.359 -1.291 . . . . 0.0 110.671 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 46.5 t -125.1 129.04 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.519 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.494 HG22 HG13 ' A' ' 154' ' ' ILE . 75.8 mt -86.51 101.31 1.92 Allowed Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 7.4 Cg_exo -71.18 137.18 30.86 Favored 'Trans proline' 0 CA--C 1.514 -0.484 0 C-N-CA 123.118 2.546 . . . . 0.0 114.318 -168.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.33 92.79 3.37 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.841 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -158.78 -50.53 0.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.238 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 173.57 150.19 0.07 Allowed 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.432 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 71.0 p -110.54 -30.22 7.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.085 0.469 . . . . 0.0 110.639 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.81 2.85 88.43 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.49 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 94.4 mt -96.49 155.22 16.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.047 0.451 . . . . 0.0 110.789 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.89 174.3 54.88 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.567 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.452 ' O ' HG22 ' A' ' 135' ' ' THR . 20.6 Cg_exo -65.34 -19.14 61.77 Favored 'Trans proline' 0 N--CA 1.466 -0.144 0 C-N-CA 122.877 2.385 . . . . 0.0 112.966 -173.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.65 -27.87 66.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.957 0.408 . . . . 0.0 111.071 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.522 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 34.4 mmtp -73.32 -6.82 48.54 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.057 0.456 . . . . 0.0 111.44 -175.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 132' ' ' PRO . 6.1 t -66.47 -20.49 66.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.865 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.1 t -62.32 -42.2 99.18 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -70.52 -46.4 63.71 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.308 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.57 ' CE2' HD21 ' A' ' 178' ' ' LEU . 74.4 m-85 -58.63 -47.33 84.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.301 0.572 . . . . 0.0 109.547 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -68.75 -25.64 64.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.436 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.31 -33.18 75.16 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.162 0.506 . . . . 0.0 109.945 176.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -98.78 26.35 5.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.073 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.9 t 55.69 55.16 7.43 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.687 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.521 HG23 HG21 ' A' ' 158' ' ' VAL . 39.8 mt -112.6 135.54 21.52 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.037 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 2.8 Cg_exo -74.38 117.42 4.97 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.008 2.472 . . . . 0.0 111.079 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.492 ' CG2' HD11 ' A' ' 152' ' ' ILE . 40.7 p -131.43 148.62 52.67 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.802 -172.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.467 ' HE2' HG21 ' A' ' 155' ' ' ILE . 41.9 mtmt -138.74 137.67 36.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.087 174.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 48.1 mm -83.63 109.18 16.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.1 p -74.86 -72.34 0.3 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.025 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -145.19 80.16 1.6 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.949 0.404 . . . . 0.0 110.153 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.57 -0.09 56.93 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.35 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.7 p -128.22 150.24 50.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.514 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -90.51 124.35 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.208 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.472 ' N ' HD13 ' A' ' 152' ' ' ILE . 33.8 tt0 -116.97 154.56 30.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.365 0.603 . . . . 0.0 110.508 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.501 HD11 ' CE2' ' A' ' 138' ' ' PHE . 48.2 mm -96.14 131.07 43.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.424 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.467 HG21 ' HE2' ' A' ' 146' ' ' LYS . 13.5 pt -94.49 -37.81 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.008 0.432 . . . . 0.0 111.714 -175.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -121.13 128.55 52.65 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -60.16 126.2 26.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.312 0.577 . . . . 0.0 109.475 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 20.8 t -99.92 128.62 51.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.402 -169.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -75.48 73.44 2.52 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 167.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.469 HG21 HD21 ' A' ' 175' ' ' LEU . 5.8 tp -64.93 -42.58 95.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.826 -175.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 15.6 mt -118.46 155.15 31.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.191 0.52 . . . . 0.0 110.176 175.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -149.4 130.87 7.36 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.409 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 81.2 Cg_exo -44.87 106.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.566 2.844 . . . . 0.0 112.835 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 127.96 -22.59 5.4 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.237 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -85.66 153.7 22.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.653 0.264 . . . . 0.0 110.374 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.419 ' HE2' ' HA2' ' A' ' 114' ' ' GLY . 82.8 tttt -102.09 111.86 24.29 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 56.4 t -49.14 123.41 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.5 0 O-C-N 123.955 0.784 . . . . 0.0 111.858 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.32 177.42 51.7 Favored Glycine 0 CA--C 1.519 0.291 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.094 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.94 -65.88 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.915 0.388 . . . . 0.0 111.774 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 49.8 m -65.55 -24.15 67.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.201 0.524 . . . . 0.0 109.829 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.1 -50.2 62.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.016 177.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.44 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -60.94 -39.67 90.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.309 175.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.554 ' O ' ' HG3' ' A' ' 177' ' ' MET . 49.9 m -60.23 -44.08 95.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.549 177.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.506 HD11 ' CE2' ' A' ' 138' ' ' PHE . 48.2 tp -60.34 -49.88 75.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.386 177.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.469 HD21 HG21 ' A' ' 160' ' ' ILE . 87.4 mt -61.82 -30.24 70.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.368 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -72.11 -42.81 65.66 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' A' ' 173' ' ' THR . 63.2 mtm -67.07 -32.91 74.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.703 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.57 HD21 ' CE2' ' A' ' 138' ' ' PHE . 2.7 mm? -72.96 -11.93 60.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.732 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 64.8 t30 . . . . . 0 CA--C 1.532 0.255 0 CA-C-O 121.528 0.68 . . . . 0.0 109.8 -178.584 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -129.2 128.86 23.3 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.004 -173.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 167' ' ' VAL . 10.1 Cg_endo -54.59 126.19 21.53 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.496 2.797 . . . . 0.0 112.653 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 116.5 -23.6 10.25 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.695 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.8 140.25 38.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.81 131.5 34.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.675 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -65.09 110.27 4.01 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.814 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 117' ' ' ALA . 11.6 Cg_exo -72.93 -37.79 3.38 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.942 2.428 . . . . 0.0 112.637 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.9 mt -119.46 160.02 23.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.331 -173.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.416 ' CA ' ' HD3' ' A' ' 163' ' ' PRO . 10.3 t -86.32 77.03 9.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.801 0.81 . . . . 0.0 108.949 175.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.81 134.75 29.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.759 -176.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 59.3 t -125.71 121.66 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.38 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.544 HG22 HG13 ' A' ' 154' ' ' ILE . 47.8 mt -79.23 106.38 4.45 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.453 ' HB2' ' CE1' ' A' ' 126' ' ' HIS . 16.2 Cg_exo -66.3 145.48 78.02 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.995 2.463 . . . . 0.0 113.461 -170.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.463 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -73.01 82.39 1.23 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.335 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.48 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 1.6 p-80 -174.72 179.32 1.71 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.415 175.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -55.61 135.75 50.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.988 0.423 . . . . 0.0 110.595 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.7 p -96.38 -2.41 45.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.008 0.432 . . . . 0.0 111.425 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 76.69 19.98 77.09 Favored Glycine 0 N--CA 1.453 -0.208 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.6 mt -116.08 147.97 40.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.315 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.55 168.27 54.58 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.897 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.419 ' O ' HG22 ' A' ' 135' ' ' THR . 15.4 Cg_exo -70.05 14.53 0.27 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 123.349 2.7 . . . . 0.0 113.637 -175.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -90.41 -31.64 16.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.437 0.637 . . . . 0.0 109.769 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.53 ' HD2' ' HE1' ' A' ' 177' ' ' MET . 47.3 mmtm -72.88 -11.04 60.44 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.823 -175.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 132' ' ' PRO . 15.3 t -64.8 -22.5 67.0 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.634 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.0 p -63.43 -37.26 86.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.001 0.429 . . . . 0.0 109.937 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -76.02 -42.43 47.99 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.22 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.626 ' CE2' HD11 ' A' ' 174' ' ' LEU . 76.2 m-85 -59.12 -51.03 71.78 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 121.448 0.642 . . . . 0.0 109.391 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -65.91 -30.38 70.96 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.244 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.18 98.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.477 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 141' ' ' LEU . 4.1 mm? -86.33 23.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.948 177.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.3 m 56.24 50.16 13.93 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.533 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.474 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 23.4 mt -104.25 131.23 22.11 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.688 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 2.7 Cg_exo -73.93 112.18 3.48 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.883 2.389 . . . . 0.0 111.059 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 55.8 p -127.59 162.41 26.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.122 0.487 . . . . 0.0 111.974 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.535 ' HE2' HG22 ' A' ' 155' ' ' ILE . 60.9 pttt -150.85 148.69 28.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.124 172.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 45.0 mm -88.81 115.14 28.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.014 0.435 . . . . 0.0 109.997 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 35.2 t -80.13 -80.78 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.026 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -127.23 65.49 1.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.882 0.372 . . . . 0.0 110.07 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 70.43 15.82 73.14 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -174.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.8 p -136.19 150.77 49.16 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.48 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -84.88 128.46 38.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.197 0.522 . . . . 0.0 110.457 -178.422 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.48 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 20.0 tt0 -118.3 148.04 42.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.589 0.709 . . . . 0.0 110.963 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.544 HG13 HG22 ' A' ' 123' ' ' ILE . 41.7 mm -93.13 138.02 21.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.297 177.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.535 HG22 ' HE2' ' A' ' 146' ' ' LYS . 16.5 pt -100.93 -37.72 5.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.599 -0.44 . . . . 0.0 112.161 -176.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -121.04 139.61 53.06 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -56.41 111.13 0.9 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.377 0.608 . . . . 0.0 110.665 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.495 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 16.6 t -85.72 128.55 39.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.079 -175.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -91.72 72.39 5.81 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.1 tp -66.83 -42.74 89.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.755 -170.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 161' ' ' LEU . 13.3 mt -119.04 140.79 49.45 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.63 0.728 . . . . 0.0 111.803 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.97 127.02 27.01 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.302 174.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 9.4 Cg_endo -54.33 100.2 0.06 OUTLIER 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.501 2.134 . . . . 0.0 111.622 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 127.22 -16.13 6.38 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.289 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -78.4 175.61 10.13 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -119.69 109.82 16.09 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 42.1 t -51.4 125.64 5.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 123.881 0.738 . . . . 0.0 111.367 -176.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.28 -177.6 51.9 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.996 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.08 -65.2 0.87 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.81 0.338 . . . . 0.0 111.9 -175.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 51.0 m -65.1 -24.51 67.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -67.35 -48.67 66.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.094 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.429 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -58.58 -46.37 87.07 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.277 0.56 . . . . 0.0 110.193 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 21.3 m -58.11 -38.99 77.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.699 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.626 HD11 ' CE2' ' A' ' 138' ' ' PHE . 25.8 tp -68.24 -42.42 79.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.209 0.528 . . . . 0.0 110.937 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.6 mt -70.19 -17.48 63.16 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.95 0.405 . . . . 0.0 110.605 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -81.08 -47.84 12.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.184 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.53 ' HE1' ' HD2' ' A' ' 134' ' ' LYS . 20.6 ptp -64.99 -33.42 75.99 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.229 0.538 . . . . 0.0 110.67 177.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 174' ' ' LEU . 0.3 OUTLIER -65.78 -32.21 73.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.946 178.263 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 64.6 t30 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.896 0.855 . . . . 0.0 108.797 -173.585 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.562 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -121.29 125.55 26.87 Favored Pre-proline 0 C--N 1.314 -0.942 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.785 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 9.5 Cg_endo -53.87 118.54 5.06 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.574 2.849 . . . . 0.0 112.481 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.45 -17.67 11.22 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.645 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.27 150.48 28.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.911 0.386 . . . . 0.0 110.28 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.3 mm -86.11 135.61 24.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.394 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -73.71 109.34 6.44 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.738 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -78.88 -36.62 0.73 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.255 2.636 . . . . 0.0 113.421 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.5 mt -114.66 159.74 20.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.18 0.514 . . . . 0.0 111.654 -172.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.5 m -81.78 71.57 8.8 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.284 173.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 19.7 t -66.67 129.59 31.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.362 -177.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 47.8 t -123.21 122.54 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.441 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.406 HG22 HG13 ' A' ' 154' ' ' ILE . 56.9 mt -80.6 106.21 4.96 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.91 142.15 80.75 Favored 'Trans proline' 0 CA--C 1.511 -0.67 0 C-N-CA 123.209 2.606 . . . . 0.0 113.952 -170.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.444 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -68.56 83.52 0.27 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.301 175.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -172.94 157.55 3.6 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -170.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.15 130.58 43.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.057 0.456 . . . . 0.0 110.969 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 37.2 p -84.89 -9.49 58.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.063 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.46 -0.61 87.64 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.571 -177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.427 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 90.3 mt -86.3 154.19 21.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.773 0.321 . . . . 0.0 110.471 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.9 168.67 54.07 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.987 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.465 ' O ' HG22 ' A' ' 135' ' ' THR . 17.0 Cg_exo -67.46 -3.1 9.47 Favored 'Trans proline' 0 CA--C 1.527 0.138 0 C-N-CA 123.198 2.599 . . . . 0.0 113.119 -174.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -78.8 -32.32 46.32 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.17 0.51 . . . . 0.0 110.548 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.496 ' HD2' ' HE1' ' A' ' 177' ' ' MET . 48.0 mmtm -69.79 -11.38 60.81 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.472 -174.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 132' ' ' PRO . 6.8 t -66.38 -17.97 65.08 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.029 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.0 t -62.16 -42.25 99.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -75.0 -40.86 60.42 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.233 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.585 ' CE1' HD11 ' A' ' 174' ' ' LEU . 71.3 m-85 -59.81 -50.66 72.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.225 0.536 . . . . 0.0 109.688 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -65.05 -30.62 71.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.221 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.29 93.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.876 0.369 . . . . 0.0 110.578 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.403 ' HA ' HD13 ' A' ' 141' ' ' LEU . 4.1 mm? -91.38 31.41 1.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.709 175.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.0 p 52.2 49.62 20.19 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.88 0.872 . . . . 0.0 112.574 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.477 HG23 HG21 ' A' ' 158' ' ' VAL . 24.9 mt -108.55 131.16 21.95 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 3.5 Cg_exo -76.6 114.63 3.9 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.072 2.515 . . . . 0.0 111.339 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 82.3 p -129.25 162.65 27.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.978 0.418 . . . . 0.0 111.427 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.452 ' HE3' HG22 ' A' ' 155' ' ' ILE . 22.6 pttp -151.89 142.99 23.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.641 171.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 44.5 mm -81.28 119.44 30.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.891 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.2 t -68.12 -36.09 79.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.135 -178.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -173.96 -66.31 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.424 ' O ' ' HD3' ' A' ' 132' ' ' PRO . . . -128.91 6.62 6.47 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 173.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 22.7 p -128.42 152.12 48.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.87 0.367 . . . . 0.0 110.296 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.472 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -86.64 130.79 36.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.222 179.653 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -117.79 153.23 33.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.307 0.575 . . . . 0.0 110.716 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.491 HD11 ' CE1' ' A' ' 138' ' ' PHE . 29.1 mm -98.04 130.81 46.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.259 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.452 HG22 ' HE3' ' A' ' 146' ' ' LYS . 25.3 pt -93.14 -35.8 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.918 0.39 . . . . 0.0 111.885 -176.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -123.83 136.88 54.66 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.343 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -61.09 118.59 6.98 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.461 0.475 . . . . 0.0 109.774 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.3 t -92.91 128.77 44.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.09 -172.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -78.45 67.98 4.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 170.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.403 HG23 ' N ' ' A' ' 161' ' ' LEU . 7.1 tp -61.19 -51.46 72.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.875 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.438 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 14.8 mt -114.77 159.87 20.09 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.287 0.565 . . . . 0.0 110.059 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.544 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -153.49 132.36 6.85 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.94 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 4.2 Cg_endo -48.26 110.59 0.34 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.596 2.864 . . . . 0.0 112.706 -176.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.09 -19.09 8.84 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.304 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -79.84 174.9 11.12 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -125.85 107.2 10.27 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -176.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 34.3 t -51.89 122.66 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 O-C-N 123.857 0.723 . . . . 0.0 111.44 -176.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.83 -175.63 46.87 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.794 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -71.39 -65.02 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 111.886 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.8 m -62.07 -29.31 70.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.476 0.655 . . . . 0.0 109.615 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -67.51 -48.31 67.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.083 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.427 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.54 -39.14 83.02 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.241 0.543 . . . . 0.0 110.451 175.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 26.5 m -61.26 -41.29 96.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.528 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.585 HD11 ' CE1' ' A' ' 138' ' ' PHE . 28.6 tp -67.88 -42.16 81.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.896 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.2 mt -69.02 -20.95 64.15 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.845 0.355 . . . . 0.0 110.648 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -78.51 -46.97 18.31 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.141 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.514 ' HG2' ' HA ' ' A' ' 174' ' ' LEU . 22.1 ptp -66.19 -24.18 66.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.51 0.671 . . . . 0.0 110.342 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.11 -29.56 48.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.289 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 122.026 0.917 . . . . 0.0 108.727 -174.341 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -138.95 -58.94 0.6 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.831 0.348 . . . . 0.0 110.31 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.14 54.79 0.65 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.399 0.618 . . . . 0.0 109.826 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.33 -37.01 78.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.231 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.53 ' NE2' ' HA ' ' A' ' 176' ' ' ASN . 47.6 tt0 -86.54 109.93 19.45 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.466 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 184' ' ' SER . . . -66.8 147.64 98.99 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.79 86.36 0.14 Allowed 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.185 2.59 . . . . 0.0 112.637 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.86 116.76 12.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.931 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' A' ' 113' ' ' PRO . 6.7 tmm_? -138.43 130.12 15.73 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.747 -175.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 9.5 Cg_endo -54.22 122.89 12.28 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.541 2.827 . . . . 0.0 112.959 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 120.42 -25.81 7.21 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.616 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.71 147.36 35.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.94 0.4 . . . . 0.0 110.613 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.58 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 48.3 mm -81.44 143.47 12.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.964 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 118' ' ' PRO . . . -85.03 103.74 3.76 Favored Pre-proline 0 C--N 1.328 -0.334 0 O-C-N 123.485 0.491 . . . . 0.0 110.569 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.58 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 3.3 Cg_exo -79.91 -30.45 2.26 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.879 2.386 . . . . 0.0 113.018 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.435 HD22 ' HB2' ' A' ' 118' ' ' PRO . 2.0 mm? -110.65 165.93 11.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.146 0.498 . . . . 0.0 111.556 -173.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.3 m -92.72 84.76 5.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.634 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 21.1 t -82.58 134.32 27.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.523 -176.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 53.9 t -126.88 125.16 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.57 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.503 HG22 HG13 ' A' ' 154' ' ' ILE . 75.8 mt -82.36 108.16 11.01 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 19.4 Cg_exo -64.66 147.26 89.91 Favored 'Trans proline' 0 CA--C 1.511 -0.643 0 C-N-CA 122.875 2.383 . . . . 0.0 113.614 -171.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.411 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -72.99 81.71 1.21 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.145 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.444 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 48.1 t-80 -168.46 156.11 8.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 0.4 OUTLIER -63.31 132.09 50.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.362 0.601 . . . . 0.0 110.366 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.511 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 77.6 p -83.37 -14.2 53.33 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.439 -172.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.67 -14.67 57.72 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -175.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.485 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 95.2 mt -77.31 149.07 35.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.365 -0.417 . . . . 0.0 110.539 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.67 162.33 34.25 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.617 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.36 -12.25 26.51 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 123.03 2.487 . . . . 0.0 112.689 -174.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.81 -30.36 66.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.787 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.485 ' HG3' ' HB3' ' A' ' 130' ' ' LEU . 74.3 mmtt -71.68 -6.37 40.64 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.977 0.418 . . . . 0.0 111.252 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.0 t -65.2 -21.04 66.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.553 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.2 t -65.01 -38.63 91.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.735 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -73.58 -42.48 61.54 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.424 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.574 ' CZ ' HD21 ' A' ' 178' ' ' LEU . 86.1 m-85 -59.97 -48.75 80.44 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -65.79 -28.8 69.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.019 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.32 -34.36 77.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.054 0.454 . . . . 0.0 110.179 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 141' ' ' LEU . 3.9 mm? -94.9 18.87 11.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.182 174.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t 59.81 58.29 2.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.854 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 40.8 mt -115.08 135.66 22.52 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.462 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.43 ' HB2' ' CG1' ' A' ' 155' ' ' ILE . 3.4 Cg_exo -74.59 118.01 5.17 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.037 2.492 . . . . 0.0 111.054 174.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.411 ' CG2' HD11 ' A' ' 152' ' ' ILE . 35.4 p -128.84 152.57 48.35 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -172.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -148.05 147.85 30.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.421 172.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 43.6 mm -84.6 128.51 38.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.89 0.376 . . . . 0.0 110.605 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 45.5 t -99.96 -83.33 0.43 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.277 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -113.36 53.34 0.77 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.955 0.407 . . . . 0.0 110.178 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 70.05 14.11 70.54 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -171.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.2 p -130.65 151.33 51.23 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.491 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -79.65 128.01 38.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.288 0.566 . . . . 0.0 110.167 -178.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.444 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 37.7 tt0 -116.86 153.93 31.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.536 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.503 HG13 HG22 ' A' ' 123' ' ' ILE . 42.5 mm -99.88 133.05 44.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.737 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.43 ' CG1' ' HB2' ' A' ' 144' ' ' PRO . 16.0 pt -95.06 -34.72 5.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -176.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -122.39 132.13 54.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.057 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -54.96 115.46 2.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.434 0.635 . . . . 0.0 110.456 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 24.5 t -91.51 126.85 44.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.873 -171.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.621 ' O ' ' HE3' ' A' ' 162' ' ' LYS . 10.8 p-80 -80.24 73.87 7.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.432 0.635 . . . . 0.0 109.298 170.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.42 HD11 ' HG3' ' A' ' 171' ' ' GLU . 6.9 tp -64.94 -50.43 75.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.196 -174.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 15.7 mt -113.23 147.78 36.82 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.429 0.633 . . . . 0.0 110.664 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.621 ' HE3' ' O ' ' A' ' 159' ' ' HIS . 6.6 mptt -127.74 133.32 24.98 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.409 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 11.5 Cg_endo -56.56 101.87 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.391 2.061 . . . . 0.0 111.727 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.88 -5.94 12.44 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.772 -175.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -86.32 -173.33 4.49 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -135.49 116.18 13.92 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.694 0.283 . . . . 0.0 110.304 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.7 t -61.26 121.86 10.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.289 -177.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.63 -170.91 46.69 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.969 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -76.27 -63.83 1.24 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.973 0.415 . . . . 0.0 111.669 -175.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.5 m -66.27 -23.94 66.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.42 ' HG3' HD11 ' A' ' 160' ' ' ILE . 22.2 tt0 -70.18 -50.07 43.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.963 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.426 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -56.21 -46.69 79.37 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.289 0.566 . . . . 0.0 110.066 174.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.609 ' O ' ' HG3' ' A' ' 177' ' ' MET . 22.5 m -59.07 -42.17 89.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.585 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.528 HD11 ' CE2' ' A' ' 138' ' ' PHE . 48.9 tp -59.67 -49.11 79.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.708 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.02 -29.27 69.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.241 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.53 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 79.8 m-20 -74.53 -33.22 62.71 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.141 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.609 ' HG3' ' O ' ' A' ' 173' ' ' THR . 63.9 mtm -79.33 -26.14 42.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.326 0.584 . . . . 0.0 110.089 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.574 HD21 ' CZ ' ' A' ' 138' ' ' PHE . 1.4 mm? -78.28 -15.08 59.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.229 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 61.25 34.47 18.66 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.543 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.518 ' O ' ' HD3' ' A' ' 182' ' ' PRO . 73.2 mt -105.43 143.89 15.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.43 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 14.1 t -96.69 104.69 19.08 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 120.881 0.372 . . . . 0.0 110.922 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 180' ' ' ILE . 95.1 Cg_endo -85.12 6.48 5.67 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.558 2.172 . . . . 0.0 113.191 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.458 ' HB2' ' HB1' ' A' ' 109' ' ' ALA . 98.0 m-85 -135.5 -79.21 0.43 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.062 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 13.1 p -153.57 159.4 42.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.764 0.316 . . . . 0.0 111.258 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -120.9 12.97 11.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.954 0.407 . . . . 0.0 111.285 -176.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.914 0 CA-C-O 118.59 -1.117 . . . . 0.0 111.935 178.763 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.618 0.247 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -149.06 -38.18 0.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 0.0 110.946 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.423 ' HA ' HD21 ' A' ' 179' ' ' ASN . 18.9 ptmt -142.45 60.11 1.45 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.682 0.753 . . . . 0.0 109.59 172.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.14 -9.43 12.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.394 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.471 ' HB2' ' HA ' ' A' ' 179' ' ' ASN . 47.6 tt0 -50.07 141.31 11.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.325 0.583 . . . . 0.0 112.084 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.52 ' HB3' ' HD2' ' A' ' 182' ' ' PRO . . . -105.36 157.24 34.86 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.257 175.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.29 84.18 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.859 2.373 . . . . 0.0 112.599 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.475 ' HB2' ' HG2' ' A' ' 182' ' ' PRO . . . -83.01 113.41 20.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.429 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.464 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 4.2 tmt_? -128.97 129.78 23.43 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.567 -177.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 167' ' ' VAL . 10.1 Cg_endo -52.72 122.51 11.08 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.262 2.642 . . . . 0.0 111.561 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 120.72 -18.37 9.23 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 119.946 -1.121 . . . . 0.0 112.017 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.53 143.51 27.68 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.95 0.405 . . . . 0.0 110.597 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.2 mm -80.84 131.73 33.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.965 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -67.37 110.81 5.82 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.203 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -77.24 -32.32 3.14 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.193 2.595 . . . . 0.0 113.433 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 90.5 mt -121.43 160.71 23.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.97 0.414 . . . . 0.0 111.609 -172.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.5 m -83.6 77.41 9.85 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.542 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 31.7 t -70.89 133.86 31.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.778 -176.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 51.1 t -123.74 129.27 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.341 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.49 HG22 HG13 ' A' ' 154' ' ' ILE . 78.7 mt -86.5 108.54 18.29 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 173.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.51 140.08 93.22 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 123.209 2.606 . . . . 0.0 114.079 -171.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.442 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -72.78 85.65 1.23 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.72 175.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.484 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 3.4 t-80 -171.85 176.14 3.69 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -174.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -62.75 137.88 58.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.042 0.448 . . . . 0.0 110.038 173.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.453 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 42.9 p -92.84 -11.11 34.43 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.554 -176.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.81 15.54 80.55 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.291 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 87.7 mt -114.75 152.54 31.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.354 -0.423 . . . . 0.0 110.135 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.15 167.24 51.85 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.925 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.38 6.58 1.13 Allowed 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 123.314 2.676 . . . . 0.0 112.794 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -86.88 -35.0 19.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.697 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.504 ' HE2' ' SD ' ' A' ' 177' ' ' MET . 25.4 mmmt -74.99 -3.05 30.05 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 121.602 0.715 . . . . 0.0 110.783 -172.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.0 t -63.77 -21.8 66.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.008 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.7 p -61.09 -41.2 96.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.882 0.372 . . . . 0.0 109.997 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -70.31 -44.96 67.23 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.497 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.492 ' CZ ' HD21 ' A' ' 178' ' ' LEU . 78.3 m-85 -58.69 -46.77 86.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.514 0.673 . . . . 0.0 109.861 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -69.81 -27.15 64.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.198 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.81 -31.91 73.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.996 0.427 . . . . 0.0 110.057 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 141' ' ' LEU . 4.0 mm? -94.42 22.73 5.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 173.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.9 t 59.21 43.17 17.44 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.35 174.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 29.5 mt -102.0 134.01 20.35 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 4.6 Cg_exo -71.79 108.72 2.49 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.721 2.281 . . . . 0.0 110.937 175.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.466 HG21 ' CB ' ' A' ' 138' ' ' PHE . 40.8 p -122.68 144.9 48.84 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.108 0.48 . . . . 0.0 112.053 -174.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -140.11 148.93 42.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.836 172.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 38.9 mm -88.0 131.42 35.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.836 0.35 . . . . 0.0 110.45 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.9 t -136.65 124.33 22.41 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.738 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.6 tttp 58.9 37.92 24.59 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.513 0.673 . . . . 0.0 111.022 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 71.34 13.63 73.85 Favored Glycine 0 N--CA 1.454 -0.147 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.069 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.7 p -130.06 151.96 50.04 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.51 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -77.38 123.62 34.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.303 0.573 . . . . 0.0 109.685 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.484 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 39.4 tt0 -113.42 152.38 30.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.584 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.49 HG13 HG22 ' A' ' 123' ' ' ILE . 46.3 mm -97.16 129.45 47.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.532 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 9.2 pt -92.63 -35.92 7.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.838 0.351 . . . . 0.0 111.887 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -122.53 132.09 54.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.508 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -58.12 114.48 2.4 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.69 0.757 . . . . 0.0 109.818 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.5 t -84.68 127.64 39.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.837 -170.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -82.59 72.76 9.66 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 171.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.495 HG21 HD21 ' A' ' 175' ' ' LEU . 7.2 tp -70.14 -47.14 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.475 -172.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 182' ' ' PRO . 17.3 mt -117.01 160.0 21.63 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.286 0.565 . . . . 0.0 110.49 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -157.94 131.07 4.57 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.291 -179.17 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 89.6 Cg_exo -44.85 108.89 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.799 2.999 . . . . 0.0 113.078 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 122.36 -22.27 7.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.109 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -81.85 178.59 8.22 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -126.62 118.46 24.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.722 0.296 . . . . 0.0 110.401 -175.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 26.3 t -59.9 121.58 7.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.709 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.44 -177.2 50.55 Favored Glycine 0 C--O 1.226 -0.394 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.676 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.9 -62.65 1.47 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.897 0.379 . . . . 0.0 111.546 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.2 m -65.51 -24.93 67.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -69.09 -49.43 57.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.138 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.421 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.29 -42.27 90.91 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.18 0.514 . . . . 0.0 110.106 175.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.606 ' O ' ' HG3' ' A' ' 177' ' ' MET . 33.0 m -61.38 -39.17 89.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.738 177.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 51.8 tp -61.44 -49.06 78.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.52 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.495 HD21 HG21 ' A' ' 160' ' ' ILE . 84.4 mt -71.61 -18.57 62.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -73.48 -42.27 62.08 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.606 ' HG3' ' O ' ' A' ' 173' ' ' THR . 58.2 mtm -71.67 -32.7 68.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.442 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.526 ' HB3' HG13 ' A' ' 180' ' ' ILE . 2.4 mm? -77.49 -16.37 58.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.231 -176.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 108' ' ' GLN . 40.1 t-20 60.42 47.98 8.24 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.499 0.666 . . . . 0.0 109.592 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.652 ' O ' ' HD3' ' A' ' 182' ' ' PRO . 86.3 mt -110.52 159.08 10.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.027 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.2 m -103.98 90.33 2.92 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.652 ' HD3' ' O ' ' A' ' 180' ' ' ILE . 27.9 Cg_exo -68.0 -16.39 45.06 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 121.786 1.657 . . . . 0.0 112.222 172.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.413 ' HB2' ' HB1' ' A' ' 109' ' ' ALA . 82.6 m-85 -120.23 -70.32 0.79 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.436 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 69.0 p -159.18 159.74 34.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.862 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -99.78 158.21 15.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.486 -1.175 . . . . 0.0 111.668 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 95.7 mmm . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 111.286 0.106 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -160.56 -72.89 0.07 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.758 0.313 . . . . 0.0 110.361 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -66.37 -35.16 79.64 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 173.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.8 p -104.15 70.95 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 122.355 1.074 . . . . 0.0 109.414 169.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.479 ' NE2' ' HA ' ' A' ' 176' ' ' ASN . 58.9 tp60 -162.39 95.18 0.92 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.278 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.57 ' HB1' ' HB2' ' A' ' 183' ' ' PHE . . . -53.51 146.41 24.48 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.429 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.5 74.68 0.2 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.473 2.782 . . . . 0.0 112.475 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.407 ' HB3' ' ND2' ' A' ' 176' ' ' ASN . . . -73.27 104.5 4.32 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.672 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -133.87 133.93 22.72 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.079 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 167' ' ' VAL . 9.3 Cg_endo -54.15 118.52 5.09 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.738 2.959 . . . . 0.0 113.101 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.91 -6.69 15.47 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.025 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.4 145.19 24.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.7 0.286 . . . . 0.0 110.372 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.3 mm -81.45 127.15 39.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.255 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.684 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -58.3 112.33 4.76 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.452 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 117' ' ' ALA . 12.8 Cg_exo -73.86 -49.7 0.19 Allowed 'Trans proline' 0 CA--C 1.528 0.176 0 C-N-CA 123.257 2.638 . . . . 0.0 112.88 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 75.4 mt -105.07 159.93 15.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.116 0.484 . . . . 0.0 111.697 -173.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.0 m -85.77 82.26 8.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.517 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.49 HG13 HG21 ' A' ' 180' ' ' ILE . 21.9 t -81.59 132.96 30.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.082 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 45.3 t -123.7 128.32 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.978 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . 58.1 mt -83.78 107.88 11.82 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 17.2 Cg_exo -65.84 137.89 51.04 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 C-N-CA 122.922 2.414 . . . . 0.0 113.728 -170.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -84.04 72.63 10.45 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.122 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -151.79 -56.69 0.14 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.587 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.448 HD22 ' C ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER -177.28 150.29 0.71 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.96 0.41 . . . . 0.0 110.971 175.519 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.485 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 81.7 p -115.06 -19.27 10.96 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.792 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 77.36 4.35 84.02 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.848 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.412 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 93.1 mt -94.82 150.65 19.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.058 0.456 . . . . 0.0 111.159 -175.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -72.39 169.64 51.43 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.862 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.497 ' O ' HG22 ' A' ' 135' ' ' THR . 20.4 Cg_exo -64.95 -17.74 60.26 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.898 2.398 . . . . 0.0 113.167 -173.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -59.21 -36.55 75.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.416 0.627 . . . . 0.0 110.795 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.426 ' HB3' ' CE ' ' A' ' 177' ' ' MET . 70.3 mmtt -71.66 -11.47 60.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.684 -170.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 132' ' ' PRO . 5.1 t -65.76 -21.86 66.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.074 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 26.0 t -62.92 -39.45 94.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -75.84 -40.36 54.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.226 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.506 ' CE2' HD11 ' A' ' 154' ' ' ILE . 71.3 m-85 -59.8 -48.46 81.59 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -66.35 -29.72 69.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.111 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.27 77.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.828 0.347 . . . . 0.0 110.318 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.46 HD13 ' HA ' ' A' ' 141' ' ' LEU . 4.0 mm? -91.47 19.6 6.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 174.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.2 m 60.14 43.78 13.74 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.617 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.479 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 26.5 mt -99.66 133.56 21.72 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.61 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 3.2 Cg_exo -75.8 108.5 2.7 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.853 2.369 . . . . 0.0 110.982 175.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.51 ' CG2' HD11 ' A' ' 152' ' ' ILE . 45.9 p -122.26 164.78 17.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.226 0.536 . . . . 0.0 112.181 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.588 ' HE2' HG22 ' A' ' 155' ' ' ILE . 54.2 pttt -149.93 143.31 25.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.517 173.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 44.1 mm -87.24 110.24 20.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 27.8 p -63.97 -34.52 78.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.775 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -170.64 -67.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.486 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -130.43 4.43 5.88 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 175.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.4 p -125.04 151.67 45.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.517 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -90.16 130.95 38.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 121.242 0.544 . . . . 0.0 110.046 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.501 ' N ' HD13 ' A' ' 152' ' ' ILE . 40.0 tt0 -123.89 156.43 36.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.276 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.506 HD11 ' CE2' ' A' ' 138' ' ' PHE . 1.9 mp -101.87 137.23 30.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.389 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.588 HG22 ' HE2' ' A' ' 146' ' ' LYS . 7.9 pt -91.76 -37.19 8.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.877 0.37 . . . . 0.0 111.929 -177.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -121.31 123.86 43.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.01 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -52.24 122.11 8.06 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 123.737 0.648 . . . . 0.0 110.545 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 19.8 t -94.38 126.29 46.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.992 -170.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.466 ' HB3' ' HD2' ' A' ' 162' ' ' LYS . 91.7 m-70 -80.06 76.74 6.79 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 171.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.1 tp -72.72 -42.31 62.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.246 -172.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.558 ' C ' ' HD3' ' A' ' 162' ' ' LYS . 10.1 mt -121.89 142.06 50.65 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.493 0.663 . . . . 0.0 111.876 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.558 ' HD3' ' C ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER -132.62 124.6 19.04 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.705 175.066 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 89.9 Cg_exo -44.0 101.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.279 2.652 . . . . 0.0 112.837 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 130.72 -25.76 4.15 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.058 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 162' ' ' LYS . 3.6 m-20 -76.07 158.5 31.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.853 0.359 . . . . 0.0 111.07 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -98.4 118.69 35.63 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 44.6 t -61.47 126.01 18.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.738 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.58 -178.91 52.09 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.662 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.78 -63.8 1.09 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.894 0.378 . . . . 0.0 111.582 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 36.0 t -63.94 -24.84 67.88 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -68.56 -47.18 67.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.908 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.404 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.0 -47.08 86.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.31 174.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.404 HG22 ' SD ' ' A' ' 177' ' ' MET . 57.6 m -55.48 -46.52 76.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.422 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.499 HD11 ' CE2' ' A' ' 138' ' ' PHE . 58.3 tp -58.83 -44.48 90.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.108 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.8 mt -68.34 -29.87 68.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.44 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.479 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 33.5 m-80 -73.22 -35.1 66.23 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.426 ' CE ' ' HB3' ' A' ' 134' ' ' LYS . 35.9 mtp -66.55 -34.97 79.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.781 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.488 HD21 ' CE2' ' A' ' 138' ' ' PHE . 2.1 mm? -78.3 -9.78 59.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.395 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 64.79 28.38 12.9 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.683 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.49 HG21 HG13 ' A' ' 121' ' ' VAL . 81.2 mt -102.65 128.05 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.434 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.7 m -94.26 105.12 16.0 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.725 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.532 ' HB3' HD12 ' A' ' 161' ' ' LEU . 5.3 Cg_exo -75.53 -13.65 20.26 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.86 2.373 . . . . 0.0 113.357 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.57 ' HB2' ' HB1' ' A' ' 109' ' ' ALA . 26.7 m-85 -113.85 -76.36 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.152 0.501 . . . . 0.0 110.908 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 46.9 t -136.84 156.75 48.09 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.339 -176.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -93.83 5.13 52.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.145 0.498 . . . . 0.0 110.179 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.141 0 CA-C-O 118.163 -1.354 . . . . 0.0 111.173 178.931 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 121.264 0.554 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -158.45 138.85 12.55 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.6 mttm 52.72 47.9 23.68 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.68 0.612 . . . . 0.0 109.89 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.9 t -72.48 -73.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.041 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.412 ' HA ' ' OE1' ' A' ' 108' ' ' GLN . 6.3 tp60 -70.28 109.31 4.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.23 0.538 . . . . 0.0 111.35 -174.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 184' ' ' SER . . . -63.63 150.41 90.54 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.87 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.06 78.69 0.3 Allowed 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 123.355 2.703 . . . . 0.0 113.311 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.37 103.65 3.51 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 174.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.452 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 7.8 tmm_? -133.51 128.74 20.26 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.588 -174.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.465 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 7.4 Cg_endo -51.61 124.26 14.0 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.749 2.966 . . . . 0.0 112.94 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.53 -29.48 6.63 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.648 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.26 146.48 41.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.935 0.398 . . . . 0.0 110.358 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.404 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 42.7 mm -81.7 136.95 22.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.57 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -75.2 109.71 8.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.134 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 10.1 Cg_exo -75.49 -44.66 0.29 Allowed 'Trans proline' 0 CA--C 1.527 0.164 0 C-N-CA 123.186 2.591 . . . . 0.0 113.312 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 91.3 mt -105.08 162.25 13.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.258 0.551 . . . . 0.0 111.916 -172.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.5 m -87.66 83.07 7.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.634 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.2 t -78.7 132.9 31.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.372 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 54.5 t -123.23 131.45 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.442 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 158' ' ' VAL . 75.0 mt -91.46 107.22 20.22 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.65 146.5 95.29 Favored 'Trans proline' 0 CA--C 1.513 -0.555 0 C-N-CA 122.736 2.291 . . . . 0.0 113.085 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.34 78.26 3.1 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.491 -1.232 . . . . 0.0 110.719 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.454 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 6.9 t-80 -167.13 153.43 8.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.94 132.29 46.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.353 0.597 . . . . 0.0 111.661 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.8 p -87.92 -4.8 58.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.424 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.98 4.42 90.52 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -175.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.529 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 87.6 mt -94.64 152.3 18.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.2 -0.5 . . . . 0.0 110.559 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.41 162.68 53.26 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.823 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -57.97 -29.23 85.96 Favored 'Trans proline' 0 C--O 1.224 -0.197 0 C-N-CA 123.021 2.481 . . . . 0.0 112.451 -174.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.49 -31.43 62.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.209 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.529 ' HG3' ' HB3' ' A' ' 130' ' ' LEU . 45.3 mmtm -70.11 -10.45 58.81 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.468 0.651 . . . . 0.0 111.089 -174.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.3 t -67.82 -14.98 63.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.799 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.7 t -64.61 -42.12 95.76 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -72.64 -42.26 64.6 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.939 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.49 ' CE1' HD11 ' A' ' 154' ' ' ILE . 83.2 m-85 -59.67 -47.02 87.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.701 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -65.16 -32.75 74.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.67 -36.14 81.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.579 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 141' ' ' LEU . 3.9 mm? -93.16 21.92 5.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.324 175.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.7 t 59.85 50.66 6.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.47 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.498 HG23 HG21 ' A' ' 158' ' ' VAL . 21.9 mt -105.68 133.08 20.36 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.57 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 7.5 Cg_exo -72.62 110.82 3.09 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.854 2.37 . . . . 0.0 110.693 174.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.428 HG21 ' CB ' ' A' ' 138' ' ' PHE . 17.4 p -126.62 155.94 41.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.217 -170.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -145.83 159.21 43.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.762 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 45.0 mm -100.55 102.9 14.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.2 m -80.82 -44.12 18.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.679 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -156.18 60.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.121 0.486 . . . . 0.0 111.413 -176.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 75.1 -3.69 44.39 Favored Glycine 0 C--O 1.229 -0.196 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.459 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.0 p -124.01 154.88 39.22 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.454 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -85.62 129.42 38.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.354 0.597 . . . . 0.0 110.429 -176.659 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.454 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 33.5 tt0 -127.46 149.18 50.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.624 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.49 HD11 ' CE1' ' A' ' 138' ' ' PHE . 3.0 mp -95.48 140.25 17.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.327 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.441 ' CG1' ' HB2' ' A' ' 144' ' ' PRO . 14.8 pt -96.22 -35.6 5.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -123.19 126.99 48.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.161 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -55.37 121.12 8.25 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.403 0.621 . . . . 0.0 110.35 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.2 t -93.89 124.25 46.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.865 -170.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -78.37 77.96 4.85 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 168.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.424 HG21 HD21 ' A' ' 175' ' ' LEU . 6.4 tp -68.6 -45.99 80.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.411 -172.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.4 mt -114.71 149.07 37.37 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.442 0.639 . . . . 0.0 111.211 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.55 132.13 24.26 Favored Pre-proline 0 C--N 1.315 -0.935 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.729 175.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 9.8 Cg_endo -54.02 100.82 0.07 OUTLIER 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.875 2.384 . . . . 0.0 111.839 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 123.64 -12.39 8.31 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.1 -176.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -82.75 -176.15 6.14 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -128.62 112.59 14.43 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.654 0.264 . . . . 0.0 110.346 -174.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 28.0 t -58.86 123.23 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.98 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.33 -177.42 47.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.98 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -67.66 -67.66 0.44 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.78 0.324 . . . . 0.0 111.719 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.1 p -63.7 -25.47 68.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.135 0.493 . . . . 0.0 110.187 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -68.22 -47.49 67.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.884 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.438 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -58.99 -45.09 91.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.853 174.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.615 ' O ' ' HG3' ' A' ' 177' ' ' MET . 32.3 m -56.58 -43.59 80.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.691 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 53.8 tp -60.88 -46.9 88.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.651 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.424 HD21 HG21 ' A' ' 160' ' ' ILE . 85.1 mt -71.22 -21.03 62.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.972 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -72.53 -43.72 63.15 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.615 ' HG3' ' O ' ' A' ' 173' ' ' THR . 44.9 mtm -69.24 -31.54 70.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.303 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -76.67 -11.54 59.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.552 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 61.08 25.63 15.63 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.471 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 83.0 mt -101.64 125.12 55.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.23 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.7 m -88.28 113.32 54.68 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.137 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.477 ' HG2' ' CD2' ' A' ' 183' ' ' PHE . 72.7 Cg_endo -79.67 -11.48 14.08 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.703 2.269 . . . . 0.0 113.162 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.488 ' HB2' ' HB1' ' A' ' 109' ' ' ALA . 92.1 m-85 -109.16 -73.85 0.67 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.814 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.567 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 30.1 t -158.01 150.23 22.14 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.805 0.336 . . . . 0.0 110.808 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -129.18 125.01 36.07 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 CA-C-O 118.531 -1.15 . . . . 0.0 111.698 -176.749 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.431 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 121.465 0.65 . . . . 0.0 110.945 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -145.32 -56.49 0.32 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.577 ' HE2' ' HA ' ' A' ' 106' ' ' LYS . 8.9 mmpt? -100.7 -33.01 10.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.793 173.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.2 p -156.68 154.67 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.13 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 67.19 92.67 0.08 Allowed 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 172.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.72 155.37 77.0 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.648 168.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 104' ' ' MET . 26.1 Cg_endo -61.99 102.92 0.27 Allowed 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.448 2.099 . . . . 0.0 112.56 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.33 104.75 9.13 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.59 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -128.58 127.33 23.58 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.929 -173.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.504 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 16.2 Cg_endo -59.48 121.42 9.85 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 123.229 2.62 . . . . 0.0 112.268 178.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA2' ' HE2' ' A' ' 166' ' ' LYS . . . 122.11 -23.02 7.41 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.36 -176.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.62 143.71 36.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.861 0.362 . . . . 0.0 110.219 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.3 mm -83.1 129.79 36.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.259 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 118' ' ' PRO . . . -69.68 110.72 7.0 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.222 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 117' ' ' ALA . 6.3 Cg_exo -77.47 -38.34 0.76 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 123.199 2.6 . . . . 0.0 112.955 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 79.2 mt -112.85 160.96 17.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.567 -171.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.0 p -87.89 80.36 7.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.805 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 22.1 t -73.99 135.07 28.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.742 -175.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 55.2 t -125.72 123.08 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.895 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 158' ' ' VAL . 81.5 mt -81.78 108.88 12.39 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 14.9 Cg_exo -66.26 145.39 77.98 Favored 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 122.952 2.435 . . . . 0.0 113.559 -171.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.549 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -73.91 69.94 1.44 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.119 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.584 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 82.3 m-70 -154.04 -175.18 5.26 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -174.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -63.94 137.99 58.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.048 0.451 . . . . 0.0 110.34 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.465 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 66.2 p -98.93 -14.9 19.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.64 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.0 6.3 87.32 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.531 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.491 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 91.2 mt -99.5 151.81 20.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.945 0.402 . . . . 0.0 111.071 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -72.32 167.91 52.87 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.513 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.62 -29.56 88.72 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.611 2.207 . . . . 0.0 112.469 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.73 -22.48 64.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.578 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 34.7 mmtp -76.75 -7.32 55.15 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.148 0.499 . . . . 0.0 110.954 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 5.8 t -67.69 -20.09 65.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.775 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.2 m -64.12 -40.13 95.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -71.7 -42.93 66.78 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.162 0.506 . . . . 0.0 110.284 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.524 ' CE1' HD11 ' A' ' 174' ' ' LEU . 70.1 m-85 -60.67 -48.42 81.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.635 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -63.11 -31.95 73.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.017 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.48 -36.35 82.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.355 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 141' ' ' LEU . 3.9 mm? -95.67 27.01 3.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.569 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.4 t 55.98 52.21 10.89 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.171 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.509 HG23 HG21 ' A' ' 158' ' ' VAL . 24.2 mt -108.44 135.79 19.96 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.837 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.509 ' HB2' ' CG1' ' A' ' 155' ' ' ILE . 5.4 Cg_exo -77.73 111.71 3.17 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.059 2.506 . . . . 0.0 111.199 175.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.457 ' CG2' HD11 ' A' ' 152' ' ' ILE . 47.4 p -125.65 163.78 22.02 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.187 0.518 . . . . 0.0 112.017 -172.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -154.22 149.37 26.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.103 170.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 45.0 mm -84.17 116.68 28.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.9 t -71.83 -33.69 68.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.448 -176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -168.27 -70.88 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.015 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -131.48 9.76 5.56 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.6 p -129.57 153.92 47.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.035 -0.582 . . . . 0.0 109.558 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.487 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -89.17 128.33 41.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.242 0.544 . . . . 0.0 110.031 -178.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.584 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 32.5 tt0 -119.96 152.27 37.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.365 0.602 . . . . 0.0 110.517 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 125' ' ' ALA . 34.5 mm -93.31 135.52 27.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.514 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.509 ' CG1' ' HB2' ' A' ' 144' ' ' PRO . 26.1 pt -94.93 -38.34 8.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -124.62 134.02 53.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.794 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -58.27 119.7 7.36 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.521 0.513 . . . . 0.0 110.302 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 18.7 t -90.25 129.91 40.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.002 -171.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.522 ' O ' ' HE3' ' A' ' 162' ' ' LYS . 71.1 m-70 -85.45 75.2 10.23 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 171.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.3 tp -71.02 -48.03 58.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.475 -171.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 14.5 mt -112.14 148.62 33.61 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.46 0.648 . . . . 0.0 110.806 176.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.527 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 6.3 mptt -128.47 131.51 23.81 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.246 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.64 105.86 0.15 Allowed 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.542 2.161 . . . . 0.0 111.719 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.01 -3.0 22.71 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.953 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -88.07 -175.57 5.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.413 ' HE2' ' HA2' ' A' ' 114' ' ' GLY . 87.0 tttt -132.07 112.07 12.03 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -177.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 24.6 t -54.13 125.42 8.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.32 -176.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.56 -176.86 48.4 Favored Glycine 0 C--O 1.226 -0.344 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.832 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.504 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -70.91 -69.5 0.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.905 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 69.8 m -68.17 -20.93 64.91 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -65.48 -48.22 73.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.523 173.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.437 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.19 -45.81 90.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.303 175.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.608 ' O ' ' HG3' ' A' ' 177' ' ' MET . 28.4 m -58.24 -40.43 81.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.028 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.524 HD11 ' CE1' ' A' ' 138' ' ' PHE . 54.7 tp -63.54 -49.96 71.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.624 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.486 HD22 HG21 ' A' ' 180' ' ' ILE . 52.3 mt -65.6 -23.26 66.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.723 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -74.6 -42.27 58.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.644 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.608 ' HG3' ' O ' ' A' ' 173' ' ' THR . 62.2 mtm -71.49 -31.19 66.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.409 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 180' ' ' ILE . 2.7 mm? -77.84 -9.91 59.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.549 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 10.6 p30 42.69 36.66 0.86 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 124.176 0.922 . . . . 0.0 110.377 -170.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 178' ' ' LEU . 11.5 tt -76.18 -13.2 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.893 -1.048 . . . . 0.0 112.059 -165.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 184' ' ' SER . 14.8 m 60.76 71.87 0.78 Allowed Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.072 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.422 ' HG2' ' CD1' ' A' ' 183' ' ' PHE . 65.0 Cg_endo -74.46 -4.83 16.03 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.702 2.268 . . . . 0.0 113.659 -175.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.422 ' CD1' ' HG2' ' A' ' 182' ' ' PRO . 89.6 m-85 -125.62 -61.37 1.26 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.396 0.617 . . . . 0.0 109.963 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 181' ' ' SER . 25.3 p -155.35 -171.71 3.9 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.237 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -97.98 -35.7 10.37 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.166 0.508 . . . . 0.0 109.871 176.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.383 -1.232 . . . . 0.0 111.468 176.487 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.822 0.344 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -158.1 105.59 1.95 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.396 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 93.7 mttt 55.87 54.32 8.25 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.467 0.479 . . . . 0.0 110.65 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.3 m -72.33 -14.97 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -171.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -73.53 99.85 3.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.268 0.556 . . . . 0.0 110.335 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.639 ' CB ' ' HB2' ' A' ' 183' ' ' PHE . . . -66.04 148.48 98.35 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.67 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.432 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 18.5 Cg_endo -58.4 96.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.225 2.616 . . . . 0.0 112.918 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.76 105.73 9.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.969 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.439 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 6.2 tmm_? -129.68 128.08 22.98 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.511 -175.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.556 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 10.9 Cg_endo -56.61 118.23 5.04 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.549 2.833 . . . . 0.0 112.935 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.02 -21.04 6.61 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.13 153.5 26.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.862 0.363 . . . . 0.0 110.327 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.5 mm -86.63 135.01 26.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.73 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -75.82 109.62 8.58 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.614 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -76.33 -38.12 1.18 Allowed 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 123.125 2.55 . . . . 0.0 113.308 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.5 mt -116.93 167.54 11.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.193 0.52 . . . . 0.0 111.683 -171.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.0 m -87.94 79.17 8.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.823 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 30.4 t -69.1 134.28 30.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.564 -177.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 43.2 t -123.83 131.52 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.332 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.485 HG22 HG13 ' A' ' 154' ' ' ILE . 88.0 mt -90.36 101.86 4.21 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 122' ' ' VAL . 29.8 Cg_exo -61.81 141.93 91.88 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.506 2.804 . . . . 0.0 114.172 -170.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.5 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -71.78 84.67 0.92 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.903 -1.499 . . . . 0.0 112.53 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.528 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 40.9 p-80 -175.52 179.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -57.13 135.89 56.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.0 0.429 . . . . 0.0 110.654 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.6 p -94.57 -4.84 47.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.215 0.531 . . . . 0.0 110.717 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.49 2.49 89.61 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.434 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.2 mt -93.82 150.76 20.1 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.469 -0.365 . . . . 0.0 110.315 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.41 162.61 54.25 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.465 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 150' ' ' GLY . 52.1 Cg_exo -53.54 -28.43 45.38 Favored 'Trans proline' 0 C--O 1.225 -0.173 0 C-N-CA 123.074 2.516 . . . . 0.0 112.909 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -55.31 -33.01 62.91 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.511 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 68.4 mmtt -71.57 -7.85 50.29 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.225 0.536 . . . . 0.0 110.976 -174.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 4.4 t -65.95 -21.91 66.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.993 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.7 t -63.67 -39.12 93.54 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -73.09 -42.82 62.59 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.359 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.548 ' CE2' HD11 ' A' ' 178' ' ' LEU . 71.9 m-85 -59.41 -49.37 78.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.43 0.633 . . . . 0.0 109.406 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -66.5 -28.94 68.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.304 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.05 -39.78 93.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.974 0.416 . . . . 0.0 110.125 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.78 23.55 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.149 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 40.0 m 58.65 50.4 9.0 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.996 174.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.479 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 35.5 mt -105.72 133.32 20.25 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.629 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 6.7 Cg_exo -71.96 119.18 6.02 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.997 2.465 . . . . 0.0 110.845 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.407 HG22 HD11 ' A' ' 152' ' ' ILE . 38.2 p -127.46 148.96 50.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -169.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.566 ' HD3' HG21 ' A' ' 155' ' ' ILE . 11.5 mtpp -149.64 139.89 22.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.76 174.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 50.4 mm -81.48 121.73 35.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.067 0.461 . . . . 0.0 110.747 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 14.2 t -76.85 -66.17 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.232 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -158.51 81.76 0.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.462 0.648 . . . . 0.0 110.229 174.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' A' ' 132' ' ' PRO . . . 69.26 17.22 71.99 Favored Glycine 0 CA--C 1.511 -0.185 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -173.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.6 p -139.18 149.91 44.97 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.471 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -90.75 125.7 43.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.339 0.59 . . . . 0.0 109.624 179.12 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.528 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 26.0 tt0 -116.03 148.83 39.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.687 0.756 . . . . 0.0 111.065 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.536 HD11 ' CE2' ' A' ' 138' ' ' PHE . 38.6 mm -92.37 132.28 37.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.155 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.566 HG21 ' HD3' ' A' ' 146' ' ' LYS . 32.4 pt -97.51 -37.38 6.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.874 0.368 . . . . 0.0 111.772 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -119.78 127.83 53.16 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -53.76 116.68 2.64 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.345 0.403 . . . . 0.0 110.116 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.7 t -88.43 129.69 39.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -172.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -83.44 72.94 10.22 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.558 HG21 HD21 ' A' ' 175' ' ' LEU . 6.6 tp -66.55 -54.67 23.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.596 -171.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.403 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 16.1 mt -108.26 151.76 25.53 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.335 0.588 . . . . 0.0 111.081 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 9.5 mptt -130.37 133.24 24.66 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.034 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 76.6 Cg_exo -51.32 103.81 0.08 OUTLIER 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.01 2.473 . . . . 0.0 112.38 176.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.99 -13.11 10.59 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.14 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -81.73 -179.86 7.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -128.11 117.04 20.9 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 21.5 t -52.51 122.44 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.248 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -82.6 -179.41 52.74 Favored Glycine 0 C--O 1.228 -0.257 0 CA-C-N 116.027 -0.533 . . . . 0.0 113.107 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.556 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -70.11 -70.33 0.3 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.759 0.314 . . . . 0.0 111.37 -177.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 41.0 m -67.72 -21.25 65.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.054 0.454 . . . . 0.0 110.132 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -66.56 -46.26 76.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.661 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.461 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -63.08 -44.65 95.16 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.192 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.582 ' O ' ' HG3' ' A' ' 177' ' ' MET . 14.9 m -54.93 -47.14 74.81 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.087 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.686 ' O ' HD22 ' A' ' 178' ' ' LEU . 37.3 tp -54.98 -60.96 2.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.626 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.558 HD21 HG21 ' A' ' 160' ' ' ILE . 73.1 mt -59.26 -26.74 65.18 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.553 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -70.04 -42.47 72.87 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.582 ' HG3' ' O ' ' A' ' 173' ' ' THR . 55.5 mtm -68.14 -32.17 72.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.11 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.686 HD22 ' O ' ' A' ' 174' ' ' LEU . 0.1 OUTLIER -68.9 -21.27 64.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.885 176.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 4.6 t30 65.59 26.17 11.62 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.534 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.432 HG13 ' HB3' ' A' ' 178' ' ' LEU . 84.6 mt -96.27 139.38 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.246 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 10.9 t -88.73 114.79 61.35 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.272 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.493 ' HG2' ' CD2' ' A' ' 183' ' ' PHE . 64.6 Cg_endo -83.88 -10.73 9.25 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.338 2.025 . . . . 0.0 112.545 175.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.639 ' HB2' ' CB ' ' A' ' 109' ' ' ALA . 71.7 m-85 -120.9 -125.15 0.27 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 31.4 m -108.12 -73.39 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.488 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -148.4 168.62 22.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.512 0.196 . . . . 0.0 110.527 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.432 ' HA2' ' HD3' ' A' ' 110' ' ' PRO . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.707 -1.052 . . . . 0.0 112.226 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.727 ' SD ' ' HD3' ' A' ' 110' ' ' PRO . 3.3 mpp? . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.504 0.192 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -163.33 -60.6 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.599 ' HG3' ' H ' ' A' ' 107' ' ' VAL . 14.5 ptpt -111.29 -72.25 0.73 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.372 175.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.599 ' H ' ' HG3' ' A' ' 106' ' ' LYS . 1.1 m -160.87 46.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 O-C-N 123.309 0.381 . . . . 0.0 111.002 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 181' ' ' SER . 51.0 tt0 -141.33 119.83 12.38 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.929 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.511 ' CB ' ' HB2' ' A' ' 183' ' ' PHE . . . -88.75 160.79 43.4 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.505 174.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.727 ' HD3' ' SD ' ' A' ' 104' ' ' MET . 45.1 Cg_endo -68.43 93.84 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.378 2.052 . . . . 0.0 112.799 -175.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.64 108.27 10.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.269 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.451 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 5.9 tmm_? -129.76 127.2 22.84 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.303 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.501 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 9.9 Cg_endo -53.85 116.27 2.9 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.525 2.817 . . . . 0.0 112.597 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.2 -26.28 4.2 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.44 152.34 34.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.845 0.355 . . . . 0.0 110.646 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.2 mm -87.09 130.8 36.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.391 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -69.64 110.2 6.02 Favored Pre-proline 0 C--N 1.328 -0.345 0 O-C-N 123.589 0.556 . . . . 0.0 110.899 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.571 ' HB2' HD22 ' A' ' 119' ' ' LEU . 4.2 Cg_exo -79.83 -28.82 3.08 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 123.27 2.647 . . . . 0.0 113.62 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.571 HD22 ' HB2' ' A' ' 118' ' ' PRO . 2.4 mm? -116.43 160.25 20.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.153 0.501 . . . . 0.0 111.727 -174.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.2 m -84.57 71.24 10.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.599 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 21.9 t -64.73 136.49 26.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.022 -175.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 45.1 t -124.27 130.88 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.837 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' A' ' 158' ' ' VAL . 75.2 mt -88.48 107.01 14.38 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.504 ' HB2' ' CD2' ' A' ' 126' ' ' HIS . 24.3 Cg_exo -63.15 140.25 76.99 Favored 'Trans proline' 0 CA--C 1.518 -0.313 0 C-N-CA 122.935 2.424 . . . . 0.0 112.95 -174.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.78 83.15 2.74 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.168 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.53 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 32.1 p80 -166.88 169.92 12.72 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -55.85 135.54 51.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.139 0.495 . . . . 0.0 110.746 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.0 p -95.68 -2.6 47.7 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.286 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 73.5 6.44 70.75 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.715 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.525 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 96.3 mt -92.34 156.04 17.51 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.617 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.63 151.97 45.95 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.17 -27.63 66.65 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.846 -174.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.64 -25.14 66.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.214 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.538 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 74.3 mmtt -67.01 -9.81 42.95 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.063 0.459 . . . . 0.0 111.095 -177.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.483 ' HB ' HG13 ' A' ' 152' ' ' ILE . 12.9 t -65.56 -20.91 66.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.905 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.1 t -65.09 -36.22 83.62 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.412 ' O ' ' HB3' ' A' ' 140' ' ' ALA . 54.2 m-85 -75.0 -44.34 48.69 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.327 177.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.629 ' CE1' HD11 ' A' ' 154' ' ' ILE . 85.0 m-85 -59.58 -49.44 77.76 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -64.48 -30.9 71.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.837 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 137' ' ' PHE . . . -58.84 -39.93 82.7 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.955 0.407 . . . . 0.0 110.195 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 141' ' ' LEU . 4.0 mm? -93.13 26.15 2.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.381 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.2 m 58.59 41.08 22.86 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.066 174.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.455 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 27.8 mt -97.3 133.35 23.99 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.796 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 4.7 Cg_exo -73.06 107.15 2.3 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.977 2.451 . . . . 0.0 111.106 174.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.473 HG21 ' CB ' ' A' ' 138' ' ' PHE . 43.1 p -124.78 171.51 10.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.249 0.547 . . . . 0.0 112.445 -173.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.489 ' HE3' HG22 ' A' ' 155' ' ' ILE . 21.4 pttp -165.36 163.8 19.81 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.747 173.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 41.0 mm -101.56 125.69 55.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.7 m -73.46 -44.69 57.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.565 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.543 ' HA ' ' HE3' ' A' ' 149' ' ' LYS . 0.1 OUTLIER -163.3 -58.73 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.686 178.082 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -136.43 4.86 3.77 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.018 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.1 p -129.74 149.93 51.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -85.25 130.36 36.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.268 0.556 . . . . 0.0 110.041 -178.423 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.552 ' N ' HD13 ' A' ' 152' ' ' ILE . 30.0 tt0 -120.19 149.82 41.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.157 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.629 HD11 ' CE1' ' A' ' 138' ' ' PHE . 2.9 mp -97.64 136.98 26.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.898 176.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.489 HG22 ' HE3' ' A' ' 146' ' ' LYS . 13.4 pt -95.62 -35.27 5.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.003 0.43 . . . . 0.0 111.893 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -122.46 125.23 45.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.108 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -51.8 123.14 9.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.313 0.578 . . . . 0.0 110.523 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 12.0 t -95.94 130.04 45.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.401 -168.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.457 ' O ' ' HE3' ' A' ' 162' ' ' LYS . 37.7 m80 -79.15 71.33 5.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 168.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.0 tp -63.25 -49.42 83.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.223 -173.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.431 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 13.8 mt -112.3 156.19 22.83 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.303 0.573 . . . . 0.0 111.176 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 7.7 mptt -132.46 132.22 22.68 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.631 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 10.7 Cg_endo -55.86 96.01 0.05 OUTLIER 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.766 2.311 . . . . 0.0 112.024 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 129.71 -13.41 5.85 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.95 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -84.46 153.93 23.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -97.5 107.59 20.13 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 54.8 t -46.72 124.5 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 O-C-N 123.861 0.725 . . . . 0.0 111.945 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.75 -179.29 50.21 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.207 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.501 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -70.84 -68.33 0.44 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.773 0.32 . . . . 0.0 111.598 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.8 m -61.82 -25.05 67.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.355 0.598 . . . . 0.0 109.679 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -69.73 -48.75 58.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.354 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.446 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -60.47 -44.19 96.16 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.246 176.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.654 ' O ' ' HG3' ' A' ' 177' ' ' MET . 27.0 m -59.76 -40.93 89.82 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.544 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.506 HD11 ' CE1' ' A' ' 138' ' ' PHE . 36.5 tp -60.32 -49.08 79.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.823 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 83.3 mt -64.63 -30.22 71.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.906 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -70.05 -42.73 72.49 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.329 0.585 . . . . 0.0 109.616 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.654 ' HG3' ' O ' ' A' ' 173' ' ' THR . 60.3 mtm -71.11 -28.56 64.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.425 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.508 HD21 ' CZ ' ' A' ' 138' ' ' PHE . 0.9 OUTLIER -78.97 -15.3 58.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.654 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 64.3 32.94 11.89 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 123.958 0.786 . . . . 0.0 109.74 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 81.4 mt -107.21 131.43 57.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.019 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.418 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 22.8 t -86.02 120.73 72.77 Favored Pre-proline 0 N--CA 1.447 -0.589 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.236 -177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.485 ' O ' ' HD2' ' A' ' 118' ' ' PRO . 72.2 Cg_endo -87.77 -0.83 7.3 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.594 2.196 . . . . 0.0 112.666 174.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.511 ' HB2' ' CB ' ' A' ' 109' ' ' ALA . 92.4 m-85 -130.3 -89.39 0.48 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.651 0.262 . . . . 0.0 111.008 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.442 ' H ' ' HB2' ' A' ' 109' ' ' ALA . 17.3 m -112.66 126.27 55.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.0 0.428 . . . . 0.0 111.145 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -83.14 102.88 12.14 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.319 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.335 0 CA-C-O 118.917 -0.935 . . . . 0.0 111.718 179.616 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -131.05 82.07 2.03 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 55.03 76.52 0.25 Allowed 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.737 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 185' ' ' TYR . 27.1 m -76.33 -10.99 13.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.482 -173.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.499 ' NE2' ' HA ' ' A' ' 176' ' ' ASN . 60.3 tt0 -80.47 106.67 12.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.035 0.445 . . . . 0.0 110.964 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.78 147.14 98.61 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.56 171.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.65 106.51 0.2 Allowed 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 123.039 2.493 . . . . 0.0 112.569 -177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -74.46 105.56 5.66 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.944 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -130.38 127.66 22.5 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.614 -174.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.44 ' HD3' ' CB ' ' A' ' 172' ' ' ALA . 26.0 Cg_endo -62.92 143.01 90.53 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.323 2.682 . . . . 0.0 112.552 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.419 ' HA2' ' HE2' ' A' ' 166' ' ' LYS . . . 111.98 -12.86 26.84 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.061 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.0 153.08 17.96 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.711 0.291 . . . . 0.0 110.571 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.7 mm -85.58 126.94 40.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.097 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.581 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -60.6 110.27 2.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 123.845 0.716 . . . . 0.0 111.387 -177.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -74.38 -46.69 0.27 Allowed 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 123.146 2.564 . . . . 0.0 112.578 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 91.0 mt -106.88 159.96 15.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.217 -173.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.8 t -85.02 75.72 10.35 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 182' ' ' PRO . 25.9 t -63.88 134.98 28.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.359 -1.291 . . . . 0.0 110.671 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 46.5 t -125.1 129.04 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.519 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.494 HG22 HG13 ' A' ' 154' ' ' ILE . 75.8 mt -86.51 101.31 1.92 Allowed Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 7.4 Cg_exo -71.18 137.18 30.86 Favored 'Trans proline' 0 CA--C 1.514 -0.484 0 C-N-CA 123.118 2.546 . . . . 0.0 114.318 -168.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.33 92.79 3.37 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.841 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -158.78 -50.53 0.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.238 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 173.57 150.19 0.07 Allowed 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.432 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 71.0 p -110.54 -30.22 7.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.085 0.469 . . . . 0.0 110.639 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.81 2.85 88.43 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.49 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 94.4 mt -96.49 155.22 16.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.047 0.451 . . . . 0.0 110.789 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.89 174.3 54.88 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.567 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.452 ' O ' HG22 ' A' ' 135' ' ' THR . 20.6 Cg_exo -65.34 -19.14 61.77 Favored 'Trans proline' 0 N--CA 1.466 -0.144 0 C-N-CA 122.877 2.385 . . . . 0.0 112.966 -173.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.65 -27.87 66.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.957 0.408 . . . . 0.0 111.071 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.522 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 34.4 mmtp -73.32 -6.82 48.54 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.057 0.456 . . . . 0.0 111.44 -175.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 132' ' ' PRO . 6.1 t -66.47 -20.49 66.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.865 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.1 t -62.32 -42.2 99.18 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -70.52 -46.4 63.71 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.308 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.57 ' CE2' HD21 ' A' ' 178' ' ' LEU . 74.4 m-85 -58.63 -47.33 84.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.301 0.572 . . . . 0.0 109.547 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -68.75 -25.64 64.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.436 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.31 -33.18 75.16 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.162 0.506 . . . . 0.0 109.945 176.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -98.78 26.35 5.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.073 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.9 t 55.69 55.16 7.43 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.687 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.521 HG23 HG21 ' A' ' 158' ' ' VAL . 39.8 mt -112.6 135.54 21.52 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.037 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 2.8 Cg_exo -74.38 117.42 4.97 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.008 2.472 . . . . 0.0 111.079 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.492 ' CG2' HD11 ' A' ' 152' ' ' ILE . 40.7 p -131.43 148.62 52.67 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.802 -172.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.467 ' HE2' HG21 ' A' ' 155' ' ' ILE . 41.9 mtmt -138.74 137.67 36.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.087 174.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 48.1 mm -83.63 109.18 16.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.1 p -74.86 -72.34 0.3 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.025 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -145.19 80.16 1.6 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.949 0.404 . . . . 0.0 110.153 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.57 -0.09 56.93 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.35 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.7 p -128.22 150.24 50.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.514 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -90.51 124.35 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.208 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.472 ' N ' HD13 ' A' ' 152' ' ' ILE . 33.8 tt0 -116.97 154.56 30.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.365 0.603 . . . . 0.0 110.508 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.501 HD11 ' CE2' ' A' ' 138' ' ' PHE . 48.2 mm -96.14 131.07 43.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.424 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.467 HG21 ' HE2' ' A' ' 146' ' ' LYS . 13.5 pt -94.49 -37.81 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.008 0.432 . . . . 0.0 111.714 -175.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -121.13 128.55 52.65 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -60.16 126.2 26.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.312 0.577 . . . . 0.0 109.475 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 20.8 t -99.92 128.62 51.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.402 -169.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -75.48 73.44 2.52 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 167.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.469 HG21 HD21 ' A' ' 175' ' ' LEU . 5.8 tp -64.93 -42.58 95.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.826 -175.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 15.6 mt -118.46 155.15 31.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.191 0.52 . . . . 0.0 110.176 175.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -149.4 130.87 7.36 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.409 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 81.2 Cg_exo -44.87 106.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.566 2.844 . . . . 0.0 112.835 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 127.96 -22.59 5.4 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.237 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -85.66 153.7 22.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.653 0.264 . . . . 0.0 110.374 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.419 ' HE2' ' HA2' ' A' ' 114' ' ' GLY . 82.8 tttt -102.09 111.86 24.29 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 56.4 t -49.14 123.41 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.5 0 O-C-N 123.955 0.784 . . . . 0.0 111.858 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.32 177.42 51.7 Favored Glycine 0 CA--C 1.519 0.291 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.094 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.94 -65.88 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.915 0.388 . . . . 0.0 111.774 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 49.8 m -65.55 -24.15 67.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.201 0.524 . . . . 0.0 109.829 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.1 -50.2 62.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.016 177.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.44 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -60.94 -39.67 90.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.309 175.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.554 ' O ' ' HG3' ' A' ' 177' ' ' MET . 49.9 m -60.23 -44.08 95.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.549 177.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.506 HD11 ' CE2' ' A' ' 138' ' ' PHE . 48.2 tp -60.34 -49.88 75.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.386 177.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.469 HD21 HG21 ' A' ' 160' ' ' ILE . 87.4 mt -61.82 -30.24 70.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.368 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.499 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 62.1 t30 -72.11 -42.81 65.66 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' A' ' 173' ' ' THR . 63.2 mtm -67.07 -32.91 74.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.703 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.57 HD21 ' CE2' ' A' ' 138' ' ' PHE . 2.7 mm? -72.96 -11.93 60.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.732 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 61.28 31.84 19.35 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.528 0.68 . . . . 0.0 109.8 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.538 ' O ' ' HD3' ' A' ' 182' ' ' PRO . 78.2 mt -104.4 141.45 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.506 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.2 m -84.19 107.4 10.67 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.842 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 180' ' ' ILE . 95.7 Cg_endo -92.0 -3.74 3.97 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.196 1.93 . . . . 0.0 113.286 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.424 ' CD1' ' HG2' ' A' ' 182' ' ' PRO . 94.2 m-85 -132.2 -73.39 0.52 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.916 0.389 . . . . 0.0 111.405 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 26.6 t -129.21 174.66 9.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.045 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.61 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 90.1 m-85 -110.27 -171.15 1.78 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.498 ' N ' ' HA ' ' A' ' 107' ' ' VAL . . . . . . . . 0 C--O 1.248 1.012 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.595 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 5.0 mpp? . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.389 0.138 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -179.39 161.9 1.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -176.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.499 ' HE3' ' OXT' ' A' ' 186' ' ' GLY . 56.2 pttt 38.48 59.28 1.52 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.868 0.867 . . . . 0.0 111.982 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.9 m -65.82 -28.37 43.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.148 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.63 ' OE1' ' HA ' ' A' ' 179' ' ' ASN . 52.3 tp60 -90.69 92.95 9.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.164 0.507 . . . . 0.0 111.226 -176.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.81 144.14 81.54 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.017 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.36 92.57 0.07 OUTLIER 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.113 2.542 . . . . 0.0 112.894 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.08 107.07 10.38 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -129.2 128.86 23.3 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.004 -173.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 167' ' ' VAL . 10.1 Cg_endo -54.59 126.19 21.53 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.496 2.797 . . . . 0.0 112.653 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 116.5 -23.6 10.25 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.695 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.8 140.25 38.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.81 131.5 34.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.675 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -65.09 110.27 4.01 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.814 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 117' ' ' ALA . 11.6 Cg_exo -72.93 -37.79 3.38 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.942 2.428 . . . . 0.0 112.637 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.9 mt -119.46 160.02 23.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.331 -173.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.416 ' CA ' ' HD3' ' A' ' 163' ' ' PRO . 10.3 t -86.32 77.03 9.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.801 0.81 . . . . 0.0 108.949 175.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.81 134.75 29.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.759 -176.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 59.3 t -125.71 121.66 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.38 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.544 HG22 HG13 ' A' ' 154' ' ' ILE . 47.8 mt -79.23 106.38 4.45 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.453 ' HB2' ' CE1' ' A' ' 126' ' ' HIS . 16.2 Cg_exo -66.3 145.48 78.02 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.995 2.463 . . . . 0.0 113.461 -170.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.463 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -73.01 82.39 1.23 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.335 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.48 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 1.6 p-80 -174.72 179.32 1.71 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.415 175.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -55.61 135.75 50.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.988 0.423 . . . . 0.0 110.595 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.7 p -96.38 -2.41 45.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.008 0.432 . . . . 0.0 111.425 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 76.69 19.98 77.09 Favored Glycine 0 N--CA 1.453 -0.208 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.6 mt -116.08 147.97 40.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.315 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.55 168.27 54.58 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.897 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.419 ' O ' HG22 ' A' ' 135' ' ' THR . 15.4 Cg_exo -70.05 14.53 0.27 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 123.349 2.7 . . . . 0.0 113.637 -175.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -90.41 -31.64 16.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.437 0.637 . . . . 0.0 109.769 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.53 ' HD2' ' HE1' ' A' ' 177' ' ' MET . 47.3 mmtm -72.88 -11.04 60.44 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.823 -175.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 132' ' ' PRO . 15.3 t -64.8 -22.5 67.0 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.634 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.0 p -63.43 -37.26 86.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.001 0.429 . . . . 0.0 109.937 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -76.02 -42.43 47.99 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.22 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.626 ' CE2' HD11 ' A' ' 174' ' ' LEU . 76.2 m-85 -59.12 -51.03 71.78 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 121.448 0.642 . . . . 0.0 109.391 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -65.91 -30.38 70.96 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.244 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.18 98.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.477 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 141' ' ' LEU . 4.1 mm? -86.33 23.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.948 177.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.3 m 56.24 50.16 13.93 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.533 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.474 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 23.4 mt -104.25 131.23 22.11 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.688 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 2.7 Cg_exo -73.93 112.18 3.48 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.883 2.389 . . . . 0.0 111.059 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 55.8 p -127.59 162.41 26.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.122 0.487 . . . . 0.0 111.974 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.535 ' HE2' HG22 ' A' ' 155' ' ' ILE . 60.9 pttt -150.85 148.69 28.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.124 172.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 45.0 mm -88.81 115.14 28.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.014 0.435 . . . . 0.0 109.997 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 35.2 t -80.13 -80.78 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.026 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -127.23 65.49 1.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.882 0.372 . . . . 0.0 110.07 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 70.43 15.82 73.14 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -174.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.8 p -136.19 150.77 49.16 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.48 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -84.88 128.46 38.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.197 0.522 . . . . 0.0 110.457 -178.422 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.48 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 20.0 tt0 -118.3 148.04 42.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.589 0.709 . . . . 0.0 110.963 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.544 HG13 HG22 ' A' ' 123' ' ' ILE . 41.7 mm -93.13 138.02 21.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.297 177.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.535 HG22 ' HE2' ' A' ' 146' ' ' LYS . 16.5 pt -100.93 -37.72 5.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.599 -0.44 . . . . 0.0 112.161 -176.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -121.04 139.61 53.06 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -56.41 111.13 0.9 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.377 0.608 . . . . 0.0 110.665 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.495 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 16.6 t -85.72 128.55 39.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.079 -175.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -91.72 72.39 5.81 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.1 tp -66.83 -42.74 89.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.755 -170.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 161' ' ' LEU . 13.3 mt -119.04 140.79 49.45 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.63 0.728 . . . . 0.0 111.803 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.97 127.02 27.01 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.302 174.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 9.4 Cg_endo -54.33 100.2 0.06 OUTLIER 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.501 2.134 . . . . 0.0 111.622 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 127.22 -16.13 6.38 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.289 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -78.4 175.61 10.13 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -119.69 109.82 16.09 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 42.1 t -51.4 125.64 5.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 123.881 0.738 . . . . 0.0 111.367 -176.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.28 -177.6 51.9 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.996 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.08 -65.2 0.87 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.81 0.338 . . . . 0.0 111.9 -175.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 51.0 m -65.1 -24.51 67.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -67.35 -48.67 66.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.094 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.429 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -58.58 -46.37 87.07 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.277 0.56 . . . . 0.0 110.193 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 21.3 m -58.11 -38.99 77.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.699 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.626 HD11 ' CE2' ' A' ' 138' ' ' PHE . 25.8 tp -68.24 -42.42 79.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.209 0.528 . . . . 0.0 110.937 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.6 mt -70.19 -17.48 63.16 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.95 0.405 . . . . 0.0 110.605 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.439 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 8.5 t30 -81.08 -47.84 12.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.184 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.53 ' HE1' ' HD2' ' A' ' 134' ' ' LYS . 20.6 ptp -64.99 -33.42 75.99 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.229 0.538 . . . . 0.0 110.67 177.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.448 ' HB3' ' HB ' ' A' ' 180' ' ' ILE . 0.3 OUTLIER -65.78 -32.21 73.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.946 178.263 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASN . . . . . 0.63 ' HA ' ' OE1' ' A' ' 108' ' ' GLN . 64.6 t30 56.88 42.5 26.33 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.896 0.855 . . . . 0.0 108.797 -173.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 178' ' ' LEU . 16.2 tt -94.76 -7.53 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.254 -171.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.0 m 60.21 72.47 0.74 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.565 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.93 -7.07 18.06 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.25 1.967 . . . . 0.0 113.282 -176.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -123.14 -63.15 1.28 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.107 0.48 . . . . 0.0 110.053 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 25.6 t -138.97 153.61 48.2 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.331 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -110.0 14.7 22.93 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.142 0.496 . . . . 0.0 110.219 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.499 ' OXT' ' HE3' ' A' ' 106' ' ' LYS . . . . . . . . 0 C--O 1.25 1.136 0 CA-C-O 118.181 -1.344 . . . . 0.0 111.114 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 74.4 mtm . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -127.96 106.94 9.43 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.481 -171.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 54.51 34.37 20.95 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 123.559 0.537 . . . . 0.0 110.675 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.414 ' HA ' ' HB2' ' A' ' 185' ' ' TYR . 59.1 t -71.99 -27.55 27.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.114 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -59.29 111.16 1.26 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.718 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.533 ' CB ' ' HB2' ' A' ' 183' ' ' PHE . . . -76.51 149.21 81.06 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.65 173.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.88 96.4 0.09 OUTLIER 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.782 2.321 . . . . 0.0 112.615 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -74.3 102.54 4.39 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -121.29 125.55 26.87 Favored Pre-proline 0 C--N 1.314 -0.942 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.785 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 9.5 Cg_endo -53.87 118.54 5.06 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.574 2.849 . . . . 0.0 112.481 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.45 -17.67 11.22 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.645 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.27 150.48 28.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.911 0.386 . . . . 0.0 110.28 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.3 mm -86.11 135.61 24.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.394 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -73.71 109.34 6.44 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.738 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -78.88 -36.62 0.73 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.255 2.636 . . . . 0.0 113.421 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.5 mt -114.66 159.74 20.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.18 0.514 . . . . 0.0 111.654 -172.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.5 m -81.78 71.57 8.8 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.284 173.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 19.7 t -66.67 129.59 31.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.362 -177.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 47.8 t -123.21 122.54 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.441 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.406 HG22 HG13 ' A' ' 154' ' ' ILE . 56.9 mt -80.6 106.21 4.96 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.91 142.15 80.75 Favored 'Trans proline' 0 CA--C 1.511 -0.67 0 C-N-CA 123.209 2.606 . . . . 0.0 113.952 -170.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.444 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -68.56 83.52 0.27 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.301 175.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -172.94 157.55 3.6 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -170.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.15 130.58 43.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.057 0.456 . . . . 0.0 110.969 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 37.2 p -84.89 -9.49 58.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.063 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.46 -0.61 87.64 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.571 -177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.427 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 90.3 mt -86.3 154.19 21.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.773 0.321 . . . . 0.0 110.471 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.9 168.67 54.07 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.987 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.465 ' O ' HG22 ' A' ' 135' ' ' THR . 17.0 Cg_exo -67.46 -3.1 9.47 Favored 'Trans proline' 0 CA--C 1.527 0.138 0 C-N-CA 123.198 2.599 . . . . 0.0 113.119 -174.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -78.8 -32.32 46.32 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.17 0.51 . . . . 0.0 110.548 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.496 ' HD2' ' HE1' ' A' ' 177' ' ' MET . 48.0 mmtm -69.79 -11.38 60.81 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.472 -174.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 132' ' ' PRO . 6.8 t -66.38 -17.97 65.08 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.029 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.0 t -62.16 -42.25 99.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -75.0 -40.86 60.42 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.233 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.585 ' CE1' HD11 ' A' ' 174' ' ' LEU . 71.3 m-85 -59.81 -50.66 72.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.225 0.536 . . . . 0.0 109.688 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -65.05 -30.62 71.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.221 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.29 93.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.876 0.369 . . . . 0.0 110.578 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.403 ' HA ' HD13 ' A' ' 141' ' ' LEU . 4.1 mm? -91.38 31.41 1.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.709 175.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.0 p 52.2 49.62 20.19 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.88 0.872 . . . . 0.0 112.574 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.477 HG23 HG21 ' A' ' 158' ' ' VAL . 24.9 mt -108.55 131.16 21.95 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 3.5 Cg_exo -76.6 114.63 3.9 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.072 2.515 . . . . 0.0 111.339 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 82.3 p -129.25 162.65 27.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.978 0.418 . . . . 0.0 111.427 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.452 ' HE3' HG22 ' A' ' 155' ' ' ILE . 22.6 pttp -151.89 142.99 23.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.641 171.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 44.5 mm -81.28 119.44 30.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.891 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.2 t -68.12 -36.09 79.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.135 -178.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -173.96 -66.31 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.424 ' O ' ' HD3' ' A' ' 132' ' ' PRO . . . -128.91 6.62 6.47 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 173.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 22.7 p -128.42 152.12 48.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.87 0.367 . . . . 0.0 110.296 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.472 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -86.64 130.79 36.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.222 179.653 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -117.79 153.23 33.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.307 0.575 . . . . 0.0 110.716 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.491 HD11 ' CE1' ' A' ' 138' ' ' PHE . 29.1 mm -98.04 130.81 46.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.259 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.452 HG22 ' HE3' ' A' ' 146' ' ' LYS . 25.3 pt -93.14 -35.8 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.918 0.39 . . . . 0.0 111.885 -176.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -123.83 136.88 54.66 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.343 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -61.09 118.59 6.98 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.461 0.475 . . . . 0.0 109.774 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.3 t -92.91 128.77 44.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.09 -172.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -78.45 67.98 4.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 170.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.403 HG23 ' N ' ' A' ' 161' ' ' LEU . 7.1 tp -61.19 -51.46 72.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.875 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.438 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 14.8 mt -114.77 159.87 20.09 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.287 0.565 . . . . 0.0 110.059 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.544 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -153.49 132.36 6.85 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.94 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 4.2 Cg_endo -48.26 110.59 0.34 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.596 2.864 . . . . 0.0 112.706 -176.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.09 -19.09 8.84 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.304 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -79.84 174.9 11.12 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -125.85 107.2 10.27 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -176.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 34.3 t -51.89 122.66 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 O-C-N 123.857 0.723 . . . . 0.0 111.44 -176.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.83 -175.63 46.87 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.794 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -71.39 -65.02 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 111.886 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.8 m -62.07 -29.31 70.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.476 0.655 . . . . 0.0 109.615 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -67.51 -48.31 67.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.083 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.427 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.54 -39.14 83.02 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.241 0.543 . . . . 0.0 110.451 175.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 26.5 m -61.26 -41.29 96.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.528 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.585 HD11 ' CE1' ' A' ' 138' ' ' PHE . 28.6 tp -67.88 -42.16 81.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.896 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.2 mt -69.02 -20.95 64.15 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.845 0.355 . . . . 0.0 110.648 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -78.51 -46.97 18.31 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.141 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.514 ' HG2' ' HA ' ' A' ' 174' ' ' LEU . 22.1 ptp -66.19 -24.18 66.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.51 0.671 . . . . 0.0 110.342 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.502 ' HB3' ' HB ' ' A' ' 180' ' ' ILE . 0.3 OUTLIER -78.11 -29.56 48.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.289 179.39 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 57.91 34.3 24.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 122.026 0.917 . . . . 0.0 108.727 -174.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 178' ' ' LEU . 17.7 tt -86.48 -12.47 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.646 -169.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 18.8 t 59.37 82.34 0.23 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.207 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.42 -7.08 19.85 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.405 2.07 . . . . 0.0 113.162 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.533 ' HB2' ' CB ' ' A' ' 109' ' ' ALA . 82.5 m-85 -119.95 -96.93 0.47 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.607 0.241 . . . . 0.0 110.756 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 27.2 t -162.02 149.3 14.12 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.766 0.317 . . . . 0.0 110.688 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.414 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 42.5 t80 -72.12 -51.48 21.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.625 0.726 . . . . 0.0 109.124 171.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.12 0 CA-C-O 118.371 -1.239 . . . . 0.0 110.95 178.54 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' A' ' 113' ' ' PRO . 6.7 tmm_? -138.43 130.12 15.73 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.747 -175.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 9.5 Cg_endo -54.22 122.89 12.28 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.541 2.827 . . . . 0.0 112.959 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 120.42 -25.81 7.21 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.616 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.71 147.36 35.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.94 0.4 . . . . 0.0 110.613 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.58 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 48.3 mm -81.44 143.47 12.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.964 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 118' ' ' PRO . . . -85.03 103.74 3.76 Favored Pre-proline 0 C--N 1.328 -0.334 0 O-C-N 123.485 0.491 . . . . 0.0 110.569 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.58 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 3.3 Cg_exo -79.91 -30.45 2.26 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.879 2.386 . . . . 0.0 113.018 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.435 HD22 ' HB2' ' A' ' 118' ' ' PRO . 2.0 mm? -110.65 165.93 11.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.146 0.498 . . . . 0.0 111.556 -173.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.3 m -92.72 84.76 5.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.634 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 21.1 t -82.58 134.32 27.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.523 -176.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 53.9 t -126.88 125.16 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.57 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.503 HG22 HG13 ' A' ' 154' ' ' ILE . 75.8 mt -82.36 108.16 11.01 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 19.4 Cg_exo -64.66 147.26 89.91 Favored 'Trans proline' 0 CA--C 1.511 -0.643 0 C-N-CA 122.875 2.383 . . . . 0.0 113.614 -171.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.411 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -72.99 81.71 1.21 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.145 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.444 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 48.1 t-80 -168.46 156.11 8.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 0.4 OUTLIER -63.31 132.09 50.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.362 0.601 . . . . 0.0 110.366 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.511 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 77.6 p -83.37 -14.2 53.33 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.439 -172.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.67 -14.67 57.72 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -175.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.485 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 95.2 mt -77.31 149.07 35.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.365 -0.417 . . . . 0.0 110.539 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.67 162.33 34.25 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.617 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.36 -12.25 26.51 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 123.03 2.487 . . . . 0.0 112.689 -174.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.81 -30.36 66.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.787 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.485 ' HG3' ' HB3' ' A' ' 130' ' ' LEU . 74.3 mmtt -71.68 -6.37 40.64 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.977 0.418 . . . . 0.0 111.252 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.0 t -65.2 -21.04 66.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.553 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.2 t -65.01 -38.63 91.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.735 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -73.58 -42.48 61.54 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.424 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.574 ' CZ ' HD21 ' A' ' 178' ' ' LEU . 86.1 m-85 -59.97 -48.75 80.44 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -65.79 -28.8 69.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.019 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.32 -34.36 77.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.054 0.454 . . . . 0.0 110.179 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 141' ' ' LEU . 3.9 mm? -94.9 18.87 11.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.182 174.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t 59.81 58.29 2.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.854 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 40.8 mt -115.08 135.66 22.52 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.462 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.43 ' HB2' ' CG1' ' A' ' 155' ' ' ILE . 3.4 Cg_exo -74.59 118.01 5.17 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.037 2.492 . . . . 0.0 111.054 174.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.411 ' CG2' HD11 ' A' ' 152' ' ' ILE . 35.4 p -128.84 152.57 48.35 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -172.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -148.05 147.85 30.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.421 172.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 43.6 mm -84.6 128.51 38.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.89 0.376 . . . . 0.0 110.605 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 45.5 t -99.96 -83.33 0.43 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.277 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -113.36 53.34 0.77 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.955 0.407 . . . . 0.0 110.178 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 70.05 14.11 70.54 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -171.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.2 p -130.65 151.33 51.23 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.491 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -79.65 128.01 38.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.288 0.566 . . . . 0.0 110.167 -178.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.444 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 37.7 tt0 -116.86 153.93 31.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.536 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.503 HG13 HG22 ' A' ' 123' ' ' ILE . 42.5 mm -99.88 133.05 44.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.737 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.43 ' CG1' ' HB2' ' A' ' 144' ' ' PRO . 16.0 pt -95.06 -34.72 5.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -176.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -122.39 132.13 54.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.057 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -54.96 115.46 2.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.434 0.635 . . . . 0.0 110.456 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 24.5 t -91.51 126.85 44.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.873 -171.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.621 ' O ' ' HE3' ' A' ' 162' ' ' LYS . 10.8 p-80 -80.24 73.87 7.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.432 0.635 . . . . 0.0 109.298 170.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.42 HD11 ' HG3' ' A' ' 171' ' ' GLU . 6.9 tp -64.94 -50.43 75.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.196 -174.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 15.7 mt -113.23 147.78 36.82 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.429 0.633 . . . . 0.0 110.664 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.621 ' HE3' ' O ' ' A' ' 159' ' ' HIS . 6.6 mptt -127.74 133.32 24.98 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.409 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 11.5 Cg_endo -56.56 101.87 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.391 2.061 . . . . 0.0 111.727 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.88 -5.94 12.44 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.772 -175.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -86.32 -173.33 4.49 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -135.49 116.18 13.92 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.694 0.283 . . . . 0.0 110.304 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.7 t -61.26 121.86 10.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.289 -177.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.63 -170.91 46.69 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.969 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -76.27 -63.83 1.24 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.973 0.415 . . . . 0.0 111.669 -175.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.5 m -66.27 -23.94 66.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.42 ' HG3' HD11 ' A' ' 160' ' ' ILE . 22.2 tt0 -70.18 -50.07 43.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.963 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.426 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -56.21 -46.69 79.37 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.289 0.566 . . . . 0.0 110.066 174.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.609 ' O ' ' HG3' ' A' ' 177' ' ' MET . 22.5 m -59.07 -42.17 89.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.585 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.528 HD11 ' CE2' ' A' ' 138' ' ' PHE . 48.9 tp -59.67 -49.11 79.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.708 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.02 -29.27 69.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.241 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -74.53 -33.22 62.71 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.141 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.609 ' HG3' ' O ' ' A' ' 173' ' ' THR . 63.9 mtm -79.33 -26.14 42.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.326 0.584 . . . . 0.0 110.089 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.574 HD21 ' CZ ' ' A' ' 138' ' ' PHE . 1.4 mm? -78.28 -15.08 59.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.229 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 . . . . . 0 CA--C 1.521 -0.138 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.543 -178.56 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 120.926 0.394 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.464 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 4.2 tmt_? -128.97 129.78 23.43 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.567 -177.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 167' ' ' VAL . 10.1 Cg_endo -52.72 122.51 11.08 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.262 2.642 . . . . 0.0 111.561 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 120.72 -18.37 9.23 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 119.946 -1.121 . . . . 0.0 112.017 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.53 143.51 27.68 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.95 0.405 . . . . 0.0 110.597 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.2 mm -80.84 131.73 33.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.965 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -67.37 110.81 5.82 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.203 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -77.24 -32.32 3.14 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.193 2.595 . . . . 0.0 113.433 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 90.5 mt -121.43 160.71 23.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.97 0.414 . . . . 0.0 111.609 -172.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.5 m -83.6 77.41 9.85 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.542 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 31.7 t -70.89 133.86 31.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.778 -176.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 51.1 t -123.74 129.27 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.341 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.49 HG22 HG13 ' A' ' 154' ' ' ILE . 78.7 mt -86.5 108.54 18.29 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 173.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.51 140.08 93.22 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 123.209 2.606 . . . . 0.0 114.079 -171.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.442 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -72.78 85.65 1.23 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.72 175.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.484 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 3.4 t-80 -171.85 176.14 3.69 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -174.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -62.75 137.88 58.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.042 0.448 . . . . 0.0 110.038 173.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.453 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 42.9 p -92.84 -11.11 34.43 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.554 -176.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.81 15.54 80.55 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.291 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 87.7 mt -114.75 152.54 31.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.354 -0.423 . . . . 0.0 110.135 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.15 167.24 51.85 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.925 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.38 6.58 1.13 Allowed 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 123.314 2.676 . . . . 0.0 112.794 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -86.88 -35.0 19.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.697 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.504 ' HE2' ' SD ' ' A' ' 177' ' ' MET . 25.4 mmmt -74.99 -3.05 30.05 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 121.602 0.715 . . . . 0.0 110.783 -172.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.0 t -63.77 -21.8 66.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.008 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.7 p -61.09 -41.2 96.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.882 0.372 . . . . 0.0 109.997 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -70.31 -44.96 67.23 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.497 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.492 ' CZ ' HD21 ' A' ' 178' ' ' LEU . 78.3 m-85 -58.69 -46.77 86.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.514 0.673 . . . . 0.0 109.861 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -69.81 -27.15 64.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.198 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.81 -31.91 73.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.996 0.427 . . . . 0.0 110.057 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 141' ' ' LEU . 4.0 mm? -94.42 22.73 5.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 173.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.9 t 59.21 43.17 17.44 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.35 174.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 29.5 mt -102.0 134.01 20.35 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 4.6 Cg_exo -71.79 108.72 2.49 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.721 2.281 . . . . 0.0 110.937 175.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.466 HG21 ' CB ' ' A' ' 138' ' ' PHE . 40.8 p -122.68 144.9 48.84 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.108 0.48 . . . . 0.0 112.053 -174.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -140.11 148.93 42.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.836 172.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 38.9 mm -88.0 131.42 35.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.836 0.35 . . . . 0.0 110.45 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.9 t -136.65 124.33 22.41 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.738 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.6 tttp 58.9 37.92 24.59 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.513 0.673 . . . . 0.0 111.022 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 71.34 13.63 73.85 Favored Glycine 0 N--CA 1.454 -0.147 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.069 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.7 p -130.06 151.96 50.04 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.51 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -77.38 123.62 34.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.303 0.573 . . . . 0.0 109.685 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.484 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 39.4 tt0 -113.42 152.38 30.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.584 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.49 HG13 HG22 ' A' ' 123' ' ' ILE . 46.3 mm -97.16 129.45 47.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.532 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 9.2 pt -92.63 -35.92 7.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.838 0.351 . . . . 0.0 111.887 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -122.53 132.09 54.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.508 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -58.12 114.48 2.4 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.69 0.757 . . . . 0.0 109.818 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.5 t -84.68 127.64 39.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.837 -170.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -82.59 72.76 9.66 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 171.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.495 HG21 HD21 ' A' ' 175' ' ' LEU . 7.2 tp -70.14 -47.14 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.475 -172.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 17.3 mt -117.01 160.0 21.63 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.286 0.565 . . . . 0.0 110.49 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -157.94 131.07 4.57 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.291 -179.17 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 89.6 Cg_exo -44.85 108.89 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.799 2.999 . . . . 0.0 113.078 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 122.36 -22.27 7.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.109 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -81.85 178.59 8.22 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -126.62 118.46 24.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.722 0.296 . . . . 0.0 110.401 -175.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 26.3 t -59.9 121.58 7.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.709 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.44 -177.2 50.55 Favored Glycine 0 C--O 1.226 -0.394 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.676 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.9 -62.65 1.47 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.897 0.379 . . . . 0.0 111.546 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.2 m -65.51 -24.93 67.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -69.09 -49.43 57.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.138 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.421 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.29 -42.27 90.91 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.18 0.514 . . . . 0.0 110.106 175.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.606 ' O ' ' HG3' ' A' ' 177' ' ' MET . 33.0 m -61.38 -39.17 89.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.738 177.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 51.8 tp -61.44 -49.06 78.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.52 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.495 HD21 HG21 ' A' ' 160' ' ' ILE . 84.4 mt -71.61 -18.57 62.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -73.48 -42.27 62.08 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.606 ' HG3' ' O ' ' A' ' 173' ' ' THR . 58.2 mtm -71.67 -32.7 68.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.442 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.492 HD21 ' CZ ' ' A' ' 138' ' ' PHE . 2.4 mm? -77.49 -16.37 58.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.231 -176.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 121.499 0.666 . . . . 0.0 109.592 -179.374 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.407 ' HB3' ' ND2' ' A' ' 176' ' ' ASN . . . . . . . . 0 CA--C 1.513 -0.473 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -133.87 133.93 22.72 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.079 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 167' ' ' VAL . 9.3 Cg_endo -54.15 118.52 5.09 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.738 2.959 . . . . 0.0 113.101 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.91 -6.69 15.47 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.025 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.4 145.19 24.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.7 0.286 . . . . 0.0 110.372 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.3 mm -81.45 127.15 39.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.255 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.684 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -58.3 112.33 4.76 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.452 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 117' ' ' ALA . 12.8 Cg_exo -73.86 -49.7 0.19 Allowed 'Trans proline' 0 CA--C 1.528 0.176 0 C-N-CA 123.257 2.638 . . . . 0.0 112.88 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 75.4 mt -105.07 159.93 15.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.116 0.484 . . . . 0.0 111.697 -173.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.0 m -85.77 82.26 8.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.517 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 21.9 t -81.59 132.96 30.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.082 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 45.3 t -123.7 128.32 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.978 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . 58.1 mt -83.78 107.88 11.82 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 17.2 Cg_exo -65.84 137.89 51.04 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 C-N-CA 122.922 2.414 . . . . 0.0 113.728 -170.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -84.04 72.63 10.45 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.122 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -151.79 -56.69 0.14 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.587 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.448 HD22 ' C ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER -177.28 150.29 0.71 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.96 0.41 . . . . 0.0 110.971 175.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.485 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 81.7 p -115.06 -19.27 10.96 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.792 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 77.36 4.35 84.02 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.848 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.412 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 93.1 mt -94.82 150.65 19.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.058 0.456 . . . . 0.0 111.159 -175.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -72.39 169.64 51.43 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.862 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.497 ' O ' HG22 ' A' ' 135' ' ' THR . 20.4 Cg_exo -64.95 -17.74 60.26 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.898 2.398 . . . . 0.0 113.167 -173.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -59.21 -36.55 75.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.416 0.627 . . . . 0.0 110.795 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.426 ' HB3' ' CE ' ' A' ' 177' ' ' MET . 70.3 mmtt -71.66 -11.47 60.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.684 -170.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 132' ' ' PRO . 5.1 t -65.76 -21.86 66.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.074 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 26.0 t -62.92 -39.45 94.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -75.84 -40.36 54.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.226 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.506 ' CE2' HD11 ' A' ' 154' ' ' ILE . 71.3 m-85 -59.8 -48.46 81.59 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -66.35 -29.72 69.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.111 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.27 77.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.828 0.347 . . . . 0.0 110.318 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.46 HD13 ' HA ' ' A' ' 141' ' ' LEU . 4.0 mm? -91.47 19.6 6.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 174.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.2 m 60.14 43.78 13.74 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.617 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.479 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 26.5 mt -99.66 133.56 21.72 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.61 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 3.2 Cg_exo -75.8 108.5 2.7 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.853 2.369 . . . . 0.0 110.982 175.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.51 ' CG2' HD11 ' A' ' 152' ' ' ILE . 45.9 p -122.26 164.78 17.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.226 0.536 . . . . 0.0 112.181 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.588 ' HE2' HG22 ' A' ' 155' ' ' ILE . 54.2 pttt -149.93 143.31 25.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.517 173.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 44.1 mm -87.24 110.24 20.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 27.8 p -63.97 -34.52 78.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.775 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -170.64 -67.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.486 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -130.43 4.43 5.88 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 175.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.4 p -125.04 151.67 45.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.517 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -90.16 130.95 38.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 121.242 0.544 . . . . 0.0 110.046 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.501 ' N ' HD13 ' A' ' 152' ' ' ILE . 40.0 tt0 -123.89 156.43 36.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.276 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.506 HD11 ' CE2' ' A' ' 138' ' ' PHE . 1.9 mp -101.87 137.23 30.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.389 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.588 HG22 ' HE2' ' A' ' 146' ' ' LYS . 7.9 pt -91.76 -37.19 8.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.877 0.37 . . . . 0.0 111.929 -177.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -121.31 123.86 43.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.01 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -52.24 122.11 8.06 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 123.737 0.648 . . . . 0.0 110.545 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 19.8 t -94.38 126.29 46.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.992 -170.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.466 ' HB3' ' HD2' ' A' ' 162' ' ' LYS . 91.7 m-70 -80.06 76.74 6.79 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 171.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.1 tp -72.72 -42.31 62.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.246 -172.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.558 ' C ' ' HD3' ' A' ' 162' ' ' LYS . 10.1 mt -121.89 142.06 50.65 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.493 0.663 . . . . 0.0 111.876 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.558 ' HD3' ' C ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER -132.62 124.6 19.04 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.705 175.066 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 89.9 Cg_exo -44.0 101.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.279 2.652 . . . . 0.0 112.837 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 130.72 -25.76 4.15 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.058 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 162' ' ' LYS . 3.6 m-20 -76.07 158.5 31.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.853 0.359 . . . . 0.0 111.07 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -98.4 118.69 35.63 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 44.6 t -61.47 126.01 18.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.738 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.58 -178.91 52.09 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.662 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.78 -63.8 1.09 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.894 0.378 . . . . 0.0 111.582 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 36.0 t -63.94 -24.84 67.88 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -68.56 -47.18 67.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.908 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.404 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.0 -47.08 86.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.31 174.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.404 HG22 ' SD ' ' A' ' 177' ' ' MET . 57.6 m -55.48 -46.52 76.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.422 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.499 HD11 ' CE2' ' A' ' 138' ' ' PHE . 58.3 tp -58.83 -44.48 90.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.108 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.8 mt -68.34 -29.87 68.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.44 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.407 ' ND2' ' HB3' ' A' ' 111' ' ' ALA . 33.5 m-80 -73.22 -35.1 66.23 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.426 ' CE ' ' HB3' ' A' ' 134' ' ' LYS . 35.9 mtp -66.55 -34.97 79.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.781 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.488 HD21 ' CE2' ' A' ' 138' ' ' PHE . 2.1 mm? -78.3 -9.78 59.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.395 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 . . . . . 0 N--CA 1.465 0.285 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.683 -176.406 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.343 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.452 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 7.8 tmm_? -133.51 128.74 20.26 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.588 -174.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.465 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 7.4 Cg_endo -51.61 124.26 14.0 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.749 2.966 . . . . 0.0 112.94 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.53 -29.48 6.63 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.648 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.26 146.48 41.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.935 0.398 . . . . 0.0 110.358 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.404 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 42.7 mm -81.7 136.95 22.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.57 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -75.2 109.71 8.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.134 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 10.1 Cg_exo -75.49 -44.66 0.29 Allowed 'Trans proline' 0 CA--C 1.527 0.164 0 C-N-CA 123.186 2.591 . . . . 0.0 113.312 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 91.3 mt -105.08 162.25 13.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.258 0.551 . . . . 0.0 111.916 -172.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.5 m -87.66 83.07 7.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.634 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.2 t -78.7 132.9 31.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.372 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 54.5 t -123.23 131.45 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.442 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 158' ' ' VAL . 75.0 mt -91.46 107.22 20.22 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.65 146.5 95.29 Favored 'Trans proline' 0 CA--C 1.513 -0.555 0 C-N-CA 122.736 2.291 . . . . 0.0 113.085 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.34 78.26 3.1 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.491 -1.232 . . . . 0.0 110.719 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.454 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 6.9 t-80 -167.13 153.43 8.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.94 132.29 46.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.353 0.597 . . . . 0.0 111.661 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.8 p -87.92 -4.8 58.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.424 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.98 4.42 90.52 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -175.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.529 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 87.6 mt -94.64 152.3 18.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.2 -0.5 . . . . 0.0 110.559 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.41 162.68 53.26 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.823 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -57.97 -29.23 85.96 Favored 'Trans proline' 0 C--O 1.224 -0.197 0 C-N-CA 123.021 2.481 . . . . 0.0 112.451 -174.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.49 -31.43 62.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.209 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.529 ' HG3' ' HB3' ' A' ' 130' ' ' LEU . 45.3 mmtm -70.11 -10.45 58.81 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.468 0.651 . . . . 0.0 111.089 -174.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.3 t -67.82 -14.98 63.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.799 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.7 t -64.61 -42.12 95.76 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -72.64 -42.26 64.6 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.939 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.49 ' CE1' HD11 ' A' ' 154' ' ' ILE . 83.2 m-85 -59.67 -47.02 87.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.701 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -65.16 -32.75 74.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.67 -36.14 81.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.579 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 141' ' ' LEU . 3.9 mm? -93.16 21.92 5.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.324 175.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.7 t 59.85 50.66 6.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.47 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.498 HG23 HG21 ' A' ' 158' ' ' VAL . 21.9 mt -105.68 133.08 20.36 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.57 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 7.5 Cg_exo -72.62 110.82 3.09 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.854 2.37 . . . . 0.0 110.693 174.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.428 HG21 ' CB ' ' A' ' 138' ' ' PHE . 17.4 p -126.62 155.94 41.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.217 -170.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -145.83 159.21 43.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.762 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 45.0 mm -100.55 102.9 14.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.2 m -80.82 -44.12 18.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.679 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -156.18 60.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.121 0.486 . . . . 0.0 111.413 -176.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 75.1 -3.69 44.39 Favored Glycine 0 C--O 1.229 -0.196 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.459 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.0 p -124.01 154.88 39.22 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.454 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -85.62 129.42 38.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.354 0.597 . . . . 0.0 110.429 -176.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.454 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 33.5 tt0 -127.46 149.18 50.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.624 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.49 HD11 ' CE1' ' A' ' 138' ' ' PHE . 3.0 mp -95.48 140.25 17.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.327 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.441 ' CG1' ' HB2' ' A' ' 144' ' ' PRO . 14.8 pt -96.22 -35.6 5.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -123.19 126.99 48.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.161 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -55.37 121.12 8.25 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.403 0.621 . . . . 0.0 110.35 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.2 t -93.89 124.25 46.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.865 -170.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -78.37 77.96 4.85 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 168.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.424 HG21 HD21 ' A' ' 175' ' ' LEU . 6.4 tp -68.6 -45.99 80.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.411 -172.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.4 mt -114.71 149.07 37.37 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.442 0.639 . . . . 0.0 111.211 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.55 132.13 24.26 Favored Pre-proline 0 C--N 1.315 -0.935 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.729 175.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 9.8 Cg_endo -54.02 100.82 0.07 OUTLIER 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.875 2.384 . . . . 0.0 111.839 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 123.64 -12.39 8.31 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.1 -176.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -82.75 -176.15 6.14 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -128.62 112.59 14.43 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.654 0.264 . . . . 0.0 110.346 -174.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 28.0 t -58.86 123.23 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.98 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.33 -177.42 47.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.98 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -67.66 -67.66 0.44 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.78 0.324 . . . . 0.0 111.719 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.1 p -63.7 -25.47 68.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.135 0.493 . . . . 0.0 110.187 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -68.22 -47.49 67.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.884 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.438 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -58.99 -45.09 91.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.853 174.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.615 ' O ' ' HG3' ' A' ' 177' ' ' MET . 32.3 m -56.58 -43.59 80.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.691 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 53.8 tp -60.88 -46.9 88.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.651 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.424 HD21 HG21 ' A' ' 160' ' ' ILE . 85.1 mt -71.22 -21.03 62.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.972 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -72.53 -43.72 63.15 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.615 ' HG3' ' O ' ' A' ' 173' ' ' THR . 44.9 mtm -69.24 -31.54 70.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.303 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -76.67 -11.54 59.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.552 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 . . . . . 0 N--CA 1.464 0.265 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.471 -178.24 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.461 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -128.58 127.33 23.58 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.929 -173.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.504 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 16.2 Cg_endo -59.48 121.42 9.85 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 123.229 2.62 . . . . 0.0 112.268 178.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA2' ' HE2' ' A' ' 166' ' ' LYS . . . 122.11 -23.02 7.41 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.36 -176.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.62 143.71 36.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.861 0.362 . . . . 0.0 110.219 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.3 mm -83.1 129.79 36.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.259 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 118' ' ' PRO . . . -69.68 110.72 7.0 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.222 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 117' ' ' ALA . 6.3 Cg_exo -77.47 -38.34 0.76 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 123.199 2.6 . . . . 0.0 112.955 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 79.2 mt -112.85 160.96 17.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.567 -171.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.0 p -87.89 80.36 7.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.805 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 22.1 t -73.99 135.07 28.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.742 -175.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 55.2 t -125.72 123.08 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.895 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 158' ' ' VAL . 81.5 mt -81.78 108.88 12.39 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 14.9 Cg_exo -66.26 145.39 77.98 Favored 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 122.952 2.435 . . . . 0.0 113.559 -171.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.549 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -73.91 69.94 1.44 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.119 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.584 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 82.3 m-70 -154.04 -175.18 5.26 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -174.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -63.94 137.99 58.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.048 0.451 . . . . 0.0 110.34 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.465 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 66.2 p -98.93 -14.9 19.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.64 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.0 6.3 87.32 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.531 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.491 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 91.2 mt -99.5 151.81 20.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.945 0.402 . . . . 0.0 111.071 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -72.32 167.91 52.87 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.513 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.62 -29.56 88.72 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.611 2.207 . . . . 0.0 112.469 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.73 -22.48 64.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.578 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 34.7 mmtp -76.75 -7.32 55.15 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.148 0.499 . . . . 0.0 110.954 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 5.8 t -67.69 -20.09 65.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.775 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.2 m -64.12 -40.13 95.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -71.7 -42.93 66.78 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.162 0.506 . . . . 0.0 110.284 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.524 ' CE1' HD11 ' A' ' 174' ' ' LEU . 70.1 m-85 -60.67 -48.42 81.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.635 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -63.11 -31.95 73.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.017 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.48 -36.35 82.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.355 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 141' ' ' LEU . 3.9 mm? -95.67 27.01 3.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.569 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.4 t 55.98 52.21 10.89 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.171 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.509 HG23 HG21 ' A' ' 158' ' ' VAL . 24.2 mt -108.44 135.79 19.96 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.837 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.509 ' HB2' ' CG1' ' A' ' 155' ' ' ILE . 5.4 Cg_exo -77.73 111.71 3.17 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.059 2.506 . . . . 0.0 111.199 175.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.457 ' CG2' HD11 ' A' ' 152' ' ' ILE . 47.4 p -125.65 163.78 22.02 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.187 0.518 . . . . 0.0 112.017 -172.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -154.22 149.37 26.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.103 170.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 45.0 mm -84.17 116.68 28.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.9 t -71.83 -33.69 68.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.448 -176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -168.27 -70.88 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.015 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -131.48 9.76 5.56 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.6 p -129.57 153.92 47.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.035 -0.582 . . . . 0.0 109.558 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.487 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -89.17 128.33 41.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.242 0.544 . . . . 0.0 110.031 -178.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.584 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 32.5 tt0 -119.96 152.27 37.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.365 0.602 . . . . 0.0 110.517 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 125' ' ' ALA . 34.5 mm -93.31 135.52 27.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.514 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.509 ' CG1' ' HB2' ' A' ' 144' ' ' PRO . 26.1 pt -94.93 -38.34 8.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -124.62 134.02 53.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.794 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -58.27 119.7 7.36 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.521 0.513 . . . . 0.0 110.302 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 18.7 t -90.25 129.91 40.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.002 -171.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.522 ' O ' ' HE3' ' A' ' 162' ' ' LYS . 71.1 m-70 -85.45 75.2 10.23 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 171.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.3 tp -71.02 -48.03 58.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.475 -171.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 14.5 mt -112.14 148.62 33.61 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.46 0.648 . . . . 0.0 110.806 176.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.527 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 6.3 mptt -128.47 131.51 23.81 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.246 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.64 105.86 0.15 Allowed 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.542 2.161 . . . . 0.0 111.719 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.01 -3.0 22.71 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.953 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -88.07 -175.57 5.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.413 ' HE2' ' HA2' ' A' ' 114' ' ' GLY . 87.0 tttt -132.07 112.07 12.03 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -177.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 24.6 t -54.13 125.42 8.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.32 -176.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.56 -176.86 48.4 Favored Glycine 0 C--O 1.226 -0.344 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.832 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.504 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -70.91 -69.5 0.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.905 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 69.8 m -68.17 -20.93 64.91 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -65.48 -48.22 73.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.523 173.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.437 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.19 -45.81 90.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.303 175.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.608 ' O ' ' HG3' ' A' ' 177' ' ' MET . 28.4 m -58.24 -40.43 81.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.028 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.524 HD11 ' CE1' ' A' ' 138' ' ' PHE . 54.7 tp -63.54 -49.96 71.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.624 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.3 mt -65.6 -23.26 66.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.723 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -74.6 -42.27 58.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.644 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.608 ' HG3' ' O ' ' A' ' 173' ' ' THR . 62.2 mtm -71.49 -31.19 66.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.409 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.84 -9.91 59.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.549 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 10.6 p30 . . . . . 0 N--CA 1.475 0.793 0 O-C-N 124.176 0.922 . . . . 0.0 110.377 -170.572 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.484 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.439 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 6.2 tmm_? -129.68 128.08 22.98 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.511 -175.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.556 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 10.9 Cg_endo -56.61 118.23 5.04 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.549 2.833 . . . . 0.0 112.935 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.02 -21.04 6.61 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.13 153.5 26.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.862 0.363 . . . . 0.0 110.327 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.5 mm -86.63 135.01 26.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.73 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -75.82 109.62 8.58 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.614 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -76.33 -38.12 1.18 Allowed 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 123.125 2.55 . . . . 0.0 113.308 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.5 mt -116.93 167.54 11.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.193 0.52 . . . . 0.0 111.683 -171.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.0 m -87.94 79.17 8.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.823 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 30.4 t -69.1 134.28 30.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.564 -177.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 43.2 t -123.83 131.52 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.332 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.485 HG22 HG13 ' A' ' 154' ' ' ILE . 88.0 mt -90.36 101.86 4.21 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 122' ' ' VAL . 29.8 Cg_exo -61.81 141.93 91.88 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.506 2.804 . . . . 0.0 114.172 -170.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.5 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -71.78 84.67 0.92 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.903 -1.499 . . . . 0.0 112.53 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.528 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 7.6 p80 -175.52 179.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -57.13 135.89 56.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.0 0.429 . . . . 0.0 110.654 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.6 p -94.57 -4.84 47.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.215 0.531 . . . . 0.0 110.717 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.49 2.49 89.61 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.434 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.2 mt -93.82 150.76 20.1 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.469 -0.365 . . . . 0.0 110.315 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.41 162.61 54.25 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.465 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 150' ' ' GLY . 52.1 Cg_exo -53.54 -28.43 45.38 Favored 'Trans proline' 0 C--O 1.225 -0.173 0 C-N-CA 123.074 2.516 . . . . 0.0 112.909 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -55.31 -33.01 62.91 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.511 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 68.4 mmtt -71.57 -7.85 50.29 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.225 0.536 . . . . 0.0 110.976 -174.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 4.4 t -65.95 -21.91 66.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.993 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.7 t -63.67 -39.12 93.54 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -73.09 -42.82 62.59 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.359 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.548 ' CE2' HD11 ' A' ' 178' ' ' LEU . 71.9 m-85 -59.41 -49.37 78.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.43 0.633 . . . . 0.0 109.406 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -66.5 -28.94 68.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.304 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.05 -39.78 93.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.974 0.416 . . . . 0.0 110.125 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.78 23.55 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.149 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 40.0 m 58.65 50.4 9.0 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.996 174.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.479 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 35.5 mt -105.72 133.32 20.25 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.629 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 6.7 Cg_exo -71.96 119.18 6.02 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.997 2.465 . . . . 0.0 110.845 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.407 HG22 HD11 ' A' ' 152' ' ' ILE . 38.2 p -127.46 148.96 50.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -169.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.566 ' HD3' HG21 ' A' ' 155' ' ' ILE . 11.5 mtpp -149.64 139.89 22.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.76 174.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 50.4 mm -81.48 121.73 35.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.067 0.461 . . . . 0.0 110.747 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 14.2 t -76.85 -66.17 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.232 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -158.51 81.76 0.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.462 0.648 . . . . 0.0 110.229 174.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' A' ' 132' ' ' PRO . . . 69.26 17.22 71.99 Favored Glycine 0 CA--C 1.511 -0.185 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -173.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.6 p -139.18 149.91 44.97 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.471 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -90.75 125.7 43.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.339 0.59 . . . . 0.0 109.624 179.12 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.528 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 26.0 tt0 -116.03 148.83 39.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.687 0.756 . . . . 0.0 111.065 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.536 HD11 ' CE2' ' A' ' 138' ' ' PHE . 38.6 mm -92.37 132.28 37.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.155 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.566 HG21 ' HD3' ' A' ' 146' ' ' LYS . 32.4 pt -97.51 -37.38 6.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.874 0.368 . . . . 0.0 111.772 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -119.78 127.83 53.16 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -53.76 116.68 2.64 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.345 0.403 . . . . 0.0 110.116 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.7 t -88.43 129.69 39.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -172.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -83.44 72.94 10.22 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.558 HG21 HD21 ' A' ' 175' ' ' LEU . 6.6 tp -66.55 -54.67 23.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.596 -171.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.403 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 16.1 mt -108.26 151.76 25.53 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.335 0.588 . . . . 0.0 111.081 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 9.5 mptt -130.37 133.24 24.66 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.034 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 76.6 Cg_exo -51.32 103.81 0.08 OUTLIER 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.01 2.473 . . . . 0.0 112.38 176.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.99 -13.11 10.59 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.14 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -81.73 -179.86 7.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -128.11 117.04 20.9 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 21.5 t -52.51 122.44 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.248 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -82.6 -179.41 52.74 Favored Glycine 0 C--O 1.228 -0.257 0 CA-C-N 116.027 -0.533 . . . . 0.0 113.107 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.556 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -70.11 -70.33 0.3 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.759 0.314 . . . . 0.0 111.37 -177.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 41.0 m -67.72 -21.25 65.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.054 0.454 . . . . 0.0 110.132 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -66.56 -46.26 76.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.661 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.461 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -63.08 -44.65 95.16 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.192 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.582 ' O ' ' HG3' ' A' ' 177' ' ' MET . 14.9 m -54.93 -47.14 74.81 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.087 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.686 ' O ' HD22 ' A' ' 178' ' ' LEU . 37.3 tp -54.98 -60.96 2.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.626 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.558 HD21 HG21 ' A' ' 160' ' ' ILE . 73.1 mt -59.26 -26.74 65.18 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.553 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -70.04 -42.47 72.87 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.582 ' HG3' ' O ' ' A' ' 173' ' ' THR . 55.5 mtm -68.14 -32.17 72.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.11 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.686 HD22 ' O ' ' A' ' 174' ' ' LEU . 0.1 OUTLIER -68.9 -21.27 64.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.885 176.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 4.6 t30 . . . . . 0 C--O 1.231 0.116 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.534 -176.466 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.423 0 CA-C-O 120.863 0.363 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.451 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 5.9 tmm_? -129.76 127.2 22.84 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.303 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.501 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 9.9 Cg_endo -53.85 116.27 2.9 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.525 2.817 . . . . 0.0 112.597 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.2 -26.28 4.2 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.44 152.34 34.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.845 0.355 . . . . 0.0 110.646 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.2 mm -87.09 130.8 36.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.391 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -69.64 110.2 6.02 Favored Pre-proline 0 C--N 1.328 -0.345 0 O-C-N 123.589 0.556 . . . . 0.0 110.899 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.571 ' HB2' HD22 ' A' ' 119' ' ' LEU . 4.2 Cg_exo -79.83 -28.82 3.08 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 123.27 2.647 . . . . 0.0 113.62 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.571 HD22 ' HB2' ' A' ' 118' ' ' PRO . 2.4 mm? -116.43 160.25 20.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.153 0.501 . . . . 0.0 111.727 -174.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.2 m -84.57 71.24 10.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.599 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 21.9 t -64.73 136.49 26.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.022 -175.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 45.1 t -124.27 130.88 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.837 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' A' ' 158' ' ' VAL . 75.2 mt -88.48 107.01 14.38 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.504 ' HB2' ' CD2' ' A' ' 126' ' ' HIS . 24.3 Cg_exo -63.15 140.25 76.99 Favored 'Trans proline' 0 CA--C 1.518 -0.313 0 C-N-CA 122.935 2.424 . . . . 0.0 112.95 -174.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.78 83.15 2.74 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.168 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.53 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 32.1 p80 -166.88 169.92 12.72 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -55.85 135.54 51.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.139 0.495 . . . . 0.0 110.746 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.0 p -95.68 -2.6 47.7 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.286 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 73.5 6.44 70.75 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.715 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.525 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 96.3 mt -92.34 156.04 17.51 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.617 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.63 151.97 45.95 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.17 -27.63 66.65 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.846 -174.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.64 -25.14 66.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.214 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.538 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 74.3 mmtt -67.01 -9.81 42.95 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.063 0.459 . . . . 0.0 111.095 -177.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.483 ' HB ' HG13 ' A' ' 152' ' ' ILE . 12.9 t -65.56 -20.91 66.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.905 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.1 t -65.09 -36.22 83.62 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.412 ' O ' ' HB3' ' A' ' 140' ' ' ALA . 54.2 m-85 -75.0 -44.34 48.69 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.327 177.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.629 ' CE1' HD11 ' A' ' 154' ' ' ILE . 85.0 m-85 -59.58 -49.44 77.76 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -64.48 -30.9 71.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.837 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 137' ' ' PHE . . . -58.84 -39.93 82.7 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.955 0.407 . . . . 0.0 110.195 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 141' ' ' LEU . 4.0 mm? -93.13 26.15 2.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.381 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.2 m 58.59 41.08 22.86 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.066 174.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.455 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 27.8 mt -97.3 133.35 23.99 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.796 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 4.7 Cg_exo -73.06 107.15 2.3 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.977 2.451 . . . . 0.0 111.106 174.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.473 HG21 ' CB ' ' A' ' 138' ' ' PHE . 43.1 p -124.78 171.51 10.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.249 0.547 . . . . 0.0 112.445 -173.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.489 ' HE3' HG22 ' A' ' 155' ' ' ILE . 21.4 pttp -165.36 163.8 19.81 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.747 173.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 41.0 mm -101.56 125.69 55.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.7 m -73.46 -44.69 57.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.565 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.543 ' HA ' ' HE3' ' A' ' 149' ' ' LYS . 0.1 OUTLIER -163.3 -58.73 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.686 178.082 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -136.43 4.86 3.77 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.018 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.1 p -129.74 149.93 51.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -85.25 130.36 36.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.268 0.556 . . . . 0.0 110.041 -178.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.552 ' N ' HD13 ' A' ' 152' ' ' ILE . 30.0 tt0 -120.19 149.82 41.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.157 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.629 HD11 ' CE1' ' A' ' 138' ' ' PHE . 2.9 mp -97.64 136.98 26.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.898 176.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.489 HG22 ' HE3' ' A' ' 146' ' ' LYS . 13.4 pt -95.62 -35.27 5.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.003 0.43 . . . . 0.0 111.893 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -122.46 125.23 45.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.108 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -51.8 123.14 9.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.313 0.578 . . . . 0.0 110.523 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 12.0 t -95.94 130.04 45.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.401 -168.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.457 ' O ' ' HE3' ' A' ' 162' ' ' LYS . 37.7 m80 -79.15 71.33 5.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 168.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.0 tp -63.25 -49.42 83.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.223 -173.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.431 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 13.8 mt -112.3 156.19 22.83 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.303 0.573 . . . . 0.0 111.176 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 7.7 mptt -132.46 132.22 22.68 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.631 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 10.7 Cg_endo -55.86 96.01 0.05 OUTLIER 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.766 2.311 . . . . 0.0 112.024 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 129.71 -13.41 5.85 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.95 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -84.46 153.93 23.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -97.5 107.59 20.13 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 54.8 t -46.72 124.5 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 O-C-N 123.861 0.725 . . . . 0.0 111.945 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.75 -179.29 50.21 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.207 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.501 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -70.84 -68.33 0.44 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.773 0.32 . . . . 0.0 111.598 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.8 m -61.82 -25.05 67.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.355 0.598 . . . . 0.0 109.679 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -69.73 -48.75 58.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.354 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.446 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -60.47 -44.19 96.16 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.246 176.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.654 ' O ' ' HG3' ' A' ' 177' ' ' MET . 27.0 m -59.76 -40.93 89.82 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.544 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.506 HD11 ' CE1' ' A' ' 138' ' ' PHE . 36.5 tp -60.32 -49.08 79.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.823 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 83.3 mt -64.63 -30.22 71.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.906 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -70.05 -42.73 72.49 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.329 0.585 . . . . 0.0 109.616 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.654 ' HG3' ' O ' ' A' ' 173' ' ' THR . 60.3 mtm -71.11 -28.56 64.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.425 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.508 HD21 ' CZ ' ' A' ' 138' ' ' PHE . 0.9 OUTLIER -78.97 -15.3 58.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.654 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 . . . . . 0 N--CA 1.461 0.12 0 O-C-N 123.958 0.786 . . . . 0.0 109.74 -177.782 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.451 0 CA-C-O 121.087 0.47 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -130.38 127.66 22.5 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.614 -174.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.44 ' HD3' ' CB ' ' A' ' 172' ' ' ALA . 26.0 Cg_endo -62.92 143.01 90.53 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.323 2.682 . . . . 0.0 112.552 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.419 ' HA2' ' HE2' ' A' ' 166' ' ' LYS . . . 111.98 -12.86 26.84 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.061 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.0 153.08 17.96 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.711 0.291 . . . . 0.0 110.571 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.7 mm -85.58 126.94 40.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.097 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.581 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -60.6 110.27 2.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 123.845 0.716 . . . . 0.0 111.387 -177.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -74.38 -46.69 0.27 Allowed 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 123.146 2.564 . . . . 0.0 112.578 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 91.0 mt -106.88 159.96 15.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.217 -173.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.8 t -85.02 75.72 10.35 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 25.9 t -63.88 134.98 28.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.359 -1.291 . . . . 0.0 110.671 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 46.5 t -125.1 129.04 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.519 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.494 HG22 HG13 ' A' ' 154' ' ' ILE . 75.8 mt -86.51 101.31 1.92 Allowed Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 7.4 Cg_exo -71.18 137.18 30.86 Favored 'Trans proline' 0 CA--C 1.514 -0.484 0 C-N-CA 123.118 2.546 . . . . 0.0 114.318 -168.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.33 92.79 3.37 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.841 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -158.78 -50.53 0.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.238 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 173.57 150.19 0.07 Allowed 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.432 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 71.0 p -110.54 -30.22 7.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.085 0.469 . . . . 0.0 110.639 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.81 2.85 88.43 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.49 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 94.4 mt -96.49 155.22 16.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.047 0.451 . . . . 0.0 110.789 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.89 174.3 54.88 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.567 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.452 ' O ' HG22 ' A' ' 135' ' ' THR . 20.6 Cg_exo -65.34 -19.14 61.77 Favored 'Trans proline' 0 N--CA 1.466 -0.144 0 C-N-CA 122.877 2.385 . . . . 0.0 112.966 -173.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.65 -27.87 66.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.957 0.408 . . . . 0.0 111.071 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.522 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 34.4 mmtp -73.32 -6.82 48.54 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.057 0.456 . . . . 0.0 111.44 -175.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 132' ' ' PRO . 6.1 t -66.47 -20.49 66.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.865 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.1 t -62.32 -42.2 99.18 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -70.52 -46.4 63.71 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.308 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.57 ' CE2' HD21 ' A' ' 178' ' ' LEU . 74.4 m-85 -58.63 -47.33 84.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.301 0.572 . . . . 0.0 109.547 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -68.75 -25.64 64.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.436 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.31 -33.18 75.16 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.162 0.506 . . . . 0.0 109.945 176.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -98.78 26.35 5.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.073 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.9 t 55.69 55.16 7.43 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.687 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.521 HG23 HG21 ' A' ' 158' ' ' VAL . 39.8 mt -112.6 135.54 21.52 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.037 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 2.8 Cg_exo -74.38 117.42 4.97 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.008 2.472 . . . . 0.0 111.079 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.492 ' CG2' HD11 ' A' ' 152' ' ' ILE . 40.7 p -131.43 148.62 52.67 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.802 -172.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.467 ' HE2' HG21 ' A' ' 155' ' ' ILE . 41.9 mtmt -138.74 137.67 36.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.087 174.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 48.1 mm -83.63 109.18 16.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.1 p -74.86 -72.34 0.3 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.025 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -145.19 80.16 1.6 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.949 0.404 . . . . 0.0 110.153 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.57 -0.09 56.93 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.35 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.7 p -128.22 150.24 50.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.514 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -90.51 124.35 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.208 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.472 ' N ' HD13 ' A' ' 152' ' ' ILE . 33.8 tt0 -116.97 154.56 30.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.365 0.603 . . . . 0.0 110.508 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.501 HD11 ' CE2' ' A' ' 138' ' ' PHE . 48.2 mm -96.14 131.07 43.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.424 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.467 HG21 ' HE2' ' A' ' 146' ' ' LYS . 13.5 pt -94.49 -37.81 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.008 0.432 . . . . 0.0 111.714 -175.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -121.13 128.55 52.65 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -60.16 126.2 26.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.312 0.577 . . . . 0.0 109.475 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 20.8 t -99.92 128.62 51.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.402 -169.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -75.48 73.44 2.52 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 167.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.469 HG21 HD21 ' A' ' 175' ' ' LEU . 5.8 tp -64.93 -42.58 95.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.826 -175.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 15.6 mt -118.46 155.15 31.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.191 0.52 . . . . 0.0 110.176 175.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -149.4 130.87 7.36 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.409 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 81.2 Cg_exo -44.87 106.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.566 2.844 . . . . 0.0 112.835 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 127.96 -22.59 5.4 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.237 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -85.66 153.7 22.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.653 0.264 . . . . 0.0 110.374 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.419 ' HE2' ' HA2' ' A' ' 114' ' ' GLY . 82.8 tttt -102.09 111.86 24.29 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 56.4 t -49.14 123.41 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.5 0 O-C-N 123.955 0.784 . . . . 0.0 111.858 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.32 177.42 51.7 Favored Glycine 0 CA--C 1.519 0.291 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.094 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.94 -65.88 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.915 0.388 . . . . 0.0 111.774 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 49.8 m -65.55 -24.15 67.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.201 0.524 . . . . 0.0 109.829 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.1 -50.2 62.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.016 177.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.44 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -60.94 -39.67 90.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.309 175.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.554 ' O ' ' HG3' ' A' ' 177' ' ' MET . 49.9 m -60.23 -44.08 95.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.549 177.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.506 HD11 ' CE2' ' A' ' 138' ' ' PHE . 48.2 tp -60.34 -49.88 75.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.386 177.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.469 HD21 HG21 ' A' ' 160' ' ' ILE . 87.4 mt -61.82 -30.24 70.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.368 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -72.11 -42.81 65.66 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' A' ' 173' ' ' THR . 63.2 mtm -67.07 -32.91 74.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.703 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.57 HD21 ' CE2' ' A' ' 138' ' ' PHE . 2.7 mm? -72.96 -11.93 60.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.732 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 CA--C 1.532 0.255 0 CA-C-O 121.528 0.68 . . . . 0.0 109.8 -178.584 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -129.2 128.86 23.3 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.004 -173.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 167' ' ' VAL . 10.1 Cg_endo -54.59 126.19 21.53 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.496 2.797 . . . . 0.0 112.653 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 116.5 -23.6 10.25 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.695 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.8 140.25 38.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.81 131.5 34.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.675 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -65.09 110.27 4.01 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.814 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 117' ' ' ALA . 11.6 Cg_exo -72.93 -37.79 3.38 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.942 2.428 . . . . 0.0 112.637 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.9 mt -119.46 160.02 23.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.331 -173.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.416 ' CA ' ' HD3' ' A' ' 163' ' ' PRO . 10.3 t -86.32 77.03 9.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.801 0.81 . . . . 0.0 108.949 175.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.81 134.75 29.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.759 -176.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 59.3 t -125.71 121.66 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.38 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.544 HG22 HG13 ' A' ' 154' ' ' ILE . 47.8 mt -79.23 106.38 4.45 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.453 ' HB2' ' CE1' ' A' ' 126' ' ' HIS . 16.2 Cg_exo -66.3 145.48 78.02 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.995 2.463 . . . . 0.0 113.461 -170.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.463 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -73.01 82.39 1.23 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.335 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.48 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 1.6 p-80 -174.72 179.32 1.71 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.415 175.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -55.61 135.75 50.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.988 0.423 . . . . 0.0 110.595 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.7 p -96.38 -2.41 45.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.008 0.432 . . . . 0.0 111.425 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 76.69 19.98 77.09 Favored Glycine 0 N--CA 1.453 -0.208 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.6 mt -116.08 147.97 40.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.315 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.55 168.27 54.58 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.897 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.419 ' O ' HG22 ' A' ' 135' ' ' THR . 15.4 Cg_exo -70.05 14.53 0.27 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 123.349 2.7 . . . . 0.0 113.637 -175.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -90.41 -31.64 16.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.437 0.637 . . . . 0.0 109.769 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.53 ' HD2' ' HE1' ' A' ' 177' ' ' MET . 47.3 mmtm -72.88 -11.04 60.44 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.823 -175.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 132' ' ' PRO . 15.3 t -64.8 -22.5 67.0 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.634 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.0 p -63.43 -37.26 86.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.001 0.429 . . . . 0.0 109.937 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -76.02 -42.43 47.99 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.22 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.626 ' CE2' HD11 ' A' ' 174' ' ' LEU . 76.2 m-85 -59.12 -51.03 71.78 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 121.448 0.642 . . . . 0.0 109.391 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -65.91 -30.38 70.96 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.244 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.18 98.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.477 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 141' ' ' LEU . 4.1 mm? -86.33 23.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.948 177.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.3 m 56.24 50.16 13.93 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.533 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.474 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 23.4 mt -104.25 131.23 22.11 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.688 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 2.7 Cg_exo -73.93 112.18 3.48 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.883 2.389 . . . . 0.0 111.059 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 55.8 p -127.59 162.41 26.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.122 0.487 . . . . 0.0 111.974 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.535 ' HE2' HG22 ' A' ' 155' ' ' ILE . 60.9 pttt -150.85 148.69 28.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.124 172.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 45.0 mm -88.81 115.14 28.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.014 0.435 . . . . 0.0 109.997 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 35.2 t -80.13 -80.78 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.026 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -127.23 65.49 1.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.882 0.372 . . . . 0.0 110.07 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 70.43 15.82 73.14 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -174.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.8 p -136.19 150.77 49.16 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.48 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -84.88 128.46 38.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.197 0.522 . . . . 0.0 110.457 -178.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.48 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 20.0 tt0 -118.3 148.04 42.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.589 0.709 . . . . 0.0 110.963 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.544 HG13 HG22 ' A' ' 123' ' ' ILE . 41.7 mm -93.13 138.02 21.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.297 177.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.535 HG22 ' HE2' ' A' ' 146' ' ' LYS . 16.5 pt -100.93 -37.72 5.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.599 -0.44 . . . . 0.0 112.161 -176.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -121.04 139.61 53.06 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -56.41 111.13 0.9 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.377 0.608 . . . . 0.0 110.665 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.495 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 16.6 t -85.72 128.55 39.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.079 -175.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -91.72 72.39 5.81 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.1 tp -66.83 -42.74 89.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.755 -170.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 161' ' ' LEU . 13.3 mt -119.04 140.79 49.45 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.63 0.728 . . . . 0.0 111.803 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.97 127.02 27.01 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.302 174.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 9.4 Cg_endo -54.33 100.2 0.06 OUTLIER 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.501 2.134 . . . . 0.0 111.622 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 127.22 -16.13 6.38 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.289 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -78.4 175.61 10.13 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -119.69 109.82 16.09 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 42.1 t -51.4 125.64 5.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 123.881 0.738 . . . . 0.0 111.367 -176.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.28 -177.6 51.9 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.996 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.08 -65.2 0.87 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.81 0.338 . . . . 0.0 111.9 -175.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 51.0 m -65.1 -24.51 67.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -67.35 -48.67 66.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.094 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.429 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -58.58 -46.37 87.07 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.277 0.56 . . . . 0.0 110.193 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 21.3 m -58.11 -38.99 77.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.699 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.626 HD11 ' CE2' ' A' ' 138' ' ' PHE . 25.8 tp -68.24 -42.42 79.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.209 0.528 . . . . 0.0 110.937 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.6 mt -70.19 -17.48 63.16 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.95 0.405 . . . . 0.0 110.605 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -81.08 -47.84 12.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.184 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.53 ' HE1' ' HD2' ' A' ' 134' ' ' LYS . 20.6 ptp -64.99 -33.42 75.99 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.229 0.538 . . . . 0.0 110.67 177.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 174' ' ' LEU . 0.3 OUTLIER -65.78 -32.21 73.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.946 178.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.896 0.855 . . . . 0.0 108.797 -173.585 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.562 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -121.29 125.55 26.87 Favored Pre-proline 0 C--N 1.314 -0.942 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.785 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 9.5 Cg_endo -53.87 118.54 5.06 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.574 2.849 . . . . 0.0 112.481 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.45 -17.67 11.22 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.645 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.27 150.48 28.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.911 0.386 . . . . 0.0 110.28 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.3 mm -86.11 135.61 24.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.394 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -73.71 109.34 6.44 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.738 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -78.88 -36.62 0.73 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.255 2.636 . . . . 0.0 113.421 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.5 mt -114.66 159.74 20.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.18 0.514 . . . . 0.0 111.654 -172.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.5 m -81.78 71.57 8.8 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.284 173.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 19.7 t -66.67 129.59 31.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.362 -177.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 47.8 t -123.21 122.54 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.441 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.406 HG22 HG13 ' A' ' 154' ' ' ILE . 56.9 mt -80.6 106.21 4.96 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.91 142.15 80.75 Favored 'Trans proline' 0 CA--C 1.511 -0.67 0 C-N-CA 123.209 2.606 . . . . 0.0 113.952 -170.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.444 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -68.56 83.52 0.27 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.301 175.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -172.94 157.55 3.6 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -170.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.15 130.58 43.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.057 0.456 . . . . 0.0 110.969 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 37.2 p -84.89 -9.49 58.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.063 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.46 -0.61 87.64 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.571 -177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.427 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 90.3 mt -86.3 154.19 21.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.773 0.321 . . . . 0.0 110.471 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.9 168.67 54.07 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.987 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.465 ' O ' HG22 ' A' ' 135' ' ' THR . 17.0 Cg_exo -67.46 -3.1 9.47 Favored 'Trans proline' 0 CA--C 1.527 0.138 0 C-N-CA 123.198 2.599 . . . . 0.0 113.119 -174.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -78.8 -32.32 46.32 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.17 0.51 . . . . 0.0 110.548 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.496 ' HD2' ' HE1' ' A' ' 177' ' ' MET . 48.0 mmtm -69.79 -11.38 60.81 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.472 -174.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 132' ' ' PRO . 6.8 t -66.38 -17.97 65.08 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.029 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.0 t -62.16 -42.25 99.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -75.0 -40.86 60.42 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.233 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.585 ' CE1' HD11 ' A' ' 174' ' ' LEU . 71.3 m-85 -59.81 -50.66 72.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.225 0.536 . . . . 0.0 109.688 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -65.05 -30.62 71.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.221 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.29 93.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.876 0.369 . . . . 0.0 110.578 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.403 ' HA ' HD13 ' A' ' 141' ' ' LEU . 4.1 mm? -91.38 31.41 1.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.709 175.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.0 p 52.2 49.62 20.19 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.88 0.872 . . . . 0.0 112.574 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.477 HG23 HG21 ' A' ' 158' ' ' VAL . 24.9 mt -108.55 131.16 21.95 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 3.5 Cg_exo -76.6 114.63 3.9 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.072 2.515 . . . . 0.0 111.339 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 82.3 p -129.25 162.65 27.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.978 0.418 . . . . 0.0 111.427 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.452 ' HE3' HG22 ' A' ' 155' ' ' ILE . 22.6 pttp -151.89 142.99 23.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.641 171.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 44.5 mm -81.28 119.44 30.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.891 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.2 t -68.12 -36.09 79.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.135 -178.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -173.96 -66.31 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.424 ' O ' ' HD3' ' A' ' 132' ' ' PRO . . . -128.91 6.62 6.47 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 173.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 22.7 p -128.42 152.12 48.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.87 0.367 . . . . 0.0 110.296 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.472 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -86.64 130.79 36.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.222 179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -117.79 153.23 33.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.307 0.575 . . . . 0.0 110.716 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.491 HD11 ' CE1' ' A' ' 138' ' ' PHE . 29.1 mm -98.04 130.81 46.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.259 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.482 HG13 HD22 ' A' ' 156' ' ' ASN . 25.3 pt -93.14 -35.8 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.918 0.39 . . . . 0.0 111.885 -176.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.482 HD22 HG13 ' A' ' 155' ' ' ILE . 43.4 m-80 -123.83 136.88 54.66 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.343 177.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -61.09 118.59 6.98 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.461 0.475 . . . . 0.0 109.774 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.3 t -92.91 128.77 44.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.09 -172.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -78.45 67.98 4.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 170.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.403 HG23 ' N ' ' A' ' 161' ' ' LEU . 7.1 tp -61.19 -51.46 72.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.875 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.438 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 14.8 mt -114.77 159.87 20.09 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.287 0.565 . . . . 0.0 110.059 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.544 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -153.49 132.36 6.85 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.94 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 4.2 Cg_endo -48.26 110.59 0.34 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.596 2.864 . . . . 0.0 112.706 -176.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.09 -19.09 8.84 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.304 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -79.84 174.9 11.12 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -125.85 107.2 10.27 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -176.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 34.3 t -51.89 122.66 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 O-C-N 123.857 0.723 . . . . 0.0 111.44 -176.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.83 -175.63 46.87 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.794 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -71.39 -65.02 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 111.886 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.8 m -62.07 -29.31 70.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.476 0.655 . . . . 0.0 109.615 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -67.51 -48.31 67.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.083 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.427 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.54 -39.14 83.02 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.241 0.543 . . . . 0.0 110.451 175.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 26.5 m -61.26 -41.29 96.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.528 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.585 HD11 ' CE1' ' A' ' 138' ' ' PHE . 28.6 tp -67.88 -42.16 81.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.896 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.2 mt -69.02 -20.95 64.15 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.845 0.355 . . . . 0.0 110.648 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -78.51 -46.97 18.31 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.141 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.514 ' HG2' ' HA ' ' A' ' 174' ' ' LEU . 22.1 ptp -66.19 -24.18 66.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.51 0.671 . . . . 0.0 110.342 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.11 -29.56 48.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.289 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 122.026 0.917 . . . . 0.0 108.727 -174.341 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -138.95 -58.94 0.6 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.831 0.348 . . . . 0.0 110.31 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.14 54.79 0.65 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.399 0.618 . . . . 0.0 109.826 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.33 -37.01 78.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.231 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.53 ' NE2' ' HA ' ' A' ' 176' ' ' ASN . 47.6 tt0 -86.54 109.93 19.45 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.466 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 184' ' ' SER . . . -66.8 147.64 98.99 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.79 86.36 0.14 Allowed 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.185 2.59 . . . . 0.0 112.637 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.86 116.76 12.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.931 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' A' ' 113' ' ' PRO . 6.7 tmm_? -138.43 130.12 15.73 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.747 -175.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 9.5 Cg_endo -54.22 122.89 12.28 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.541 2.827 . . . . 0.0 112.959 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 120.42 -25.81 7.21 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.616 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.71 147.36 35.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.94 0.4 . . . . 0.0 110.613 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.58 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 48.3 mm -81.44 143.47 12.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.964 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 118' ' ' PRO . . . -85.03 103.74 3.76 Favored Pre-proline 0 C--N 1.328 -0.334 0 O-C-N 123.485 0.491 . . . . 0.0 110.569 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.58 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 3.3 Cg_exo -79.91 -30.45 2.26 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.879 2.386 . . . . 0.0 113.018 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.435 HD22 ' HB2' ' A' ' 118' ' ' PRO . 2.0 mm? -110.65 165.93 11.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.146 0.498 . . . . 0.0 111.556 -173.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.3 m -92.72 84.76 5.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.634 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 21.1 t -82.58 134.32 27.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.523 -176.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 53.9 t -126.88 125.16 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.57 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.503 HG22 HG13 ' A' ' 154' ' ' ILE . 75.8 mt -82.36 108.16 11.01 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 19.4 Cg_exo -64.66 147.26 89.91 Favored 'Trans proline' 0 CA--C 1.511 -0.643 0 C-N-CA 122.875 2.383 . . . . 0.0 113.614 -171.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.411 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -72.99 81.71 1.21 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.145 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.444 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 48.1 t-80 -168.46 156.11 8.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 0.4 OUTLIER -63.31 132.09 50.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.362 0.601 . . . . 0.0 110.366 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.511 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 77.6 p -83.37 -14.2 53.33 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.439 -172.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.67 -14.67 57.72 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -175.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.485 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 95.2 mt -77.31 149.07 35.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.365 -0.417 . . . . 0.0 110.539 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.67 162.33 34.25 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.617 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.36 -12.25 26.51 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 123.03 2.487 . . . . 0.0 112.689 -174.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.81 -30.36 66.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.787 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.485 ' HG3' ' HB3' ' A' ' 130' ' ' LEU . 74.3 mmtt -71.68 -6.37 40.64 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.977 0.418 . . . . 0.0 111.252 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.0 t -65.2 -21.04 66.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.553 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.2 t -65.01 -38.63 91.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.735 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -73.58 -42.48 61.54 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.424 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.574 ' CZ ' HD21 ' A' ' 178' ' ' LEU . 86.1 m-85 -59.97 -48.75 80.44 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -65.79 -28.8 69.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.019 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.32 -34.36 77.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.054 0.454 . . . . 0.0 110.179 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 141' ' ' LEU . 3.9 mm? -94.9 18.87 11.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.182 174.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t 59.81 58.29 2.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.854 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 40.8 mt -115.08 135.66 22.52 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.462 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.43 ' HB2' ' CG1' ' A' ' 155' ' ' ILE . 3.4 Cg_exo -74.59 118.01 5.17 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.037 2.492 . . . . 0.0 111.054 174.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.411 ' CG2' HD11 ' A' ' 152' ' ' ILE . 35.4 p -128.84 152.57 48.35 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -172.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -148.05 147.85 30.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.421 172.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 43.6 mm -84.6 128.51 38.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.89 0.376 . . . . 0.0 110.605 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 45.5 t -99.96 -83.33 0.43 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.277 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -113.36 53.34 0.77 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.955 0.407 . . . . 0.0 110.178 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 70.05 14.11 70.54 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -171.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.2 p -130.65 151.33 51.23 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.491 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -79.65 128.01 38.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.288 0.566 . . . . 0.0 110.167 -178.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.444 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 37.7 tt0 -116.86 153.93 31.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.536 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.503 HG13 HG22 ' A' ' 123' ' ' ILE . 42.5 mm -99.88 133.05 44.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.737 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.43 ' CG1' ' HB2' ' A' ' 144' ' ' PRO . 16.0 pt -95.06 -34.72 5.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -176.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -122.39 132.13 54.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.057 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -54.96 115.46 2.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.434 0.635 . . . . 0.0 110.456 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 24.5 t -91.51 126.85 44.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.873 -171.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.621 ' O ' ' HE3' ' A' ' 162' ' ' LYS . 10.8 p-80 -80.24 73.87 7.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.432 0.635 . . . . 0.0 109.298 170.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.42 HD11 ' HG3' ' A' ' 171' ' ' GLU . 6.9 tp -64.94 -50.43 75.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.196 -174.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 15.7 mt -113.23 147.78 36.82 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.429 0.633 . . . . 0.0 110.664 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.621 ' HE3' ' O ' ' A' ' 159' ' ' HIS . 6.6 mptt -127.74 133.32 24.98 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.409 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 11.5 Cg_endo -56.56 101.87 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.391 2.061 . . . . 0.0 111.727 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.88 -5.94 12.44 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.772 -175.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -86.32 -173.33 4.49 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -135.49 116.18 13.92 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.694 0.283 . . . . 0.0 110.304 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.7 t -61.26 121.86 10.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.289 -177.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.63 -170.91 46.69 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.969 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -76.27 -63.83 1.24 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.973 0.415 . . . . 0.0 111.669 -175.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.5 m -66.27 -23.94 66.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.42 ' HG3' HD11 ' A' ' 160' ' ' ILE . 22.2 tt0 -70.18 -50.07 43.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.963 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.426 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -56.21 -46.69 79.37 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.289 0.566 . . . . 0.0 110.066 174.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.609 ' O ' ' HG3' ' A' ' 177' ' ' MET . 22.5 m -59.07 -42.17 89.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.585 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.528 HD11 ' CE2' ' A' ' 138' ' ' PHE . 48.9 tp -59.67 -49.11 79.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.708 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.02 -29.27 69.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.241 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.53 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 79.8 m-20 -74.53 -33.22 62.71 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.141 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.609 ' HG3' ' O ' ' A' ' 173' ' ' THR . 63.9 mtm -79.33 -26.14 42.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.326 0.584 . . . . 0.0 110.089 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.574 HD21 ' CZ ' ' A' ' 138' ' ' PHE . 1.4 mm? -78.28 -15.08 59.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.229 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 61.25 34.47 18.66 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.543 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.518 ' O ' ' HD3' ' A' ' 182' ' ' PRO . 73.2 mt -105.43 143.89 15.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.43 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 14.1 t -96.69 104.69 19.08 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 120.881 0.372 . . . . 0.0 110.922 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 180' ' ' ILE . 95.1 Cg_endo -85.12 6.48 5.67 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.558 2.172 . . . . 0.0 113.191 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.458 ' HB2' ' HB1' ' A' ' 109' ' ' ALA . 98.0 m-85 -135.5 -79.21 0.43 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.062 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 13.1 p -153.57 159.4 42.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.764 0.316 . . . . 0.0 111.258 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -120.9 12.97 11.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.954 0.407 . . . . 0.0 111.285 -176.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.914 0 CA-C-O 118.59 -1.117 . . . . 0.0 111.935 178.763 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.618 0.247 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -149.06 -38.18 0.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 0.0 110.946 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.423 ' HA ' HD21 ' A' ' 179' ' ' ASN . 18.9 ptmt -142.45 60.11 1.45 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.682 0.753 . . . . 0.0 109.59 172.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.14 -9.43 12.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.394 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.471 ' HB2' ' HA ' ' A' ' 179' ' ' ASN . 47.6 tt0 -50.07 141.31 11.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.325 0.583 . . . . 0.0 112.084 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.52 ' HB3' ' HD2' ' A' ' 182' ' ' PRO . . . -105.36 157.24 34.86 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.257 175.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.29 84.18 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.859 2.373 . . . . 0.0 112.599 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.475 ' HB2' ' HG2' ' A' ' 182' ' ' PRO . . . -83.01 113.41 20.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.429 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.464 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 4.2 tmt_? -128.97 129.78 23.43 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.567 -177.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 167' ' ' VAL . 10.1 Cg_endo -52.72 122.51 11.08 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.262 2.642 . . . . 0.0 111.561 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 120.72 -18.37 9.23 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 119.946 -1.121 . . . . 0.0 112.017 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.53 143.51 27.68 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.95 0.405 . . . . 0.0 110.597 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.2 mm -80.84 131.73 33.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.965 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -67.37 110.81 5.82 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.203 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -77.24 -32.32 3.14 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.193 2.595 . . . . 0.0 113.433 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 90.5 mt -121.43 160.71 23.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.97 0.414 . . . . 0.0 111.609 -172.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.5 m -83.6 77.41 9.85 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.542 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 31.7 t -70.89 133.86 31.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.778 -176.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 51.1 t -123.74 129.27 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.341 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.49 HG22 HG13 ' A' ' 154' ' ' ILE . 78.7 mt -86.5 108.54 18.29 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 173.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.51 140.08 93.22 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 123.209 2.606 . . . . 0.0 114.079 -171.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.442 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -72.78 85.65 1.23 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.72 175.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.484 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 3.4 t-80 -171.85 176.14 3.69 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -174.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -62.75 137.88 58.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.042 0.448 . . . . 0.0 110.038 173.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.453 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 42.9 p -92.84 -11.11 34.43 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.554 -176.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.81 15.54 80.55 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.291 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 87.7 mt -114.75 152.54 31.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.354 -0.423 . . . . 0.0 110.135 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.15 167.24 51.85 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.925 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.38 6.58 1.13 Allowed 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 123.314 2.676 . . . . 0.0 112.794 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -86.88 -35.0 19.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.697 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.504 ' HE2' ' SD ' ' A' ' 177' ' ' MET . 25.4 mmmt -74.99 -3.05 30.05 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 121.602 0.715 . . . . 0.0 110.783 -172.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.0 t -63.77 -21.8 66.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.008 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.7 p -61.09 -41.2 96.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.882 0.372 . . . . 0.0 109.997 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -70.31 -44.96 67.23 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.497 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.492 ' CZ ' HD21 ' A' ' 178' ' ' LEU . 78.3 m-85 -58.69 -46.77 86.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.514 0.673 . . . . 0.0 109.861 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -69.81 -27.15 64.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.198 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.81 -31.91 73.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.996 0.427 . . . . 0.0 110.057 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 141' ' ' LEU . 4.0 mm? -94.42 22.73 5.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 173.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.9 t 59.21 43.17 17.44 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.35 174.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 29.5 mt -102.0 134.01 20.35 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 4.6 Cg_exo -71.79 108.72 2.49 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.721 2.281 . . . . 0.0 110.937 175.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.466 HG21 ' CB ' ' A' ' 138' ' ' PHE . 40.8 p -122.68 144.9 48.84 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.108 0.48 . . . . 0.0 112.053 -174.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -140.11 148.93 42.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.836 172.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 38.9 mm -88.0 131.42 35.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.836 0.35 . . . . 0.0 110.45 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.9 t -136.65 124.33 22.41 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.738 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.6 tttp 58.9 37.92 24.59 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.513 0.673 . . . . 0.0 111.022 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 71.34 13.63 73.85 Favored Glycine 0 N--CA 1.454 -0.147 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.069 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.7 p -130.06 151.96 50.04 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.51 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -77.38 123.62 34.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.303 0.573 . . . . 0.0 109.685 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.484 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 39.4 tt0 -113.42 152.38 30.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.584 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.49 HG13 HG22 ' A' ' 123' ' ' ILE . 46.3 mm -97.16 129.45 47.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.532 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 9.2 pt -92.63 -35.92 7.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.838 0.351 . . . . 0.0 111.887 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -122.53 132.09 54.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.508 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -58.12 114.48 2.4 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.69 0.757 . . . . 0.0 109.818 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.5 t -84.68 127.64 39.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.837 -170.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -82.59 72.76 9.66 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 171.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.495 HG21 HD21 ' A' ' 175' ' ' LEU . 7.2 tp -70.14 -47.14 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.475 -172.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 182' ' ' PRO . 17.3 mt -117.01 160.0 21.63 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.286 0.565 . . . . 0.0 110.49 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -157.94 131.07 4.57 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.291 -179.17 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 89.6 Cg_exo -44.85 108.89 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.799 2.999 . . . . 0.0 113.078 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 122.36 -22.27 7.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.109 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -81.85 178.59 8.22 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -126.62 118.46 24.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.722 0.296 . . . . 0.0 110.401 -175.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 26.3 t -59.9 121.58 7.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.709 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.44 -177.2 50.55 Favored Glycine 0 C--O 1.226 -0.394 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.676 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.9 -62.65 1.47 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.897 0.379 . . . . 0.0 111.546 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.2 m -65.51 -24.93 67.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -69.09 -49.43 57.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.138 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.421 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.29 -42.27 90.91 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.18 0.514 . . . . 0.0 110.106 175.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.606 ' O ' ' HG3' ' A' ' 177' ' ' MET . 33.0 m -61.38 -39.17 89.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.738 177.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 51.8 tp -61.44 -49.06 78.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.52 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.495 HD21 HG21 ' A' ' 160' ' ' ILE . 84.4 mt -71.61 -18.57 62.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -73.48 -42.27 62.08 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.606 ' HG3' ' O ' ' A' ' 173' ' ' THR . 58.2 mtm -71.67 -32.7 68.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.442 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.526 ' HB3' HG13 ' A' ' 180' ' ' ILE . 2.4 mm? -77.49 -16.37 58.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.231 -176.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 108' ' ' GLN . 40.1 t-20 60.42 47.98 8.24 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.499 0.666 . . . . 0.0 109.592 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.652 ' O ' ' HD3' ' A' ' 182' ' ' PRO . 86.3 mt -110.52 159.08 10.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.027 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.2 m -103.98 90.33 2.92 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.652 ' HD3' ' O ' ' A' ' 180' ' ' ILE . 27.9 Cg_exo -68.0 -16.39 45.06 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 121.786 1.657 . . . . 0.0 112.222 172.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.413 ' HB2' ' HB1' ' A' ' 109' ' ' ALA . 82.6 m-85 -120.23 -70.32 0.79 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.436 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 69.0 p -159.18 159.74 34.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.862 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -99.78 158.21 15.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.486 -1.175 . . . . 0.0 111.668 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 95.7 mmm . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 111.286 0.106 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -160.56 -72.89 0.07 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.758 0.313 . . . . 0.0 110.361 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -66.37 -35.16 79.64 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 173.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.8 p -104.15 70.95 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 122.355 1.074 . . . . 0.0 109.414 169.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.479 ' NE2' ' HA ' ' A' ' 176' ' ' ASN . 58.9 tp60 -162.39 95.18 0.92 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.278 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.57 ' HB1' ' HB2' ' A' ' 183' ' ' PHE . . . -53.51 146.41 24.48 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.429 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.5 74.68 0.2 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.473 2.782 . . . . 0.0 112.475 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.407 ' HB3' ' ND2' ' A' ' 176' ' ' ASN . . . -73.27 104.5 4.32 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.672 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -133.87 133.93 22.72 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.079 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 167' ' ' VAL . 9.3 Cg_endo -54.15 118.52 5.09 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.738 2.959 . . . . 0.0 113.101 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.91 -6.69 15.47 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.025 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.4 145.19 24.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.7 0.286 . . . . 0.0 110.372 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.3 mm -81.45 127.15 39.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.255 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.684 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -58.3 112.33 4.76 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.452 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 117' ' ' ALA . 12.8 Cg_exo -73.86 -49.7 0.19 Allowed 'Trans proline' 0 CA--C 1.528 0.176 0 C-N-CA 123.257 2.638 . . . . 0.0 112.88 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 75.4 mt -105.07 159.93 15.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.116 0.484 . . . . 0.0 111.697 -173.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.0 m -85.77 82.26 8.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.517 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.49 HG13 HG21 ' A' ' 180' ' ' ILE . 21.9 t -81.59 132.96 30.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.082 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 45.3 t -123.7 128.32 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.978 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . 58.1 mt -83.78 107.88 11.82 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 17.2 Cg_exo -65.84 137.89 51.04 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 C-N-CA 122.922 2.414 . . . . 0.0 113.728 -170.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -84.04 72.63 10.45 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.122 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -151.79 -56.69 0.14 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.587 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.448 HD22 ' C ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER -177.28 150.29 0.71 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.96 0.41 . . . . 0.0 110.971 175.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.485 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 81.7 p -115.06 -19.27 10.96 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.792 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 77.36 4.35 84.02 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.848 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.412 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 93.1 mt -94.82 150.65 19.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.058 0.456 . . . . 0.0 111.159 -175.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -72.39 169.64 51.43 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.862 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.497 ' O ' HG22 ' A' ' 135' ' ' THR . 20.4 Cg_exo -64.95 -17.74 60.26 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.898 2.398 . . . . 0.0 113.167 -173.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -59.21 -36.55 75.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.416 0.627 . . . . 0.0 110.795 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.426 ' HB3' ' CE ' ' A' ' 177' ' ' MET . 70.3 mmtt -71.66 -11.47 60.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.684 -170.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 132' ' ' PRO . 5.1 t -65.76 -21.86 66.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.074 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 26.0 t -62.92 -39.45 94.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -75.84 -40.36 54.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.226 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.506 ' CE2' HD11 ' A' ' 154' ' ' ILE . 71.3 m-85 -59.8 -48.46 81.59 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -66.35 -29.72 69.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.111 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.27 77.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.828 0.347 . . . . 0.0 110.318 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.46 HD13 ' HA ' ' A' ' 141' ' ' LEU . 4.0 mm? -91.47 19.6 6.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 174.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.2 m 60.14 43.78 13.74 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.617 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.479 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 26.5 mt -99.66 133.56 21.72 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.61 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 3.2 Cg_exo -75.8 108.5 2.7 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.853 2.369 . . . . 0.0 110.982 175.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.51 ' CG2' HD11 ' A' ' 152' ' ' ILE . 45.9 p -122.26 164.78 17.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.226 0.536 . . . . 0.0 112.181 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.588 ' HE2' HG22 ' A' ' 155' ' ' ILE . 54.2 pttt -149.93 143.31 25.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.517 173.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 44.1 mm -87.24 110.24 20.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 27.8 p -63.97 -34.52 78.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.775 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -170.64 -67.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.486 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -130.43 4.43 5.88 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 175.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.4 p -125.04 151.67 45.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.517 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -90.16 130.95 38.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 121.242 0.544 . . . . 0.0 110.046 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.501 ' N ' HD13 ' A' ' 152' ' ' ILE . 40.0 tt0 -123.89 156.43 36.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.276 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.506 HD11 ' CE2' ' A' ' 138' ' ' PHE . 1.9 mp -101.87 137.23 30.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.389 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.588 HG22 ' HE2' ' A' ' 146' ' ' LYS . 7.9 pt -91.76 -37.19 8.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.877 0.37 . . . . 0.0 111.929 -177.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -121.31 123.86 43.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.01 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -52.24 122.11 8.06 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 123.737 0.648 . . . . 0.0 110.545 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 19.8 t -94.38 126.29 46.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.992 -170.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.466 ' HB3' ' HD2' ' A' ' 162' ' ' LYS . 91.7 m-70 -80.06 76.74 6.79 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 171.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.1 tp -72.72 -42.31 62.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.246 -172.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.558 ' C ' ' HD3' ' A' ' 162' ' ' LYS . 10.1 mt -121.89 142.06 50.65 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.493 0.663 . . . . 0.0 111.876 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.558 ' HD3' ' C ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER -132.62 124.6 19.04 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.705 175.066 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 89.9 Cg_exo -44.0 101.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.279 2.652 . . . . 0.0 112.837 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 130.72 -25.76 4.15 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.058 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 162' ' ' LYS . 3.6 m-20 -76.07 158.5 31.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.853 0.359 . . . . 0.0 111.07 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -98.4 118.69 35.63 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 44.6 t -61.47 126.01 18.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.738 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.58 -178.91 52.09 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.662 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.78 -63.8 1.09 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.894 0.378 . . . . 0.0 111.582 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 36.0 t -63.94 -24.84 67.88 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -68.56 -47.18 67.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.908 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.404 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.0 -47.08 86.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.31 174.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.404 HG22 ' SD ' ' A' ' 177' ' ' MET . 57.6 m -55.48 -46.52 76.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.422 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.499 HD11 ' CE2' ' A' ' 138' ' ' PHE . 58.3 tp -58.83 -44.48 90.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.108 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.8 mt -68.34 -29.87 68.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.44 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.479 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 33.5 m-80 -73.22 -35.1 66.23 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.426 ' CE ' ' HB3' ' A' ' 134' ' ' LYS . 35.9 mtp -66.55 -34.97 79.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.781 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.488 HD21 ' CE2' ' A' ' 138' ' ' PHE . 2.1 mm? -78.3 -9.78 59.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.395 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 64.79 28.38 12.9 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.683 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.49 HG21 HG13 ' A' ' 121' ' ' VAL . 81.2 mt -102.65 128.05 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.434 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.7 m -94.26 105.12 16.0 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.725 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.532 ' HB3' HD12 ' A' ' 161' ' ' LEU . 5.3 Cg_exo -75.53 -13.65 20.26 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.86 2.373 . . . . 0.0 113.357 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.57 ' HB2' ' HB1' ' A' ' 109' ' ' ALA . 26.7 m-85 -113.85 -76.36 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.152 0.501 . . . . 0.0 110.908 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 46.9 t -136.84 156.75 48.09 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.339 -176.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -93.83 5.13 52.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.145 0.498 . . . . 0.0 110.179 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.141 0 CA-C-O 118.163 -1.354 . . . . 0.0 111.173 178.931 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 121.264 0.554 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -158.45 138.85 12.55 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.6 mttm 52.72 47.9 23.68 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.68 0.612 . . . . 0.0 109.89 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.9 t -72.48 -73.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.041 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.412 ' HA ' ' OE1' ' A' ' 108' ' ' GLN . 6.3 tp60 -70.28 109.31 4.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.23 0.538 . . . . 0.0 111.35 -174.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 184' ' ' SER . . . -63.63 150.41 90.54 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.87 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.06 78.69 0.3 Allowed 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 123.355 2.703 . . . . 0.0 113.311 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.37 103.65 3.51 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 174.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.452 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 7.8 tmm_? -133.51 128.74 20.26 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.588 -174.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.465 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 7.4 Cg_endo -51.61 124.26 14.0 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.749 2.966 . . . . 0.0 112.94 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.53 -29.48 6.63 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.648 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.26 146.48 41.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.935 0.398 . . . . 0.0 110.358 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.404 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 42.7 mm -81.7 136.95 22.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.57 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -75.2 109.71 8.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.134 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 10.1 Cg_exo -75.49 -44.66 0.29 Allowed 'Trans proline' 0 CA--C 1.527 0.164 0 C-N-CA 123.186 2.591 . . . . 0.0 113.312 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 91.3 mt -105.08 162.25 13.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.258 0.551 . . . . 0.0 111.916 -172.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.5 m -87.66 83.07 7.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.634 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.2 t -78.7 132.9 31.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.372 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 54.5 t -123.23 131.45 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.442 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 158' ' ' VAL . 75.0 mt -91.46 107.22 20.22 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.65 146.5 95.29 Favored 'Trans proline' 0 CA--C 1.513 -0.555 0 C-N-CA 122.736 2.291 . . . . 0.0 113.085 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.34 78.26 3.1 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.491 -1.232 . . . . 0.0 110.719 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.454 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 6.9 t-80 -167.13 153.43 8.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.94 132.29 46.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.353 0.597 . . . . 0.0 111.661 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.8 p -87.92 -4.8 58.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.424 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.98 4.42 90.52 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -175.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.529 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 87.6 mt -94.64 152.3 18.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.2 -0.5 . . . . 0.0 110.559 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.41 162.68 53.26 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.823 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -57.97 -29.23 85.96 Favored 'Trans proline' 0 C--O 1.224 -0.197 0 C-N-CA 123.021 2.481 . . . . 0.0 112.451 -174.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.49 -31.43 62.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.209 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.529 ' HG3' ' HB3' ' A' ' 130' ' ' LEU . 45.3 mmtm -70.11 -10.45 58.81 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.468 0.651 . . . . 0.0 111.089 -174.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.3 t -67.82 -14.98 63.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.799 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.7 t -64.61 -42.12 95.76 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -72.64 -42.26 64.6 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.939 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.49 ' CE1' HD11 ' A' ' 154' ' ' ILE . 83.2 m-85 -59.67 -47.02 87.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.701 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -65.16 -32.75 74.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.67 -36.14 81.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.579 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 141' ' ' LEU . 3.9 mm? -93.16 21.92 5.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.324 175.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.7 t 59.85 50.66 6.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.47 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.498 HG23 HG21 ' A' ' 158' ' ' VAL . 21.9 mt -105.68 133.08 20.36 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.57 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 7.5 Cg_exo -72.62 110.82 3.09 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.854 2.37 . . . . 0.0 110.693 174.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.428 HG21 ' CB ' ' A' ' 138' ' ' PHE . 17.4 p -126.62 155.94 41.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.217 -170.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -145.83 159.21 43.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.762 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 45.0 mm -100.55 102.9 14.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.2 m -80.82 -44.12 18.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.679 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -156.18 60.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.121 0.486 . . . . 0.0 111.413 -176.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 75.1 -3.69 44.39 Favored Glycine 0 C--O 1.229 -0.196 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.459 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.0 p -124.01 154.88 39.22 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.454 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -85.62 129.42 38.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.354 0.597 . . . . 0.0 110.429 -176.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.454 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 33.5 tt0 -127.46 149.18 50.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.624 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.49 HD11 ' CE1' ' A' ' 138' ' ' PHE . 3.0 mp -95.48 140.25 17.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.327 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.441 ' CG1' ' HB2' ' A' ' 144' ' ' PRO . 14.8 pt -96.22 -35.6 5.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -123.19 126.99 48.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.161 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -55.37 121.12 8.25 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.403 0.621 . . . . 0.0 110.35 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.2 t -93.89 124.25 46.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.865 -170.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -78.37 77.96 4.85 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 168.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.424 HG21 HD21 ' A' ' 175' ' ' LEU . 6.4 tp -68.6 -45.99 80.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.411 -172.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.4 mt -114.71 149.07 37.37 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.442 0.639 . . . . 0.0 111.211 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.55 132.13 24.26 Favored Pre-proline 0 C--N 1.315 -0.935 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.729 175.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 9.8 Cg_endo -54.02 100.82 0.07 OUTLIER 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.875 2.384 . . . . 0.0 111.839 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 123.64 -12.39 8.31 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.1 -176.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -82.75 -176.15 6.14 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -128.62 112.59 14.43 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.654 0.264 . . . . 0.0 110.346 -174.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 28.0 t -58.86 123.23 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.98 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.33 -177.42 47.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.98 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -67.66 -67.66 0.44 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.78 0.324 . . . . 0.0 111.719 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.1 p -63.7 -25.47 68.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.135 0.493 . . . . 0.0 110.187 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -68.22 -47.49 67.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.884 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.438 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -58.99 -45.09 91.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.853 174.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.615 ' O ' ' HG3' ' A' ' 177' ' ' MET . 32.3 m -56.58 -43.59 80.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.691 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 53.8 tp -60.88 -46.9 88.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.651 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.424 HD21 HG21 ' A' ' 160' ' ' ILE . 85.1 mt -71.22 -21.03 62.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.972 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -72.53 -43.72 63.15 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.615 ' HG3' ' O ' ' A' ' 173' ' ' THR . 44.9 mtm -69.24 -31.54 70.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.303 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -76.67 -11.54 59.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.552 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 61.08 25.63 15.63 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.471 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 83.0 mt -101.64 125.12 55.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.23 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.7 m -88.28 113.32 54.68 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.137 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.477 ' HG2' ' CD2' ' A' ' 183' ' ' PHE . 72.7 Cg_endo -79.67 -11.48 14.08 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.703 2.269 . . . . 0.0 113.162 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.488 ' HB2' ' HB1' ' A' ' 109' ' ' ALA . 92.1 m-85 -109.16 -73.85 0.67 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.814 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.567 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 30.1 t -158.01 150.23 22.14 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.805 0.336 . . . . 0.0 110.808 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -129.18 125.01 36.07 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 CA-C-O 118.531 -1.15 . . . . 0.0 111.698 -176.749 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.431 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 121.465 0.65 . . . . 0.0 110.945 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -145.32 -56.49 0.32 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.577 ' HE2' ' HA ' ' A' ' 106' ' ' LYS . 8.9 mmpt? -100.7 -33.01 10.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.793 173.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.2 p -156.68 154.67 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.13 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 67.19 92.67 0.08 Allowed 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 172.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.72 155.37 77.0 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.648 168.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 104' ' ' MET . 26.1 Cg_endo -61.99 102.92 0.27 Allowed 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.448 2.099 . . . . 0.0 112.56 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.33 104.75 9.13 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.59 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -128.58 127.33 23.58 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.929 -173.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.504 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 16.2 Cg_endo -59.48 121.42 9.85 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 123.229 2.62 . . . . 0.0 112.268 178.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA2' ' HE2' ' A' ' 166' ' ' LYS . . . 122.11 -23.02 7.41 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.36 -176.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.62 143.71 36.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.861 0.362 . . . . 0.0 110.219 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.3 mm -83.1 129.79 36.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.259 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 118' ' ' PRO . . . -69.68 110.72 7.0 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.222 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 117' ' ' ALA . 6.3 Cg_exo -77.47 -38.34 0.76 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 123.199 2.6 . . . . 0.0 112.955 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 79.2 mt -112.85 160.96 17.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.567 -171.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.0 p -87.89 80.36 7.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.805 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 22.1 t -73.99 135.07 28.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.742 -175.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 55.2 t -125.72 123.08 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.895 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 158' ' ' VAL . 81.5 mt -81.78 108.88 12.39 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 14.9 Cg_exo -66.26 145.39 77.98 Favored 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 122.952 2.435 . . . . 0.0 113.559 -171.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.549 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -73.91 69.94 1.44 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.119 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.584 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 82.3 m-70 -154.04 -175.18 5.26 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -174.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -63.94 137.99 58.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.048 0.451 . . . . 0.0 110.34 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.465 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 66.2 p -98.93 -14.9 19.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.64 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.0 6.3 87.32 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.531 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.491 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 91.2 mt -99.5 151.81 20.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.945 0.402 . . . . 0.0 111.071 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -72.32 167.91 52.87 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.513 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.62 -29.56 88.72 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.611 2.207 . . . . 0.0 112.469 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.73 -22.48 64.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.578 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 34.7 mmtp -76.75 -7.32 55.15 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.148 0.499 . . . . 0.0 110.954 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 5.8 t -67.69 -20.09 65.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.775 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.2 m -64.12 -40.13 95.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -71.7 -42.93 66.78 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.162 0.506 . . . . 0.0 110.284 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.524 ' CE1' HD11 ' A' ' 174' ' ' LEU . 70.1 m-85 -60.67 -48.42 81.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.635 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -63.11 -31.95 73.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.017 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.48 -36.35 82.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.355 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 141' ' ' LEU . 3.9 mm? -95.67 27.01 3.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.569 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.4 t 55.98 52.21 10.89 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.171 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.509 HG23 HG21 ' A' ' 158' ' ' VAL . 24.2 mt -108.44 135.79 19.96 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.837 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.509 ' HB2' ' CG1' ' A' ' 155' ' ' ILE . 5.4 Cg_exo -77.73 111.71 3.17 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.059 2.506 . . . . 0.0 111.199 175.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.457 ' CG2' HD11 ' A' ' 152' ' ' ILE . 47.4 p -125.65 163.78 22.02 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.187 0.518 . . . . 0.0 112.017 -172.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -154.22 149.37 26.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.103 170.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 45.0 mm -84.17 116.68 28.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.9 t -71.83 -33.69 68.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.448 -176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -168.27 -70.88 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.015 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -131.48 9.76 5.56 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.6 p -129.57 153.92 47.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.035 -0.582 . . . . 0.0 109.558 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.487 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -89.17 128.33 41.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.242 0.544 . . . . 0.0 110.031 -178.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.584 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 32.5 tt0 -119.96 152.27 37.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.365 0.602 . . . . 0.0 110.517 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 125' ' ' ALA . 34.5 mm -93.31 135.52 27.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.514 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.509 ' CG1' ' HB2' ' A' ' 144' ' ' PRO . 26.1 pt -94.93 -38.34 8.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -124.62 134.02 53.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.794 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -58.27 119.7 7.36 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.521 0.513 . . . . 0.0 110.302 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 18.7 t -90.25 129.91 40.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.002 -171.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.522 ' O ' ' HE3' ' A' ' 162' ' ' LYS . 71.1 m-70 -85.45 75.2 10.23 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 171.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.3 tp -71.02 -48.03 58.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.475 -171.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 14.5 mt -112.14 148.62 33.61 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.46 0.648 . . . . 0.0 110.806 176.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.527 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 6.3 mptt -128.47 131.51 23.81 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.246 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.64 105.86 0.15 Allowed 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.542 2.161 . . . . 0.0 111.719 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.01 -3.0 22.71 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.953 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -88.07 -175.57 5.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.413 ' HE2' ' HA2' ' A' ' 114' ' ' GLY . 87.0 tttt -132.07 112.07 12.03 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -177.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 24.6 t -54.13 125.42 8.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.32 -176.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.56 -176.86 48.4 Favored Glycine 0 C--O 1.226 -0.344 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.832 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.504 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -70.91 -69.5 0.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.905 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 69.8 m -68.17 -20.93 64.91 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -65.48 -48.22 73.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.523 173.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.437 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.19 -45.81 90.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.303 175.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.608 ' O ' ' HG3' ' A' ' 177' ' ' MET . 28.4 m -58.24 -40.43 81.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.028 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.524 HD11 ' CE1' ' A' ' 138' ' ' PHE . 54.7 tp -63.54 -49.96 71.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.624 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.486 HD22 HG21 ' A' ' 180' ' ' ILE . 52.3 mt -65.6 -23.26 66.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.723 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -74.6 -42.27 58.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.644 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.608 ' HG3' ' O ' ' A' ' 173' ' ' THR . 62.2 mtm -71.49 -31.19 66.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.409 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 180' ' ' ILE . 2.7 mm? -77.84 -9.91 59.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.549 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 10.6 p30 42.69 36.66 0.86 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 124.176 0.922 . . . . 0.0 110.377 -170.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 178' ' ' LEU . 11.5 tt -76.18 -13.2 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.893 -1.048 . . . . 0.0 112.059 -165.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 184' ' ' SER . 14.8 m 60.76 71.87 0.78 Allowed Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.072 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.422 ' HG2' ' CD1' ' A' ' 183' ' ' PHE . 65.0 Cg_endo -74.46 -4.83 16.03 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.702 2.268 . . . . 0.0 113.659 -175.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.422 ' CD1' ' HG2' ' A' ' 182' ' ' PRO . 89.6 m-85 -125.62 -61.37 1.26 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.396 0.617 . . . . 0.0 109.963 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 181' ' ' SER . 25.3 p -155.35 -171.71 3.9 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.237 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -97.98 -35.7 10.37 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.166 0.508 . . . . 0.0 109.871 176.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.383 -1.232 . . . . 0.0 111.468 176.487 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.822 0.344 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -158.1 105.59 1.95 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.396 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 93.7 mttt 55.87 54.32 8.25 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.467 0.479 . . . . 0.0 110.65 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.3 m -72.33 -14.97 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -171.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -73.53 99.85 3.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.268 0.556 . . . . 0.0 110.335 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.639 ' CB ' ' HB2' ' A' ' 183' ' ' PHE . . . -66.04 148.48 98.35 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.67 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.432 ' HD3' ' HA2' ' A' ' 186' ' ' GLY . 18.5 Cg_endo -58.4 96.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.225 2.616 . . . . 0.0 112.918 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.76 105.73 9.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.969 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.439 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 6.2 tmm_? -129.68 128.08 22.98 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.511 -175.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.556 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 10.9 Cg_endo -56.61 118.23 5.04 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.549 2.833 . . . . 0.0 112.935 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.02 -21.04 6.61 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.13 153.5 26.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.862 0.363 . . . . 0.0 110.327 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.5 mm -86.63 135.01 26.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.73 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -75.82 109.62 8.58 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.614 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -76.33 -38.12 1.18 Allowed 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 123.125 2.55 . . . . 0.0 113.308 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.5 mt -116.93 167.54 11.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.193 0.52 . . . . 0.0 111.683 -171.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.0 m -87.94 79.17 8.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.823 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 30.4 t -69.1 134.28 30.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.564 -177.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 43.2 t -123.83 131.52 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.332 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.485 HG22 HG13 ' A' ' 154' ' ' ILE . 88.0 mt -90.36 101.86 4.21 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 122' ' ' VAL . 29.8 Cg_exo -61.81 141.93 91.88 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.506 2.804 . . . . 0.0 114.172 -170.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.5 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -71.78 84.67 0.92 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.903 -1.499 . . . . 0.0 112.53 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.528 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 7.6 p80 -175.52 179.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -57.13 135.89 56.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.0 0.429 . . . . 0.0 110.654 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.6 p -94.57 -4.84 47.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.215 0.531 . . . . 0.0 110.717 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.49 2.49 89.61 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.434 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.2 mt -93.82 150.76 20.1 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.469 -0.365 . . . . 0.0 110.315 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.41 162.61 54.25 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.465 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 150' ' ' GLY . 52.1 Cg_exo -53.54 -28.43 45.38 Favored 'Trans proline' 0 C--O 1.225 -0.173 0 C-N-CA 123.074 2.516 . . . . 0.0 112.909 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -55.31 -33.01 62.91 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.511 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 68.4 mmtt -71.57 -7.85 50.29 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.225 0.536 . . . . 0.0 110.976 -174.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 4.4 t -65.95 -21.91 66.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.993 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.7 t -63.67 -39.12 93.54 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -73.09 -42.82 62.59 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.359 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.548 ' CE2' HD11 ' A' ' 178' ' ' LEU . 71.9 m-85 -59.41 -49.37 78.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.43 0.633 . . . . 0.0 109.406 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -66.5 -28.94 68.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.304 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.05 -39.78 93.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.974 0.416 . . . . 0.0 110.125 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.78 23.55 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.149 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 40.0 m 58.65 50.4 9.0 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.996 174.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.479 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 35.5 mt -105.72 133.32 20.25 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.629 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 6.7 Cg_exo -71.96 119.18 6.02 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.997 2.465 . . . . 0.0 110.845 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.407 HG22 HD11 ' A' ' 152' ' ' ILE . 38.2 p -127.46 148.96 50.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -169.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.566 ' HD3' HG21 ' A' ' 155' ' ' ILE . 11.5 mtpp -149.64 139.89 22.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.76 174.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 50.4 mm -81.48 121.73 35.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.067 0.461 . . . . 0.0 110.747 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 14.2 t -76.85 -66.17 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.232 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -158.51 81.76 0.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.462 0.648 . . . . 0.0 110.229 174.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' A' ' 132' ' ' PRO . . . 69.26 17.22 71.99 Favored Glycine 0 CA--C 1.511 -0.185 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -173.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.6 p -139.18 149.91 44.97 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.471 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -90.75 125.7 43.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.339 0.59 . . . . 0.0 109.624 179.12 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.528 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 26.0 tt0 -116.03 148.83 39.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.687 0.756 . . . . 0.0 111.065 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.536 HD11 ' CE2' ' A' ' 138' ' ' PHE . 38.6 mm -92.37 132.28 37.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.155 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.566 HG21 ' HD3' ' A' ' 146' ' ' LYS . 32.4 pt -97.51 -37.38 6.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.874 0.368 . . . . 0.0 111.772 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -119.78 127.83 53.16 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -53.76 116.68 2.64 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.345 0.403 . . . . 0.0 110.116 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.7 t -88.43 129.69 39.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -172.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -83.44 72.94 10.22 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.558 HG21 HD21 ' A' ' 175' ' ' LEU . 6.6 tp -66.55 -54.67 23.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.596 -171.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.403 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 16.1 mt -108.26 151.76 25.53 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.335 0.588 . . . . 0.0 111.081 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 9.5 mptt -130.37 133.24 24.66 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.034 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 76.6 Cg_exo -51.32 103.81 0.08 OUTLIER 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.01 2.473 . . . . 0.0 112.38 176.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.99 -13.11 10.59 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.14 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -81.73 -179.86 7.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -128.11 117.04 20.9 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 21.5 t -52.51 122.44 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.248 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -82.6 -179.41 52.74 Favored Glycine 0 C--O 1.228 -0.257 0 CA-C-N 116.027 -0.533 . . . . 0.0 113.107 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.556 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -70.11 -70.33 0.3 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.759 0.314 . . . . 0.0 111.37 -177.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 41.0 m -67.72 -21.25 65.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.054 0.454 . . . . 0.0 110.132 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -66.56 -46.26 76.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.661 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.461 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -63.08 -44.65 95.16 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.192 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.582 ' O ' ' HG3' ' A' ' 177' ' ' MET . 14.9 m -54.93 -47.14 74.81 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.087 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.686 ' O ' HD22 ' A' ' 178' ' ' LEU . 37.3 tp -54.98 -60.96 2.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.626 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.558 HD21 HG21 ' A' ' 160' ' ' ILE . 73.1 mt -59.26 -26.74 65.18 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.553 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -70.04 -42.47 72.87 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.582 ' HG3' ' O ' ' A' ' 173' ' ' THR . 55.5 mtm -68.14 -32.17 72.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.11 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.686 HD22 ' O ' ' A' ' 174' ' ' LEU . 0.1 OUTLIER -68.9 -21.27 64.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.885 176.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 4.6 t30 65.59 26.17 11.62 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.534 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.432 HG13 ' HB3' ' A' ' 178' ' ' LEU . 84.6 mt -96.27 139.38 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.246 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 10.9 t -88.73 114.79 61.35 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.272 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.493 ' HG2' ' CD2' ' A' ' 183' ' ' PHE . 64.6 Cg_endo -83.88 -10.73 9.25 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.338 2.025 . . . . 0.0 112.545 175.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.639 ' HB2' ' CB ' ' A' ' 109' ' ' ALA . 71.7 m-85 -120.9 -125.15 0.27 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 31.4 m -108.12 -73.39 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.488 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -148.4 168.62 22.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.512 0.196 . . . . 0.0 110.527 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.432 ' HA2' ' HD3' ' A' ' 110' ' ' PRO . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.707 -1.052 . . . . 0.0 112.226 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.727 ' SD ' ' HD3' ' A' ' 110' ' ' PRO . 3.3 mpp? . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.504 0.192 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -163.33 -60.6 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.599 ' HG3' ' H ' ' A' ' 107' ' ' VAL . 14.5 ptpt -111.29 -72.25 0.73 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.372 175.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.599 ' H ' ' HG3' ' A' ' 106' ' ' LYS . 1.1 m -160.87 46.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 O-C-N 123.309 0.381 . . . . 0.0 111.002 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 181' ' ' SER . 51.0 tt0 -141.33 119.83 12.38 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.929 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.511 ' CB ' ' HB2' ' A' ' 183' ' ' PHE . . . -88.75 160.79 43.4 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.505 174.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.727 ' HD3' ' SD ' ' A' ' 104' ' ' MET . 45.1 Cg_endo -68.43 93.84 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.378 2.052 . . . . 0.0 112.799 -175.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.64 108.27 10.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.269 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.451 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 5.9 tmm_? -129.76 127.2 22.84 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.303 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.501 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 9.9 Cg_endo -53.85 116.27 2.9 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.525 2.817 . . . . 0.0 112.597 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.2 -26.28 4.2 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.44 152.34 34.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.845 0.355 . . . . 0.0 110.646 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.2 mm -87.09 130.8 36.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.391 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -69.64 110.2 6.02 Favored Pre-proline 0 C--N 1.328 -0.345 0 O-C-N 123.589 0.556 . . . . 0.0 110.899 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.571 ' HB2' HD22 ' A' ' 119' ' ' LEU . 4.2 Cg_exo -79.83 -28.82 3.08 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 123.27 2.647 . . . . 0.0 113.62 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.571 HD22 ' HB2' ' A' ' 118' ' ' PRO . 2.4 mm? -116.43 160.25 20.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.153 0.501 . . . . 0.0 111.727 -174.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.2 m -84.57 71.24 10.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.599 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 21.9 t -64.73 136.49 26.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.022 -175.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 45.1 t -124.27 130.88 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.837 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' A' ' 158' ' ' VAL . 75.2 mt -88.48 107.01 14.38 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.504 ' HB2' ' CD2' ' A' ' 126' ' ' HIS . 24.3 Cg_exo -63.15 140.25 76.99 Favored 'Trans proline' 0 CA--C 1.518 -0.313 0 C-N-CA 122.935 2.424 . . . . 0.0 112.95 -174.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.78 83.15 2.74 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.168 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.53 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 32.1 p80 -166.88 169.92 12.72 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -55.85 135.54 51.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.139 0.495 . . . . 0.0 110.746 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.0 p -95.68 -2.6 47.7 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.286 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 73.5 6.44 70.75 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.715 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.525 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 96.3 mt -92.34 156.04 17.51 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.617 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.63 151.97 45.95 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.17 -27.63 66.65 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.846 -174.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.64 -25.14 66.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.214 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.538 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 74.3 mmtt -67.01 -9.81 42.95 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.063 0.459 . . . . 0.0 111.095 -177.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.483 ' HB ' HG13 ' A' ' 152' ' ' ILE . 12.9 t -65.56 -20.91 66.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.905 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.1 t -65.09 -36.22 83.62 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.412 ' O ' ' HB3' ' A' ' 140' ' ' ALA . 54.2 m-85 -75.0 -44.34 48.69 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.327 177.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.629 ' CE1' HD11 ' A' ' 154' ' ' ILE . 85.0 m-85 -59.58 -49.44 77.76 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -64.48 -30.9 71.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.837 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 137' ' ' PHE . . . -58.84 -39.93 82.7 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.955 0.407 . . . . 0.0 110.195 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 141' ' ' LEU . 4.0 mm? -93.13 26.15 2.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.381 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.2 m 58.59 41.08 22.86 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.066 174.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.455 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 27.8 mt -97.3 133.35 23.99 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.796 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 4.7 Cg_exo -73.06 107.15 2.3 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.977 2.451 . . . . 0.0 111.106 174.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.473 HG21 ' CB ' ' A' ' 138' ' ' PHE . 43.1 p -124.78 171.51 10.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.249 0.547 . . . . 0.0 112.445 -173.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.489 ' HE3' HG22 ' A' ' 155' ' ' ILE . 21.4 pttp -165.36 163.8 19.81 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.747 173.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 41.0 mm -101.56 125.69 55.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.7 m -73.46 -44.69 57.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.565 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.543 ' HA ' ' HE3' ' A' ' 149' ' ' LYS . 0.1 OUTLIER -163.3 -58.73 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.686 178.082 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -136.43 4.86 3.77 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.018 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.1 p -129.74 149.93 51.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -85.25 130.36 36.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.268 0.556 . . . . 0.0 110.041 -178.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.552 ' N ' HD13 ' A' ' 152' ' ' ILE . 30.0 tt0 -120.19 149.82 41.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.157 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.629 HD11 ' CE1' ' A' ' 138' ' ' PHE . 2.9 mp -97.64 136.98 26.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.898 176.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.489 HG22 ' HE3' ' A' ' 146' ' ' LYS . 13.4 pt -95.62 -35.27 5.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.003 0.43 . . . . 0.0 111.893 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -122.46 125.23 45.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.108 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -51.8 123.14 9.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.313 0.578 . . . . 0.0 110.523 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 12.0 t -95.94 130.04 45.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.401 -168.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.457 ' O ' ' HE3' ' A' ' 162' ' ' LYS . 37.7 m80 -79.15 71.33 5.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 168.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.0 tp -63.25 -49.42 83.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.223 -173.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.431 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 13.8 mt -112.3 156.19 22.83 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.303 0.573 . . . . 0.0 111.176 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 7.7 mptt -132.46 132.22 22.68 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.631 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 10.7 Cg_endo -55.86 96.01 0.05 OUTLIER 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.766 2.311 . . . . 0.0 112.024 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 129.71 -13.41 5.85 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.95 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -84.46 153.93 23.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -97.5 107.59 20.13 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 54.8 t -46.72 124.5 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 O-C-N 123.861 0.725 . . . . 0.0 111.945 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.75 -179.29 50.21 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.207 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.501 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -70.84 -68.33 0.44 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.773 0.32 . . . . 0.0 111.598 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.8 m -61.82 -25.05 67.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.355 0.598 . . . . 0.0 109.679 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -69.73 -48.75 58.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.354 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.446 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -60.47 -44.19 96.16 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.246 176.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.654 ' O ' ' HG3' ' A' ' 177' ' ' MET . 27.0 m -59.76 -40.93 89.82 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.544 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.506 HD11 ' CE1' ' A' ' 138' ' ' PHE . 36.5 tp -60.32 -49.08 79.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.823 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 83.3 mt -64.63 -30.22 71.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.906 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -70.05 -42.73 72.49 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.329 0.585 . . . . 0.0 109.616 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.654 ' HG3' ' O ' ' A' ' 173' ' ' THR . 60.3 mtm -71.11 -28.56 64.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.425 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.508 HD21 ' CZ ' ' A' ' 138' ' ' PHE . 0.9 OUTLIER -78.97 -15.3 58.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.654 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 64.3 32.94 11.89 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 123.958 0.786 . . . . 0.0 109.74 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 81.4 mt -107.21 131.43 57.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.019 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.418 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 22.8 t -86.02 120.73 72.77 Favored Pre-proline 0 N--CA 1.447 -0.589 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.236 -177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.485 ' O ' ' HD2' ' A' ' 118' ' ' PRO . 72.2 Cg_endo -87.77 -0.83 7.3 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.594 2.196 . . . . 0.0 112.666 174.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.511 ' HB2' ' CB ' ' A' ' 109' ' ' ALA . 92.4 m-85 -130.3 -89.39 0.48 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.651 0.262 . . . . 0.0 111.008 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.442 ' H ' ' HB2' ' A' ' 109' ' ' ALA . 17.3 m -112.66 126.27 55.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.0 0.428 . . . . 0.0 111.145 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -83.14 102.88 12.14 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.319 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.335 0 CA-C-O 118.917 -0.935 . . . . 0.0 111.718 179.616 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -131.05 82.07 2.03 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 55.03 76.52 0.25 Allowed 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.737 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 185' ' ' TYR . 27.1 m -76.33 -10.99 13.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.482 -173.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.499 ' NE2' ' HA ' ' A' ' 176' ' ' ASN . 60.3 tt0 -80.47 106.67 12.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.035 0.445 . . . . 0.0 110.964 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.78 147.14 98.61 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.56 171.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.65 106.51 0.2 Allowed 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 123.039 2.493 . . . . 0.0 112.569 -177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -74.46 105.56 5.66 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.944 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -130.38 127.66 22.5 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.614 -174.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.44 ' HD3' ' CB ' ' A' ' 172' ' ' ALA . 26.0 Cg_endo -62.92 143.01 90.53 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.323 2.682 . . . . 0.0 112.552 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.419 ' HA2' ' HE2' ' A' ' 166' ' ' LYS . . . 111.98 -12.86 26.84 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.061 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.0 153.08 17.96 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.711 0.291 . . . . 0.0 110.571 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.7 mm -85.58 126.94 40.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.097 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.581 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -60.6 110.27 2.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 123.845 0.716 . . . . 0.0 111.387 -177.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -74.38 -46.69 0.27 Allowed 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 123.146 2.564 . . . . 0.0 112.578 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 91.0 mt -106.88 159.96 15.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.217 -173.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.8 t -85.02 75.72 10.35 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 182' ' ' PRO . 25.9 t -63.88 134.98 28.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.359 -1.291 . . . . 0.0 110.671 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 46.5 t -125.1 129.04 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.519 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.494 HG22 HG13 ' A' ' 154' ' ' ILE . 75.8 mt -86.51 101.31 1.92 Allowed Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 7.4 Cg_exo -71.18 137.18 30.86 Favored 'Trans proline' 0 CA--C 1.514 -0.484 0 C-N-CA 123.118 2.546 . . . . 0.0 114.318 -168.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.33 92.79 3.37 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.841 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -158.78 -50.53 0.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.238 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 173.57 150.19 0.07 Allowed 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.432 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 71.0 p -110.54 -30.22 7.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.085 0.469 . . . . 0.0 110.639 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.81 2.85 88.43 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.49 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 94.4 mt -96.49 155.22 16.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.047 0.451 . . . . 0.0 110.789 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.89 174.3 54.88 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.567 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.452 ' O ' HG22 ' A' ' 135' ' ' THR . 20.6 Cg_exo -65.34 -19.14 61.77 Favored 'Trans proline' 0 N--CA 1.466 -0.144 0 C-N-CA 122.877 2.385 . . . . 0.0 112.966 -173.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.65 -27.87 66.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.957 0.408 . . . . 0.0 111.071 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.522 ' HD2' ' SD ' ' A' ' 177' ' ' MET . 34.4 mmtp -73.32 -6.82 48.54 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.057 0.456 . . . . 0.0 111.44 -175.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 132' ' ' PRO . 6.1 t -66.47 -20.49 66.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.865 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.1 t -62.32 -42.2 99.18 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -70.52 -46.4 63.71 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.308 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.57 ' CE2' HD21 ' A' ' 178' ' ' LEU . 74.4 m-85 -58.63 -47.33 84.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.301 0.572 . . . . 0.0 109.547 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -68.75 -25.64 64.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.436 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.31 -33.18 75.16 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.162 0.506 . . . . 0.0 109.945 176.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -98.78 26.35 5.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.073 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.9 t 55.69 55.16 7.43 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.687 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.521 HG23 HG21 ' A' ' 158' ' ' VAL . 39.8 mt -112.6 135.54 21.52 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.037 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 2.8 Cg_exo -74.38 117.42 4.97 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.008 2.472 . . . . 0.0 111.079 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.492 ' CG2' HD11 ' A' ' 152' ' ' ILE . 40.7 p -131.43 148.62 52.67 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.802 -172.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.467 ' HE2' HG21 ' A' ' 155' ' ' ILE . 41.9 mtmt -138.74 137.67 36.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.087 174.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 48.1 mm -83.63 109.18 16.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.1 p -74.86 -72.34 0.3 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.025 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -145.19 80.16 1.6 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.949 0.404 . . . . 0.0 110.153 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.57 -0.09 56.93 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.35 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.7 p -128.22 150.24 50.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.514 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -90.51 124.35 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.208 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.472 ' N ' HD13 ' A' ' 152' ' ' ILE . 33.8 tt0 -116.97 154.56 30.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.365 0.603 . . . . 0.0 110.508 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.501 HD11 ' CE2' ' A' ' 138' ' ' PHE . 48.2 mm -96.14 131.07 43.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.424 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.467 HG21 ' HE2' ' A' ' 146' ' ' LYS . 13.5 pt -94.49 -37.81 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.008 0.432 . . . . 0.0 111.714 -175.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -121.13 128.55 52.65 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -60.16 126.2 26.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.312 0.577 . . . . 0.0 109.475 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 20.8 t -99.92 128.62 51.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.402 -169.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -75.48 73.44 2.52 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 167.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.469 HG21 HD21 ' A' ' 175' ' ' LEU . 5.8 tp -64.93 -42.58 95.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.826 -175.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 15.6 mt -118.46 155.15 31.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.191 0.52 . . . . 0.0 110.176 175.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -149.4 130.87 7.36 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.409 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 81.2 Cg_exo -44.87 106.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.566 2.844 . . . . 0.0 112.835 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 127.96 -22.59 5.4 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.237 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -85.66 153.7 22.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.653 0.264 . . . . 0.0 110.374 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.419 ' HE2' ' HA2' ' A' ' 114' ' ' GLY . 82.8 tttt -102.09 111.86 24.29 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 56.4 t -49.14 123.41 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.5 0 O-C-N 123.955 0.784 . . . . 0.0 111.858 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.32 177.42 51.7 Favored Glycine 0 CA--C 1.519 0.291 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.094 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.94 -65.88 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.915 0.388 . . . . 0.0 111.774 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 49.8 m -65.55 -24.15 67.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.201 0.524 . . . . 0.0 109.829 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.1 -50.2 62.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.016 177.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.44 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -60.94 -39.67 90.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.309 175.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.554 ' O ' ' HG3' ' A' ' 177' ' ' MET . 49.9 m -60.23 -44.08 95.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.549 177.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.506 HD11 ' CE2' ' A' ' 138' ' ' PHE . 48.2 tp -60.34 -49.88 75.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.386 177.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.469 HD21 HG21 ' A' ' 160' ' ' ILE . 87.4 mt -61.82 -30.24 70.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.368 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.499 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 62.1 t30 -72.11 -42.81 65.66 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' A' ' 173' ' ' THR . 63.2 mtm -67.07 -32.91 74.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.703 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.57 HD21 ' CE2' ' A' ' 138' ' ' PHE . 2.7 mm? -72.96 -11.93 60.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.732 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 61.28 31.84 19.35 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.528 0.68 . . . . 0.0 109.8 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.538 ' O ' ' HD3' ' A' ' 182' ' ' PRO . 78.2 mt -104.4 141.45 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.506 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.2 m -84.19 107.4 10.67 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.842 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 180' ' ' ILE . 95.7 Cg_endo -92.0 -3.74 3.97 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.196 1.93 . . . . 0.0 113.286 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.424 ' CD1' ' HG2' ' A' ' 182' ' ' PRO . 94.2 m-85 -132.2 -73.39 0.52 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.916 0.389 . . . . 0.0 111.405 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 26.6 t -129.21 174.66 9.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.045 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.61 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 90.1 m-85 -110.27 -171.15 1.78 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.498 ' N ' ' HA ' ' A' ' 107' ' ' VAL . . . . . . . . 0 C--O 1.248 1.012 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.595 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 5.0 mpp? . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.389 0.138 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -179.39 161.9 1.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -176.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.499 ' HE3' ' OXT' ' A' ' 186' ' ' GLY . 56.2 pttt 38.48 59.28 1.52 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.868 0.867 . . . . 0.0 111.982 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.669 HG23 HD21 ' A' ' 179' ' ' ASN . 15.9 m -65.82 -28.37 43.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.148 -175.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.63 ' OE1' ' HA ' ' A' ' 179' ' ' ASN . 52.3 tp60 -90.69 92.95 9.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.164 0.507 . . . . 0.0 111.226 -176.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.81 144.14 81.54 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.017 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.36 92.57 0.07 OUTLIER 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.113 2.542 . . . . 0.0 112.894 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.08 107.07 10.38 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -129.2 128.86 23.3 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.004 -173.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 167' ' ' VAL . 10.1 Cg_endo -54.59 126.19 21.53 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.496 2.797 . . . . 0.0 112.653 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 116.5 -23.6 10.25 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.695 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.8 140.25 38.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.81 131.5 34.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.675 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -65.09 110.27 4.01 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.814 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 117' ' ' ALA . 11.6 Cg_exo -72.93 -37.79 3.38 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.942 2.428 . . . . 0.0 112.637 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.9 mt -119.46 160.02 23.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.331 -173.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.416 ' CA ' ' HD3' ' A' ' 163' ' ' PRO . 10.3 t -86.32 77.03 9.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.801 0.81 . . . . 0.0 108.949 175.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.81 134.75 29.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.759 -176.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 59.3 t -125.71 121.66 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.38 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.544 HG22 HG13 ' A' ' 154' ' ' ILE . 47.8 mt -79.23 106.38 4.45 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.453 ' HB2' ' CE1' ' A' ' 126' ' ' HIS . 16.2 Cg_exo -66.3 145.48 78.02 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.995 2.463 . . . . 0.0 113.461 -170.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.463 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -73.01 82.39 1.23 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.335 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.48 ' C ' ' HG3' ' A' ' 153' ' ' GLU . 1.6 p-80 -174.72 179.32 1.71 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.415 175.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -55.61 135.75 50.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.988 0.423 . . . . 0.0 110.595 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.7 p -96.38 -2.41 45.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.008 0.432 . . . . 0.0 111.425 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 76.69 19.98 77.09 Favored Glycine 0 N--CA 1.453 -0.208 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.6 mt -116.08 147.97 40.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.315 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.55 168.27 54.58 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.897 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.419 ' O ' HG22 ' A' ' 135' ' ' THR . 15.4 Cg_exo -70.05 14.53 0.27 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 123.349 2.7 . . . . 0.0 113.637 -175.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -90.41 -31.64 16.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.437 0.637 . . . . 0.0 109.769 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.53 ' HD2' ' HE1' ' A' ' 177' ' ' MET . 47.3 mmtm -72.88 -11.04 60.44 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.823 -175.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 132' ' ' PRO . 15.3 t -64.8 -22.5 67.0 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.634 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.0 p -63.43 -37.26 86.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.001 0.429 . . . . 0.0 109.937 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -76.02 -42.43 47.99 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.22 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.626 ' CE2' HD11 ' A' ' 174' ' ' LEU . 76.2 m-85 -59.12 -51.03 71.78 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 121.448 0.642 . . . . 0.0 109.391 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -65.91 -30.38 70.96 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.244 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.18 98.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.477 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 141' ' ' LEU . 4.1 mm? -86.33 23.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.948 177.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.3 m 56.24 50.16 13.93 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.533 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.474 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 23.4 mt -104.25 131.23 22.11 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.688 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 2.7 Cg_exo -73.93 112.18 3.48 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.883 2.389 . . . . 0.0 111.059 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 55.8 p -127.59 162.41 26.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.122 0.487 . . . . 0.0 111.974 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.535 ' HE2' HG22 ' A' ' 155' ' ' ILE . 60.9 pttt -150.85 148.69 28.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.124 172.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 45.0 mm -88.81 115.14 28.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.014 0.435 . . . . 0.0 109.997 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 35.2 t -80.13 -80.78 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.026 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -127.23 65.49 1.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.882 0.372 . . . . 0.0 110.07 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 70.43 15.82 73.14 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -174.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.8 p -136.19 150.77 49.16 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.48 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -84.88 128.46 38.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.197 0.522 . . . . 0.0 110.457 -178.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.48 ' HG3' ' C ' ' A' ' 126' ' ' HIS . 20.0 tt0 -118.3 148.04 42.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.589 0.709 . . . . 0.0 110.963 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.544 HG13 HG22 ' A' ' 123' ' ' ILE . 41.7 mm -93.13 138.02 21.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.297 177.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.535 HG22 ' HE2' ' A' ' 146' ' ' LYS . 16.5 pt -100.93 -37.72 5.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.599 -0.44 . . . . 0.0 112.161 -176.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -121.04 139.61 53.06 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -56.41 111.13 0.9 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.377 0.608 . . . . 0.0 110.665 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.495 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 16.6 t -85.72 128.55 39.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.079 -175.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -91.72 72.39 5.81 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.1 tp -66.83 -42.74 89.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.755 -170.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 161' ' ' LEU . 13.3 mt -119.04 140.79 49.45 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.63 0.728 . . . . 0.0 111.803 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.97 127.02 27.01 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.302 174.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 9.4 Cg_endo -54.33 100.2 0.06 OUTLIER 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.501 2.134 . . . . 0.0 111.622 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 127.22 -16.13 6.38 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.289 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -78.4 175.61 10.13 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -119.69 109.82 16.09 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 42.1 t -51.4 125.64 5.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 123.881 0.738 . . . . 0.0 111.367 -176.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.28 -177.6 51.9 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.996 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.08 -65.2 0.87 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.81 0.338 . . . . 0.0 111.9 -175.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 51.0 m -65.1 -24.51 67.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -67.35 -48.67 66.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.094 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.429 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -58.58 -46.37 87.07 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.277 0.56 . . . . 0.0 110.193 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 21.3 m -58.11 -38.99 77.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.699 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.626 HD11 ' CE2' ' A' ' 138' ' ' PHE . 25.8 tp -68.24 -42.42 79.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.209 0.528 . . . . 0.0 110.937 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.6 mt -70.19 -17.48 63.16 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.95 0.405 . . . . 0.0 110.605 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.439 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 8.5 t30 -81.08 -47.84 12.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.184 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.53 ' HE1' ' HD2' ' A' ' 134' ' ' LYS . 20.6 ptp -64.99 -33.42 75.99 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.229 0.538 . . . . 0.0 110.67 177.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.448 ' HB3' ' HB ' ' A' ' 180' ' ' ILE . 0.3 OUTLIER -65.78 -32.21 73.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.946 178.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . 0.669 HD21 HG23 ' A' ' 107' ' ' VAL . 2.5 t-20 56.88 42.5 26.33 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.896 0.855 . . . . 0.0 108.797 -173.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 178' ' ' LEU . 16.2 tt -94.76 -7.53 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.254 -171.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.0 m 60.21 72.47 0.74 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.565 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.93 -7.07 18.06 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.25 1.967 . . . . 0.0 113.282 -176.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -123.14 -63.15 1.28 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.107 0.48 . . . . 0.0 110.053 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 25.6 t -138.97 153.61 48.2 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.331 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -110.0 14.7 22.93 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.142 0.496 . . . . 0.0 110.219 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.499 ' OXT' ' HE3' ' A' ' 106' ' ' LYS . . . . . . . . 0 C--O 1.25 1.136 0 CA-C-O 118.181 -1.344 . . . . 0.0 111.114 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 74.4 mtm . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -127.96 106.94 9.43 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.481 -171.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 54.51 34.37 20.95 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 123.559 0.537 . . . . 0.0 110.675 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.414 ' HA ' ' HB2' ' A' ' 185' ' ' TYR . 59.1 t -71.99 -27.55 27.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.114 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -59.29 111.16 1.26 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.718 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.533 ' CB ' ' HB2' ' A' ' 183' ' ' PHE . . . -76.51 149.21 81.06 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.65 173.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.88 96.4 0.09 OUTLIER 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.782 2.321 . . . . 0.0 112.615 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -74.3 102.54 4.39 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -121.29 125.55 26.87 Favored Pre-proline 0 C--N 1.314 -0.942 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.785 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 169' ' ' ALA . 9.5 Cg_endo -53.87 118.54 5.06 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.574 2.849 . . . . 0.0 112.481 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.45 -17.67 11.22 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.645 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.27 150.48 28.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.911 0.386 . . . . 0.0 110.28 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.3 mm -86.11 135.61 24.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.394 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 163' ' ' PRO . . . -73.71 109.34 6.44 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.738 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -78.88 -36.62 0.73 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.255 2.636 . . . . 0.0 113.421 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.5 mt -114.66 159.74 20.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.18 0.514 . . . . 0.0 111.654 -172.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.5 m -81.78 71.57 8.8 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.284 173.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 161' ' ' LEU . 19.7 t -66.67 129.59 31.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.362 -177.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 158' ' ' VAL . 47.8 t -123.21 122.54 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.441 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.406 HG22 HG13 ' A' ' 154' ' ' ILE . 56.9 mt -80.6 106.21 4.96 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.91 142.15 80.75 Favored 'Trans proline' 0 CA--C 1.511 -0.67 0 C-N-CA 123.209 2.606 . . . . 0.0 113.952 -170.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.444 ' HA ' ' HB ' ' A' ' 154' ' ' ILE . . . -68.56 83.52 0.27 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.301 175.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -172.94 157.55 3.6 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -170.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.15 130.58 43.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.057 0.456 . . . . 0.0 110.969 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 37.2 p -84.89 -9.49 58.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.063 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.46 -0.61 87.64 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.571 -177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.427 ' HB3' ' HG3' ' A' ' 134' ' ' LYS . 90.3 mt -86.3 154.19 21.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.773 0.321 . . . . 0.0 110.471 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.9 168.67 54.07 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.987 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.465 ' O ' HG22 ' A' ' 135' ' ' THR . 17.0 Cg_exo -67.46 -3.1 9.47 Favored 'Trans proline' 0 CA--C 1.527 0.138 0 C-N-CA 123.198 2.599 . . . . 0.0 113.119 -174.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -78.8 -32.32 46.32 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.17 0.51 . . . . 0.0 110.548 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.496 ' HD2' ' HE1' ' A' ' 177' ' ' MET . 48.0 mmtm -69.79 -11.38 60.81 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.472 -174.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 132' ' ' PRO . 6.8 t -66.38 -17.97 65.08 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.029 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.0 t -62.16 -42.25 99.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -75.0 -40.86 60.42 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.233 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.585 ' CE1' HD11 ' A' ' 174' ' ' LEU . 71.3 m-85 -59.81 -50.66 72.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.225 0.536 . . . . 0.0 109.688 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -65.05 -30.62 71.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.221 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.29 93.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.876 0.369 . . . . 0.0 110.578 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.403 ' HA ' HD13 ' A' ' 141' ' ' LEU . 4.1 mm? -91.38 31.41 1.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.709 175.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.0 p 52.2 49.62 20.19 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.88 0.872 . . . . 0.0 112.574 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.477 HG23 HG21 ' A' ' 158' ' ' VAL . 24.9 mt -108.55 131.16 21.95 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 143' ' ' ILE . 3.5 Cg_exo -76.6 114.63 3.9 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.072 2.515 . . . . 0.0 111.339 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 82.3 p -129.25 162.65 27.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.978 0.418 . . . . 0.0 111.427 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.452 ' HE3' HG22 ' A' ' 155' ' ' ILE . 22.6 pttp -151.89 142.99 23.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.641 171.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 44.5 mm -81.28 119.44 30.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.891 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.2 t -68.12 -36.09 79.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.135 -178.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -173.96 -66.31 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.424 ' O ' ' HD3' ' A' ' 132' ' ' PRO . . . -128.91 6.62 6.47 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 173.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 22.7 p -128.42 152.12 48.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.87 0.367 . . . . 0.0 110.296 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.472 HD13 ' C ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -86.64 130.79 36.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.222 179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -117.79 153.23 33.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.307 0.575 . . . . 0.0 110.716 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.491 HD11 ' CE1' ' A' ' 138' ' ' PHE . 29.1 mm -98.04 130.81 46.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.259 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.482 HG13 HD22 ' A' ' 156' ' ' ASN . 25.3 pt -93.14 -35.8 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.918 0.39 . . . . 0.0 111.885 -176.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.482 HD22 HG13 ' A' ' 155' ' ' ILE . 43.4 m-80 -123.83 136.88 54.66 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.343 177.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -61.09 118.59 6.98 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.461 0.475 . . . . 0.0 109.774 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 21.3 t -92.91 128.77 44.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.09 -172.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -78.45 67.98 4.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 170.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.403 HG23 ' N ' ' A' ' 161' ' ' LEU . 7.1 tp -61.19 -51.46 72.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.875 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.438 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 14.8 mt -114.77 159.87 20.09 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.287 0.565 . . . . 0.0 110.059 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.544 ' HD2' ' N ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -153.49 132.36 6.85 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.94 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 117' ' ' ALA . 4.2 Cg_endo -48.26 110.59 0.34 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.596 2.864 . . . . 0.0 112.706 -176.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.09 -19.09 8.84 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.304 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -79.84 174.9 11.12 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -125.85 107.2 10.27 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -176.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 113' ' ' PRO . 34.3 t -51.89 122.66 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 O-C-N 123.857 0.723 . . . . 0.0 111.44 -176.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.83 -175.63 46.87 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.794 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 113' ' ' PRO . . . -71.39 -65.02 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 111.886 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.8 m -62.07 -29.31 70.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.476 0.655 . . . . 0.0 109.615 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -67.51 -48.31 67.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.083 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.427 ' CB ' ' HD3' ' A' ' 113' ' ' PRO . . . -59.54 -39.14 83.02 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.241 0.543 . . . . 0.0 110.451 175.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 26.5 m -61.26 -41.29 96.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.528 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.585 HD11 ' CE1' ' A' ' 138' ' ' PHE . 28.6 tp -67.88 -42.16 81.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.896 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.2 mt -69.02 -20.95 64.15 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.845 0.355 . . . . 0.0 110.648 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -78.51 -46.97 18.31 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.141 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.514 ' HG2' ' HA ' ' A' ' 174' ' ' LEU . 22.1 ptp -66.19 -24.18 66.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.51 0.671 . . . . 0.0 110.342 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.502 ' HB3' ' HB ' ' A' ' 180' ' ' ILE . 0.3 OUTLIER -78.11 -29.56 48.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.289 179.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 57.91 34.3 24.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 122.026 0.917 . . . . 0.0 108.727 -174.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 178' ' ' LEU . 17.7 tt -86.48 -12.47 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.646 -169.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 18.8 t 59.37 82.34 0.23 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.207 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.42 -7.08 19.85 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.405 2.07 . . . . 0.0 113.162 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.533 ' HB2' ' CB ' ' A' ' 109' ' ' ALA . 82.5 m-85 -119.95 -96.93 0.47 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.607 0.241 . . . . 0.0 110.756 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 27.2 t -162.02 149.3 14.12 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.766 0.317 . . . . 0.0 110.688 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.414 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 42.5 t80 -72.12 -51.48 21.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.625 0.726 . . . . 0.0 109.124 171.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.12 0 CA-C-O 118.371 -1.239 . . . . 0.0 110.95 178.54 . . . . . . . . 0 0 . 1 stop_ save_